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0ABSTRACT 
 The Petasis borono-Mannich reaction is a multicomponent condensation reaction 
of amines, carbonyl compounds, and boronic acids or esters to generate valuable building 
blocks for synthesis. Asymmetric Petasis reactions have been achieved using ligand 
exchange between boronic esters and chiral biphenol catalysts, providing access to 
optically enriched products including chiral homoallylic amines, allenes and 1,4-dienes.  
An asymmetric Petasis allylation reaction has been developed for the expedient, 
modular synthesis of enantioenriched homoallylic amines. The reaction conditions tolerate 
aldehydes and amines possessing electronic and steric properties unaccessible to this point, 
notably including challenging aliphatic substrates. This method was used in a 
diastereoselective Petasis crotylation, providing access to both syn- and anti- products in 
good yields and with excellent selectivities. 
A new chiral biphenol catalyst was designed and synthesized in order to promote 
an asymmetric traceless Petasis reaction with sulfonyl hydrazides, glycolaldehyde and 
alkynyl boronates. The transient propargylic hydrazide underwent retro-ene rearrangement, 
resulting in a stereospecific point-to-axial chirality transfer generating the enantio-enriched 
vii 
 
allene products. A complementary methodology was devised by employing sulfonyl 
hydrazides, alkynyl aldehydes and allylboronate, providing allyl allenes in excellent yields 
and enantioselectivities. The synthetic utility of the method was demonstrated by the total 
synthesis of laballenic acid, a natural product isolated from the seed oil of Leonotis 
nepetaefolia. 
The enantioselective traceless Petasis reaction was also used in the synthesis of 
enantioenriched 1,4-dienes. The use of prochiral β-branched enals in the asymmetric 
Petasis allylation followed by sigmatropic rearrangement installed an sp3 stereocenter at 
the benzylic position, affording 1,4-dienes enantioselectively and with exclusive (E)-
geometry. Asymmetric traceless Petasis crotylations were also used in the reaction with 
non-branched enals, affording enantioenriched products possessing the 3-methyl-1,4-diene 
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0CHAPTER ONE  
1Petasis Borono-Mannich Reactions 
Introduction 
The Petasis borono-Mannich reaction is a multicomponent condensation of amines, 
carbonyl compounds, and organoboron nucleophiles (Figure 1.1).1-2 The reaction was first 
reported by Nicos Petasis in 1993.3 Vinyl boronic acids reacted with the adducts of 
secondary amines and paraformaldehyde to afford tertiary allylamines (Figure 1.2, eq 1).3 
 
Figure 1.1 Petasis Borono-Mannich Reaction 
The scope of the carbonyl substrates in this Mannich reaction was broadened to 
include α-keto acids by Petasis and co-workers, which provided access to β,γ-unsaturated 
α-amino acids (Figure 1.2, eq 2).4 Aryl boronic acids were also effectively incorporated in 
this multicomponent condensation reaction, affording α-aryl glycine derivatives (Figure 
1.2, eq 2).5 The mechanism of the Petasis borono-Mannich reaction was believed to start 
with the formation of a transient iminium ion between amine and α-keto acid. The boronic 
acid then coordinated to the carboxylic acid moiety to form an activated “ate” complex 1.1, 
which rendered the carbon substituent R4 more nucleophilic. The subsequent 
intramolecular transfer of the carbon substituent to the C=N bond afforded the amino acid 
product. This new approach to amino acids was highlighted by the incorporation of low-





Figure 1.2 Early Development of Petasis Borono-Mannich Reaction 
Substrate-Controlled Asymmetric Petasis Borono-Mannich Reaction 
Petasis borono-Mannich reactions employing unsymmetrical ketones or aldehydes 
are expected to generate a new stereocenter in the condensation products. Tremendous 
efforts have been devoted to the development of asymmetric Petasis methodologies. On 
the premise that the chiral information in the substrates will influence the formation of the 
new stereogenic center, attempts have been made by using chiral amines, chiral aldehydes 
and enantiopure boronic esters.  
Chiral Amines 
The first report of an asymmetric version of the Petasis borono-Mannich reaction 
was made by Petasis and co-workers, where enantiomerically pure amines were used along 
with styrenyl boronic acid 1.2 and glyoxylic acid 1.3 (Figure 1.3).4 While (S)-α-
methylbenzylamine 1.4 afforded product 1.6 in high yield but moderate d.r. (88% yield, 




1.7 in good yield and as a single diastereomer (78% yield, >99.5:0.5 d.r.). Subsequent 
removal of the chiral auxiliary afforded (R)-homophenylalanine hydrochloride 1.8 in an 
enantiomerically pure form (>99.5:0.5 e.r.).  
 
Figure 1.3 Diastereoselective Petasis Reactions of Vinyl Boronic Acids Using Chiral Amines 
The use of chiral amines was again examined in the study with aryl boronic acids 
by the Petasis group in an attempt to access enantioenriched α-aryl glycines (Figure 1.4, eq 
1).5 (S)-α-Methylbenzylamine 1.4 was found to participate well in the reaction. 
Unfortunately, the resulting product had modest levels of diastereoselectivity. Jiang and 
co-workers tested the same chiral amine in the synthesis of optically active indolyl N-
substituted glycines (Figure 1.4, eq 2).6 Interestingly, the reaction of N-tosyl-3-
indolylboronic acid 1.11, glyoxylic acid 1.3 and (R)-α-methylbenzylamine ent-1.4 at room 
temperature afforded the crude product 1.12 with good diastereoselectivity. Harwood and 
co-workers studied a similar approach using (S)-5-phenylmorpholin-2-one 1.15 as a chiral 
template (Figure 1.4, eq 3).7  The Petasis reactions with aliphatic aldehydes and 2-




is worth noting that aliphatic aldehydes lacking α-substitution are the only suitable 
substrates in this reaction, which is recognized as one of the few examples of Petasis 
reactions where α-hydroxy or α-keto substitution is not a requirement in the formation of 
the activated boron “ate” complex.  
 
Figure 1.4 Diastereoselective Petasis Reactions of (Hetero-)Aryl Boronic Acids Using Chiral Amines (Major 
Diastereomers Shown) 
One of the major drawbacks of Jiang and Harwood’s methods is that the reaction 
scope was limited to heteroaryl-substituted boronic acids. Aryl boronic acids were 
effectively incorporated in the Petasis borono-Mannich reactions using chiral 2-substituted 




phenylboronic acid 1.17 and glyoxylic acid 1.3, 2-pyrrolidines substituted by methyl 
(1.18a), isopropyl (1.18b), phenyl (1.18c), and methoxymethyl (1.18d) groups prevalently 
resulted in great yields and excellent diastereoselectivities.  
 













aDetermined by 1H NMR of unpurified reaction mixture. bIsolated yield of the major diastereomer. 
Table 1.1 Diastereoselective Petasis Reactions of Aryl Boronic Acids with Pyrrolidine 
Chiral Aldehydes 
The use of chiral α-hydroxy aldehydes in asymmetric Petasis borono-Mannich 




β-amino alcohols (Figure 1.5).9 The observed anti-diastereoselectivity was attributed to the 
transition state of an activated “ate” complex 1.20.  
 
Figure 1.5 Diastereoselective Petasis Reactions with Chiral α-Hydroxy Aldehydes 
Chiral Boronic Esters 
The use of chiral boronic esters in the Petasis borono-Mannich reaction was first 
investigated by Scobie and co-workers (Figure 1.6).10 The enantiomerically pure boronic 
esters were readily prepared by condensation of the corresponding boronic acids with 
commercially available chiral 1,2-diols, such as tartrate or pinanediol. However, the 
resulting boronic esters, such as 1.21a, were not effective in the asymmetric induction of 
the Petasis reaction, only achieving enantiomeric ratios of up to 57.5:42.5.  
 
Figure 1.6 Asymmetric Petasis Reaction Using Chiral Boronic Esters 
Reaction of Chiral Amines and Chiral Boronic Esters 
Despite the poor stereocontrol observed by Scobie’s group using chiral boronic 




boronates in order to assess the potential matched/mismatched reaction partners which 
might lead to improvements in diastereoselectivity (Table 1.2).11 Unfortunately, use of 
enantiomerically pure tartrate-derived boronic esters 1.21b and 1.21c achieved similar 
diastereoselectivities compared to the same reactions running with styrylboronic acid 1.2. 
The yield from pinanediol-derived boronates 1.21d reduced to less than 10%, while the 
diastereoselectivity remained high. These results indicate that the effects of the chiral 
boronic esters were small and chiral amines were predominately responsible for the 
stereochemical outcome of the reactions. Additionally, chiral primary amines generally 
afforded low to moderate diastereoselectivity, which is comparable to the Petasis group’s 
previous report (reactions of 1.2 and 1.4; Petasis: 88% yield, 83:17 d.r.; Hutton: 81% yield, 







Amine     
Yielda d.r.b Yielda d.r.b Yielda d.r.b Yielda d.r.b 
 
75 3.5:1 55 2.5:1 — — 81 3.3:1 
 
60 >95:5 50 >95:5 7 >95:5 89 >95:5 
aIsolated yield of the major diastereomer. bDetermined by 1H NMR of unpurified reaction mixture. 
Table 1.2 Asymmetric Petasis Reactions Using a Combination of Chiral Boronic Esters and Chiral Amines 
Reaction of Chiral Amines and Chiral Aldehydes 
Schreiber and co-workers investigated the combination of (L)-phenylalanine 
methyl ester 1.26 with both antipodes of enantiopure lactol 1.27 as the aldehyde component 
(Figure 1.7).12 Opposite enantiopreferences were observed by using either (S)- or (R)-lactol, 
which suggested that the α-hydroxy group in the aldehyde component directs the 
stereochemical outcome of the reaction, overriding any directing effects from the 





Figure 1.7 Asymmetric Petasis Reactions Using a Combination of Chiral Aldehydes and Chiral Amines 
A catalytic diastereoselective Petasis reaction of chiral amines and aldehydes was 
developed by Schreiber and Schaus.13 By employing (S)-3,3’-Br2-BINOL as the catalyst, 
they were able to override the inherent anti-diastereoselectivity to favor the formation of 
the syn-amino alcohol product (Figure 1.8). The activation mode of the diol catalyst will 
be further discussed in the next section.  
 




Catalytic Enantioselective Petasis Borono-Mannich Reaction 
The first catalytic enantioselective Petasis borono-Mannich reaction was developed 
by Schaus and co-workers.14 The reaction of alkenyl boronic esters, secondary amines and 
ethyl glyoxylate 1.31 was catalyzed by the vaulted biaryl diol catalyst (S)-VAPOL 1.32, 
affording α-amino ester products in high yields and enantioselectivities (Figure 1.9). The 
catalytic cycle was enabled by a facile ligand exchange between the boronic ester and the 
biphenol catalyst, which will be discussed further in the next section.  
 
Figure 1.9 Enantioselective Petasis Reactions Catalyzed by VAPOL 
A hydroxy-thiourea bifunctional catalyst 1.33a was developed by Takemoto’s 
group in a Petasis-type reaction of organoboronic acids with quinolines (Figure 1.10, eq 
1).15 A multicomponent Petasis reaction between aniline, 2-oxoacetamide 1.34 and 
styrenyl boronic ester was later reported (Figure 1.10, eq 2).16 The reaction was promoted 
by a modified hydroxy-thiourea catalyst 1.33b and provided access to chiral α-amino 
amides in good yields and high enantioselectivities. In the proposed mechanism, the 
boronate first exchanged an alkoxy group with the hydroxy thiourea, forming a singly 
exchanged chiral boron species 1.35 (Figure 1.11). Subsequently, instead of coordinating 




groups, the Lewis acidic boron atom was postulated to interact with the nitrogen atom of 
the imino group, leaving the amide carbonyl available to form hydrogen bonds with the 
thiourea moiety in the catalyst. The resulting intermediate 1.36 would allow for the quasi-
intermolecular transfer of the nucleophilic R2 substituent from the boron atom to the C=N 
bond owing to dual activation (Figure 1.11).  
 





Figure 1.11 Proposed Mechanism for Hydroxy-Thiourea Catalyst 
The scope of the enantioselective Petasis reactions was further expanded to include 
salicylaldehydes by Yuan’s group.17 Three-component reactions among salicylaldehydes, 
secondary amines and arylboronic acids were catalyzed by a newly designed thiourea-
BINOL catalyst 1.38, affording good yields and moderate to excellent enantioselectivities 
(Figure 1.12). A putative reaction intermediate 1.39 was proposed, in which the boronic 
acid underwent double ligand exchange with the diol group of the thiourea-BINOL catalyst, 
forming a cyclic binaphthyl-derived boronic ester. The unattached o-phenolic hydroxy 
group from the salicylaldehyde was associated to the thiourea moiety by hydrogen bonding. 
An “ate” complex could then be formed by the secondary amine moiety from the catalyst 
backbone, rendering the aryl substitution of the boronic acid more nucleophilic. However, 
there was insufficient proof that the geometry of the transition state would allow for the 





Figure 1.12 Enantioselective Petasis Reactions of Salicylaldehydes with Aryl Boronic Acids 
A complimentary catalyst system was later reported by using more readily available 
unsubstituted BINOL as the optimal catalyst in the Petasis reactions with salicylaldehydes, 
aryl boronic acids and cyclic secondary amines.18 Unfortunately, both of these methods 
encountered issues such as limited scope of boronic acids, relatively low reactivity and 
modest enantioselectivities in some cases. To address these problems, Shi and co-workers 
developed a more reliable catalytic enantioselective Petasis reaction of salicylaldehydes 
using dibutyl vinylboronates in the presence of a BINOL-derived catalyst 1.40 (Figure 
1.13).19 Notably, based on the mechanistic study, they concluded that the amine component 





Figure 1.13 Enantioselective Petasis Reactions of Salicylaldehydes with Vinyl Boronic Esters 
Palladium-catalyzed three-component reactions of aryl boronic acids, sulfonamides 
and aldehydes were reported by Manolikakes and co-workers, which can be considered as 
transition-metal-catalyzed variations of Petasis borono-Mannich reactions (Figure 1.14). 
Aldehydes lacking α-substitution,20 or glyoxylic acid derivatives21 were both suitable 





Figure 1.14 Palladium-Catalyzed Enantioselective Petasis Borono-Mannich Reactions 
Reactivity Profile of Boronic Esters 
Boronic esters are known to be mild nucleophiles due to the metalloid character of 
the boron atom. In traditional synthetic organic chemistry, they are widely applied in 
transition-metal catalyzed coupling reactions in the well-documented Suzuki-Miyaura 
coupling.22 One extraordinary feature of the Suzuki-Miyaura mechanism is that the 
organoboron compound must be activated, for example with a base, to form a tetra-
coordinated boron “ate” complex. This activation, in line with the Petasis mechanism, 
enhances the polarization of the organic group, and facilitates the subsequent 
transmetallation process.  
Allylboronates were arguably the first class of boronic esters that were extensively 
investigated as active nucleophiles in the absence of transition-metal catalysts, which can 




(Figure 1.15). In the reaction between allylboronate and aldehydes, the carbonyl oxygen 
donates electron density into the vacant p-orbital of the boron atom to form an activated 
“ate” complex, which concomitantly lowers the LUMO of the aldehyde.  
 
Figure 1.15 Zimmerman-Traxler Transition State of Allylboration 
A systematic evaluation of the reactivity of allyl boronic ester derivatives was 
carried out by Brown and co-workers.23 A model reaction was set up with equimolar 
amounts of allylboronate 1.41 and benzaldehyde 1.42 in dichloromethane and was 
continuously monitored by 11B NMR spectroscopy. The rate of reactions was reflected by 
the half-life of the starting materials. According to the study, allylboronates 1.41b-e, 
possessing a five-membered cyclic boronic ester moiety, were comparatively less sterically 
hindered and more electrophilic than 1.41a, possessing a six-membered cyclic structure 
(Table 1.3). Notably, catechol-derived allylboronate 1.41e was considerably more reactive 
compared to other five-membered allyldioxaborolanes, which could be attributed to the 
delocalization of the lone pairs of electrons from the oxygen atoms to the adjacent phenyl 
ring. This significantly reduced the n (oxygen) → p (boron) donation and increased the 
Lewis acidity of the boron atom. Generally acyclic allylboronates 1.41f-i underwent 
allylboration more rapidly compared to the cyclic boronate 1.41a. The trend in reaction 
rates could be explained by the absence of electron-donating alkyl groups in the 
allylboronic acid 1.41i, and the presence of an electron-withdrawing group in the 




and render the boron atom more electrophilic. Lastly, the tartrate- and tartramide-derived 
boronic esters were more reactive than the non-substituted cyclic boronate 1.41d. The more 
electron-deficient ester group made boronate 1.41k more reactive compared to the amide 
derivative 1.41j. Overall, the structure of the ester moiety determined the reactivity of 
allylboronates by affecting the availability of the lone pairs of electrons on the oxygen atom 
attached to boron. These findings are valuable when it comes to designing new chiral 
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aDetermined by 11B NMR spectroscopy. bDetermined by 1H NMR spectroscopy. 
Table 1.3 Relative Reactivity of Allylboronates 
The reactivity profile of aryl- and vinyl-boronic acids or ester derivatives was 
systematically studied in Petasis borono-Mannich reactions by Hutton and co-workers 
(Table 1.4).11 Overall, the vinylboron reagents were more reactive than the aryl derivatives. 




amine component. When primary amine 1.43 and secondary amine 1.45 or  1.46 were used 
in the Petasis reaction, the pinacolyl esters 1.47e and 1.2b were much less reactive than the 
ethyleneglycolyl esters 1.47j and 1.2a, with the free boronic acids being the most reactive 
reagent among these three. These results could be explained by two factors. The presence 
of electron-donating alkyl groups in the pinacolyl- and ethyleneglycolyl-boronic esters 
enhanced the back-donation of the lone pairs from oxygen to boron, rendering the boron 
atom less electrophilic. Additionally, the pinacolyl- and ethyleneglycolyl-boronates are 
much less able to form the tetrahedral “ate” complex due to steric interactions. However, 
when a less sterically demanding amine 1.44 was used, pinacolyl- and ethyleneglycolyl-
boronates displayed increased reactivity, presumably due to a relief of steric interactions 
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64 35 35 64 77 90 
 
84 19 0 84 19 0 
 
89 43 0 90 39 5 
Table 1.4 Yields of Phenylgycine and Styrenylglycine Derivatives from Petasis Reactions 
Boronate Ligand Exchange 
McCusker and co-workers reported the first observation of ligand exchange 
between acyclic boronate and borinate esters.24 A mixture of isobutyldiethoxyborane  and 
diisobutylmethoxyborane at room temperature resulted in an equilibrium mixture of 
reactants and ligand-exchanged products (Figure 1.16). NMR study revealed that the 
equilibrium was readily achieved within 30 seconds.  
 




The ligand exchange process between cyclic boronic esters and 1,2-diols was 
extensively examined by Roy and co-workers (Figure 1.17).25 (S,S)-Diisopropyl tartrate 
boronic ester 1.47k was found to be the most labile cyclic boronate. Simple five-membered 
boronic esters 1.47h-j were relatively more prone to ligand exchange than their 
corresponding six-membered analogs 1.47g. Slower rates of transesterification were 
observed for boronates with bulky ester substitutions, such as pinanediol boronic ester 
1.47a.  
 
Figure 1.17 Increasing Order of Ligand Exchange Ability of Boronic Esters 
The possibility of using a substoichiometric amount of chiral ligands to exchange 
with boronates was realized in asymmetric boronate addition reactions. An asymmetric 
alkynylboration of enones was reported by Chong and co-workers by using (S)-3,3’-I2-
BINOL 1.48 as a chiral diol catalyst (Figure 1.18, eq 1).26 The boronate scope was further 
broadened to include alkenyl27 and aryl28 boronic esters, although the latter class of 
nucleophile demonstrated compromised reactivity and enantioselectivity (Figure 1.18, eq 





Figure 1.18 Asymmetric Conjugate Additions of Boronates to Enones 
The first example of a highly enantioselective allylboration of ketones was reported 
by Schaus and co-workers using allyldiisopropoxyborane and chiral BINOL-derived 
catalysts (Figure 1.19).29  A wide screen of diols with privileged chiral scaffolds revealed 
(S)-3,3’-Br2-BINOL 1.50 as the optimal catalyst, achieving great yields and 
enantioselectivities for the homoallylic alcohol products (Figure 1.19). NMR studies were 
carried out to determine the mechanistic pathway for the BINOL-mediated allylboration. 




formation of a single-ligand exchange complex. A double-ligand exchange complex was 
not observed throughout the course of the reaction. Based on these results, a transition state 
model was proposed, in which the BINOL catalyst played a dual role in enhancing the 
reactivity of the catalyst-associated boronate complex in order to compete with the non-
catalyzed pathway. Firstly, the electron-deficient phenyl ring delocalized the lone pairs of 
electrons from the oxygen, which according to Brown’s study23 would reduce the n 
(oxygen) → p (boron) donation and increase the Lewis acidity of the boron atom. Secondly, 
the free phenolic proton formed an intramolecular hydrogen bond with the isopropoxy 
oxygen, which according to Hall’s study30 would further enhance the electrophilicity of 
boron. The excellent enantioselectivity could be attributed to the rigid Zimmerman-Traxler 
transition state as well as the steric bias provided by the 3,3’-substitutions on the BINOL 
catalyst, which led to preferential attack of the si face of the ketone. This model was in 
agreement with the observed stereochemical outcome.  
 
 




The scope of the asymmetric allylboration was effectively expanded to nucleophilic 
additions to C=N bonds.31 The Petasis borono-Mannich reaction was thereby identified as 
the next platform to demonstrate the boronate ligand exchange paradigm. Using (S)-
VAPOL 1.32 as the optimal chiral diol catalyst, the first catalytic enantioselective Petasis 
reaction was developed by Schaus and co-workers in 2008 (Figure 1.9).14 The proposed 
catalytic cycle was consistent with previous allylboration studies (Figure 1.20). The alkenyl 
boronate 1.28 underwent single ligand exchange with VAPOL, evidenced by NMR and 
ESIMS analysis.14 The coordination between the boron center and the ester moiety from 
the hemiaminal generated in situ resulted in an activated boron “ate” complex 1.51, which 
facilitated the nucleophilic attack from the alkenyl group (Figure 1.20). This successful 
example of asymmetric Petasis reaction provided valuable insight to the present 
methodology development of asymmetric Petasis reactions.  
 




This powerful and unique organoboron ligand exchange paradigm was soon 
acknowledged by the synthetic organic community and many excellent examples emerged 
in the past decade.32 In addition to organoboronates, boronic acids can also undergo ligand 
exchange with chiral diols in the development of asymmetric conjugate additions.33-34 
Petasis-type prenylations of C=N bonds were reported by Szabó and co-workers using γ,γ-
disubstituted allylboronic acids 1.52, which resulted in the construction of quaternary 
stereocenters in the homoallylic amine products (Figure 1.21, eq 1 and 2).35 Methanol was 
revealed to be a crucial additive in the prenylation of indoles (1.53), which esterificated the 
boronic acid 1.52 prior to the ligand exchange (Figure 1.21, eq 1). This transformation 
silenced the non-catalyzed racemic reaction pathway of boronic acids, whose high 
reactivity had been observed in Brown’s original allylboration study.23 Pyridylphenol 1.57 
was found to be beneficial in obtaining higher yields for the prenylation of 3,4-
dihydroisoquinolines 1.55, presumably due to its favorable bidentate interaction with boron 





Figure 1.21 Catalytic Asymmetric Allylborations with γ,γ-Disubstituted Allylboronic Acids 
This chapter described in retrospect the development of asymmetric Petasis 
reactions and demonstrated promising prospects of the organoboron ligand exchange 
paradigm. Herein, this established methodology is further leveraged in the development of 
catalytic asymmetric Petasis reactions by using delicately designed substrates and ligands 







2Asymmetric Petasis Borono-Mannich Allylation Reactions Catalyzed by Chiral 
Biphenols 
Introduction 
Petasis borono-Mannich reactions have proven to be one of the most practical 
synthetic tools, providing access to versatile building blocks including non-natural α-amino 
acids.36 Nonetheless, the use of allyl boron reagents in Petasis reactions has not been 
adequately explored. One of the earliest examples came from Raeppel and co-workers, 
who utilized allyl trifluoroborate 2.1 in the Petasis borono-Mannich reaction with 
paraformaldehyde and a secondary amine (Figure 2.1).37 The desired homoallylic amine 
product 2.2 was the only example in this report, which was afforded in a 40% unoptimized 
yield.  
 
Figure 2.1 Allyl Trifluoroborate in Petasis Borono-Mannich Reaction 
A multicomponent reaction with allylpinacolboronate 2.4, aldehydes, and liquid 
ammonia was reported by Kobayashi and co-workers.38 The reaction afforded homoallylic 
amine products in good yield and with high chemoselectivity over the homoallylic alcohol 
products (Figure 2.2, eq 1). Crotylations with (E)- and (Z)-crotylboronate 2.7 provided 
access to anti and syn-diastereomers respectively, both in good yields and with excellent 




boronate agent 2.8 was attempted; however, only modest enantioselectivity was achieved 
(Figure 2.2, eq 4).  
 
Figure 2.2 Petasis Reaction of Allylboronates, Aldehydes and Ammonia 
Ketones were later incorporated in this Petasis borono-Mannich reaction with 
ammonia and allylboronic acid 2.9 (Figure 2.3, eq 1).39 Due to the attenuated 
electrophilicity of ketones, the more reactive allylboronic acid 2.9 was used instead of the 
pinacolboronate. Crotylations with (E)- and (Z)-crotylboronic acid were also successful, 





Figure 2.3 Petasis Reaction of Allylboronic Acid, Ketones with Ammonia 
The use of ammonia in the above-mentioned reactions was not able to leverage the 
most attractive nature of the Petasis borono-Mannich reaction, the multicomponent 
condensation that embraces different functionality at both aldehyde and amine components. 
A tandem borylation-Petasis allylation reaction was developed by Szabó and co-workers, 
which exceptionally broadened the scope of amines and allyl boron reagents (Figure 2.4).40 
Allyl boronic acids such as 2.13 were generated in situ from allylic alcohols by using a 
palladium(II)-pincer complex 2.12. Subsequently the nucleophilc allyl reagents reacted 
with glyoxylic acid 2.14 and aryl- or alkyl-substituted primary amines in a Petasis 
allylation reaction. This multicomponent reaction provided access to highly functionalized 





Figure 2.4 One-Pot Borylation-Petasis Allylation Reaction 
 The Petasis crotylation reactions generally achieved useful levels of 
diastereocontrol in the aforementioned examples; however, to the best of our knowledge, 
there has been no catalytic enantioselective examples to date. An auxiliary-controlled 
asymmetric Petasis allylation/crotylation reaction was developed by using glyoxylic acid 
2.14, pinacolboronates, and tert-butanesulfinamide 2.15 as the chiral auxiliary (Figure 
2.5).41 The initial Petasis adduct 2.16 was afforded in a moderate yield. Upon removal of 
the N-tert-butylsulfinyl group, the enantioenriched homoallylic amine 2.17 was furnished 
with excellent enantiomeric purity.  
 




We envisioned the possibility of developing a highly enantioselective Petasis 
allylation reaction under the guidance of the organoboron ligand exchange paradigm. 
Herein, we describe the first catalytic enantioselective allyl-Petasis reaction using (R)-3,3’-
Ph2-BINOL (2.19) as the optimal catalyst (Figure 2.6). The reaction proceeds via a two-
step, one-pot process. Under microwave irradiation the reaction affords chiral homoallylic 
amines in excellent yields (up to 99%) and high enantioselectivities (up to 99:1 e.r.). This 
reaction is a true multicomponent condensation reaction which tolerates enolizable 
aldehydes and aryl- or alkyl-substituted amines. The use of crotyldioxaborolane in the 
reaction provides access to anti- and syn-diastereomers both in good diastereoselectivities 
and enantioselectivities.  
 
Figure 2.6 Catalytic Enantioselective Petasis Borono-Mannich Allylation 
Background 
Synthetic Utility of Chiral Homoallylic Amines 
Chiral homoallylic amines, the direct product of the Petasis borono-Mannich 
allylation reaction, are valuable building blocks for the synthesis of biologically and 




stereogenic centers omnipresent in many synthetic targets, the alkene moiety also provides 
a useful handle for further transformations towards functionalized molecules, such as 
amino alcohols, amino acids,51-52 and azacyclic compounds53-54. For example, chiral 
homoallylic amines were utilized as key intermediates in the synthesis of halichlorine, a 
spirocyclic alkaloid with anti-inflammatory properties (Figure 2.7).55 The preparation of 
the antiobiotic indolizomycin also relied on the use of chiral homoallylic amine 
intermediates (Figure 2.7).56  
 
Figure 2.7 Natural Products Synthesized Using Chiral Homoallylic Amine Intermediates 
Catalytic Asymmetric Petasis-Type Allylation 
Asymmetric allyl additions to the C=N bond of carbonyl imino derivatives provides 
direct access to the chiral homoallylic amines. Considerable efforts have been devoted to 
the development of enantioselective imine allylation.57-58 The present methods of catalytic 
asymmetric Petasis-type allylation are in general highly enantioselective, but the imine 
substrates have to be pre-formed and the N-substituents are mostly limited to electron-
withdrawing groups. These acyl-, sulfonyl- or phosphinoyl-substituted imines are 
calculated to present increased electrophilicity (Figure 2.8)59. Moreover, these Lewis basic 
N-substituents may introduce an additional coordination site with the chiral ligands, 





Figure 2.8 Trend of Electrophilicity for N-Substituted Imines 
The difficulty in accessing these activated imines, as illustrated in Figure 2.9, 
thwarts the possibility of developing a truly multicomponent Petasis allylation reaction.57 
Also, the current catalytic systems for the Petasis-type allylation are exclusive to the nature 
of the N-substituent of the imine substrates. Herein, we examine a few productive catalytic 
systems and their compatible imine substrates in the Petasis-type allylation methodologies. 
 
Figure 2.9 Catalytic Asymmetric Petasis-Type Allylation Using Activated Imines 
N-Acyl Imines 
An asymmetric allylboration of acyl imines was reported by Schaus and co-
workers.31 This reaction required 15 mol% of (S)-3,3’-Ph2-BINOL as the catalyst and 
allyldiisopropoxyborane 2.20 as the nucleophile, affording enantioenriched homoallylic 
amines in good yields and excellent enantioselectivities (Figure 2.10). Substrates with 




afforded 2.21 in only 13% yield and with 57:43 e.r., whereas N-acetyl imine produced 2.22 
in a better yield but maintained a low enantioselectivity (52% yield, 70:30 e.r.). N-Benzoyl 
imines presented much better tolerability with different substitutions at the para-position 
of the phenyl ring, one of which achieved the best yield and highest enantioselectivity (2.23, 
92% yield, 99.5:0.5 e.r.). The cinnamoyl imine was also found to be a suitable substrate in 
the allylboration reaction (2.24, 82% yield, 95:5 e.r.). This high level of substrate generality 
enabled a new synthetic route to maraviroc 2.26, brand-named Selzentry®, which is now 
an antiretroviral drug used in the treatment of HIV. The key intermediate 2.25, a chiral 
homoallylic amide substituted by a cyclohexanecarbonyl group, was obtained in good yield 
and selectivity under standard reaction conditions. N-Benzyl and aryl-substituted imines 
were also investigated using the optimized conditions, but they only afforded the 
corresponding homoallylic amines in poor enantioselectivities and low yields (<60:40 e.r., 





Figure 2.10 Asymmetric Allylboration of Acyl Imines 
N-Sulfonyl Imines 
A cyclic sulfonyl imine was identified as the desirable electrophile for a rhodium-
catalyzed enantioselective Petasis-type allylation reaction (Figure 2.11).60 The cyclic 
structure of the imine substrate, in which the C=N bond was constrained in a Z geometry, 
appeared to be important for the success of the reaction. The use of potassium 
allyltrifluoroborate 2.1 as the allyl reagent proved to be essential for high enantioselectivity. 
Not only did cyclic aldimines undergo highly enantioselective allylations, ketimines such 
as 2.29 were also viable substrates, which accounted for one of the few examples of 




generated throughout the catalytic cycle as the actual nucleophile, which was distinct from 
the conventional Petasis reactions.  
 
Figure 2.11 Enantioselective Rhodium-Catalyzed Allylation of Cyclic Sulfonyl Imines 
N-Phosphinoyl Imines 
N-Phosphinoyl imines were discovered as a practical electrophile in the 
development of an asymmetric catalytic allylation catalyzed by NHC−Cu complexes 
(Figure 2.12).61 The allyl additions using (pinacolato)allylborons delivered the desired 
products in up to quantitative yield and 98.5:1.5 enantiomeric ratio. Aryl-, heteroaryl-, 
alkyl-, or alkenyl-substituted N-phosphinoyl imines proved to be excellent substrates. 
Coordination of the N-phosphinoylimine’s Lewis basic oxygen was likely the key contact 
point that brought the substrate and catalyst together. The proposed mechanism involved 






Figure 2.12 Enantioselective Allylation of N-Phosphinoyl Imines Catalyzed by NHC−Cu Complexes 
An organocatalyzed asymmetric allylation reaction of N-phosphinoyl imines was 
later unveiled (Figure 2.13).62 This seminal work from Hoveyda, alongside the BINOL-
catalyzed allylation of acyl imines developed by Schaus,31 was marked as one of the only 
examples of metal-free catalytic methods in this field. The reaction between N-phosphinoyl 
imines and (pinacolato)allylboron tolerated both aryl- and alkenyl-substituted imines 
(Figure 2.13, eq 1). The alkynyl-substituted imine afforded slightly lower e.r. in the product 
2.38. The aldimines derived from enolizable aldehydes, challenging substrates in metal-
catalyzed methods, furnished excellent enantioselectivity. It was determined that the N-
phosphinoyl group was crucial to the high level of enantioselectivity due to the formation 
of a three-pronged hydrogen bond with the secondary amine and amide carbonyl units from 
the catalyst. Unsurprisingly, reactions with N-aryl imines, lacking an appropriate 




Deuterium-labeled study revealed that the overall transformation took place with net α 
selectivity (Figure 2.13, eq 2). 
 
Figure 2.13 Enantioselective Petasis-Type Allylation of N-Phosphinoyl Imines 
N-Acyl Hydrazones 
An indium(Ⅰ)-catalyzed asymmetric allylboration of acylhydrazones was developed 
by Kobayashi and co-workers.63 The reaction took place with an in situ generated chiral 
indium(Ⅰ)-semicorrin catalyst, which provided excellent yields and enantioselectivities for 
aromatic and heteroaromatic substrates (Figure 2.14). But aliphatic hydrazones again 





Figure 2.14 Indium-Catalyzed Asymmetric Allylation of Acylhydrazones 
N-Alkyl Imines 
The first catalytic enantioselective allylation of ketimines was developed by 
Shibasaki, Kanai, and co-workers.64 Pinacol allylboronate was employed as the allyl 
reagent, which was then transformed into a more nucleophilic allylcopper species under 
the catalytic conditions. During the initial study, ketimines with different N-substitution 
were examined (Figure 2.15, eq 1). Compared to N-acyl hydrazone and N-
phosphinoylimine, N-benzyl imine was the least electrophilic but produced the highest 
yield of the corresponding product. The authors reasoned that the turnover-limiting step 
might be the regeneration of allylcopper, the active nucleophile, rather than the allyl 
addition. Sterically tuned cyclopentyl-DuPHOS 2.49 was identified as the optimal chiral 
ligand, and high enantioselectivity was obtained from aromatic N-benzyl ketomines 






Figure 2.15 Catalytic Enantioselective Allylation of N-Alkyl Ketoimines 
Catalytic Asymmetric Petasis-Type Crotylation 
The catalytic stereoselective crotylation of imines using γ-substituted allyl reagents 
is much less understood compared to the allylation methodologies, because the 
stereochemical outcome for crotylation can be complicated by two factors: 1) whether a 
boat transition state or a chair transition state is involved, and 2) spontaneous E/Z 
isomerization of the imine prior to crotylation. γ-Substituted allyl organometallics are 
expected to display high levels of diastereoselection because they normally react at the γ-
position through an ordered cyclic (type Ⅰ) or acyclic (type Ⅱ) transition state, depending 




organometallics containing magnesium, titanium, indium or boron undergo a cyclic six-
membered Zimmerman-Traxler transition state.65 On the other hand, allylsilane and 
allylstannane commonly proceed in an open transition state where destabilizing gauche 
interactions are minimized. Crotylation reactions using type I reagents tend to result in 
more predictable and highly diastereoselective outcomes, whereas type Ⅱ reagents are less 
predictable and usually one diastereomer is convergently produced regardless of (E)- or 
(Z)-configuration of the reagent.  
 
Figure 2.16 Models for Asymmetric Crotylation of Imines 
γ-Substituted allylboron reagents demonstrate γ-selectivity when reacting with 
imines via a cyclic transition state; however, the actual product identity and diastereomeric 
outcome rely on how many events of γ-additions occur before the formation of the final 
product (Figure 2.17).66 In some cases, the allylboron reagents undergo a pair of γ-selective 
events, resulting in formal α-addition products.  
 




Catalytic asymmetric crotylboration of acyl imines was investigated by Schaus 
(Figure 2.18).31 The use of (E)-crotylboronate 2.52 afforded the expected anti-diastereomer 
with excellent stereoselectivity. Nevertheless, using (Z)-crotylboronate 2.53 in the reaction 
provided the same anti-product 2.55 albeit in lower yield and enantioselectivity. The 
desired anti-selectivity afforded by (E)-crotylboronate could be rationalized via a chair 
transition state (Figure 2.18). Of note, the (Z)-conformer of the acyl imine was adopted in 
the transition state, which coordinated to the BINOL catalyst through hydrogen bonding. 
The E/Z isomerization of imines was previously proposed to explain the diastereoselective 
addition of boron enolates67 and crotylboranes68 to imines. Moreover, experimental and 
DFT mechanistic studies were performed by Szabó and co-workers in an anti-selective 
crotylboration of imines, which corroborated the postulation of boron-mediated E/Z 
isomerization of imines.69 On the other hand, the anti-selectivity presented by (Z)-
crotylboronate 2.53 could be explained by a boat transition state, a preferred conformer 
opposed to the chair transition state, which would give rise to pseudo-diaxial interaction 
between the terminal methyl group and the acyl unit fixated by the hydrogen bonding from 






Figure 2.18 Asymmetric Crotylboration of Acyl Imine with Crotyldiisopropoxyboranes 
Catalytic asymmetric crotylboration of dihydroisoquinolines using γ,γ-
disubstituted allylboronic acids was investigated by Szabó and co-workers (Figure 2.19).35 
Geranylboronic acid 2.59 and nerylboronic acid 2.60, respectively in (E)- and (Z)-
configuration, afforded the desired diastereomers exclusively and with excellent 
stereoselectivity. Skatole (2.63) was also assessed as the electrophile in this asymmetric 
Petasis-type prenylation reaction (Figure 2.20). The stereochemical outcome was 
consistent with the proposed type Ⅰ transition state, in which the cyclic imine was 





Figure 2.19 Asymmetric Petasis-Type Prenylation of Dihydroisoquinolines 
 
Figure 2.20 Asymmetric Petasis-Type Prenylation of Skatole 
These findings prompted us to evaluate imines without strong coordination sites. 
We sought to explore non-activated imines such as N-aryl or N-alkyl imines in the 
asymmetric Petasis crotylboration reaction, which might result in both syn- and anti- 





Figure 2.21 Proposed Diastereoselective Crotylboration 
The first report of catalytic regio- and stereoselective formal α-addition of 
allylboronates to imines was published by Kobayashi’s group.70 When α-substituted 
allylboronates were reacted with hydrazone esters under optimized conditions, the anti-
products were exclusively produced with high yields and stereoselectivities (Figure 2.22). 
It was postulated that the allyl reagent went through two γ-addition events: the 
allylboronate initially reacted with ZnF2 via a cyclic chair-like TS, affording a (Z)-
crotylzinc species, which subsequently reacted with hydrazone ester stereoselectively via 
a second γ-addition event, thereby affording the crotylated product with anti-selectivity 
(Figure 2.22). A similar pathway was observed in the indium(Ⅰ)-catalyzed asymmetric 
crotylation of acyl hydrazones, in which the first γ-addition took place between 





Figure 2.22 Formal α-Addition of Allylboronates to Hydrazono Esters 
The double γ-addition was also observed by Hoveyda and co-workers in their study 
of organocatalytic asymmetric allylboration of N-phosphinoyl imines.62 Analogous to the 
zinc-70 and indium-mediated63 mechanism, the initial association between 
(pinacolato)allylboron and the aminophenol catalyst occurred by a γ-addition event 
through a cyclic transition state. In order to leverage the high levels of stereocontrol in the 
final γ-addition to the C=N bond, Hoveyda and co-workers envisioned the inclusion of 
another 1,3-boryl shift prior to the imine addition (Figure 2.23).71 Zn(OMe)2 was found to 
serve as the optimal co-catalyst which accelerated both the allyl exchange and the 1,3-
borotropic shift processes. The re-designed reaction afforded desired γ-adducts in good 
yields and with excellent selectivity when aryl- or alkenyl-substituted phosphinoyl imines 
were employed (2.73-2.75).  Transformations with alkyl-substituted imines were 




chloro-substituted allylboronate afforded the corresponding functionalized homoallylic 
amine products 2.77 and 2.78. Overall, only anti-products could be formed regardless of 
the olefin geometry in the crotylboronate reagents.  
 
Figure 2.23 Formal γ-Addition of Allylboronates via a 1,3-Borotropic Shift 
Asymmetric Petasis-type crotylation of C=N bonds with control of 
diastereoselectivity using substituted allylboron reagents is still in its early development. 
Crotylboration of imines with a single γ-addition process is anticipated to proceed via a 
highly-organized transition state, which generally affords excellent stereochemical 
outcome. It also provides an opportunity to divergently access both diastereomers with 




Results and Discussion 
Enantioselective Petasis Borono-Mannich Allylation 
We initiated our study by examining aldimines and ketoimines in the allylboration 
reaction (Table 2.1), bearing in mind that N-aryl imines, N-alkyl imines and hydrazones 
are readily formed by condensation, which allowed for the potential development of a 
multicomponent strategy. 3,3’-Br2-BINOL was used as an archetypical biphenol catalyst. 
N-para-Methoxyphenyl (PMP) imine afforded product 2.79a with the most promising 
enantioselectivity albeit with poor yield (Table 2.1, entry 1). N-p-Methoxybenzyl imine, 
however, afforded 2.80 in good yield but with compromised selectivity (Table 2.1, entry 
2). Interestingly, the imine derived from 1,1-di(p-anisyl)methylamine failed to produce any 
desired product 2.81 (Table 2.1, entry 3); however, the homoallylic alcohol, allylation 
product of benzaldehyde, was isolated with an enantiomeric ratio of 50:50. This might be 
due to the facile equilibrium existing between the imine and the aldehyde, of which the 
latter displayed higher reactivity with allylboronate. Acetophenone-derived ketimines were 
also investigated and poor stereocontrol was observed (Table 2.1, entry 4 and 5), which 
could be attributed to reduced steric bias between the two substituents (phenyl versus 






















Reactions were run with 0.4 mmol imine, 0.6 mmol boronate, and 15 mol% catalyst in toluene (0.2 M) for 24 h at room 
temperature, followed by flash chromatography on silica gel. aIsolated yield. bDetermined by chiral HPLC analysis.  





Entry Conditions Yield (%)a e.r.b 
1 50 ℃, 0.4 M in PhCH3, 24 h 40 96:4 
2 50 ℃, neat, 24 h 86 96:4 
3 μwave (30 W, 100 ℃, 30 min), neat 97 93:7 
4 μwave (10 W, 50 ℃, 1 h), neat 91 97:3 
Reactions were run with 0.4 mmol imine, 0.6 mmol boronate, and 15 mol% catalyst under illustrated conditions. Products 
were isolated by flash chromatography on silica gel. aIsolated yield. bEnantiomeric ratios determined by chiral HPLC 
analysis. MW=microwave. 
Table 2.2 Thermal Conditions in the Allylation of Imines 
N-p-Methoxyphenyl (PMP) imine was therefore selected as the model substrate for 
the following optimization. Thermal conditions were investigated in order to overcome the 
low electrophilicity of the N-aryl imines (Table 2.2). Although elevating the reaction 
temperature to 50 ℃ achieved no substantial improvement (Table 2.2, entry 1), we were 
glad to observe that running the allylboration reaction under neat conditions largely 
increased the reaction rate (Table 2.2, entry 2). Organoboronate reagents have proven to 
be a suitable medium in microwave-promoted reactions, showcased by the 
propargylboration of ketones.72 Using higher power of microwave irradiation appeared to 
favor the uncatalyzed racemic pathway, affording nearly quantitative yield but with 




reaction at a power-max setting of 10 W for 1 h was revealed to be the optimal conditions, 
furnishing good yield and consistent enantiomeric ratio compared to the original conditions 
(Table 2.2, entry 4). 
 
Entry Dessicant Yield (%)a e.r.b 
1 3 Å MS 90 97:3 
2 4 Å MS 85 93:7 
3 5 Å MS 86 94:6 
4 MgSO4 77 96:4 
5c 3 Å MS 95 97:3 
Reaction conditions: aldehyde (0.4 mmol), p-anisidine (0.4 mmol) and powdered 3 Å molecular sieves (350 mg) were 
mixed in CH2Cl2 (1 mL) at room temperature for 2 h; CH2Cl2 was removed; allylboronate (0.6 mmol), catalyst (15 mol%) 
were added and submitted to the microwave reactor held at 10 W for 1 h (powermax mode, internal temperature was 
measured to be 50 ℃). aIsolated yield. bEnantiomeric ratios determined by chiral HPLC analysis. c0.8 mmol amine was 
used. MS=molecular sieves. 
Table 2.3 Preliminary Examination of Asymmetric Petasis Allylation  
We next tested the possibility of a multicomponent Petasis allylation reaction 
through a proof-of-concept experiment: PMP-imine 2.84 was formed in situ in the presence 
of a dessicant, followed by evaporation of the solvent and a one-pot operation of 
allylboration (Table 2.3). Dichloromethane was found to be the most suitable solvent for 
the initial condensation step, since both starting materials could be easily dissolved and 




the instability of imines. Different dessicants were investigated, among which powdered 3 
Å molecular sieves were found to be the most reliable (Table 2.3, entry 1). Small amount 
of homoallylic alcohol was observed in the product by crude NMR, which accounted for 
the unaccomplished yield. A higher yield of 2.79a was obtained by increasing the amount 
of amine to 2 equivalents, which effectively suppressed the undesirable allylboration of the 
uncondensed aldehyde (2.85a) (Table 2.3, entry 5).  
 
Reaction conditions: aldehyde (0.4 mmol), p-anisidine (0.8 mmol) and powdered 3 Å molecular sieves (350 mg) were 
mixed in CH2Cl2 (1 mL) at room temperature for 2 h; CH2Cl2 was removed; allylboronate (0.6 mmol), catalyst, t-BuOH 
were added and submitted to the microwave reactor held at 10 W for 1 h. aIsolated yield. bDetermined by chiral HPLC 
analysis.  
Table 2.4 Reducing Catalyst Loadings by Addition of t-BuOH 
Entry x Catalyst y Yield (%)a e.r.b 
1 10 Br 0 68 97:3 
2 10 Ph 0 75 98:2 
3 5 Br 1.5 80 96:4 
4 5 Ph 1.5 84 97:3 
5 5 Ph 3 91 97:3 
6 2 Ph 3 90 97:3 




We attempted to reduce the catalyst loadings by employing t-BuOH as an additive, 
which proved to accelerate the catalytic turn-over in the asymmetric allylboration of 
ketones.73 Without the addition of t-BuOH, both 3,3’-Br2-BINOL 2.64 and 3,3’-Ph2-
BINOL 2.19 catalyzed the reaction with significant decrease of yields when the catalyst 
loadings were reduced to 5-10 mol% (Table 2.4, entry 1-4). Notably, 3,3’-Ph2-BINOL 2.19 
demonstrated better performance at a lower catalyst concentration compared to 2.64. The 
conditions for the multicomponent reaction were finalized by choosing 3,3’-Ph2-BINOL 
as the optimal catalyst with the inclusion of 3 equivalents of t-BuOH, which successfully 
reduced the catalyst loading to as low as 2 mol% (with regard to allylboronate 2.18).  
Substrate Scope of Aldehyde Component 
We examined the scope of the Petasis borono-Mannich allylation using p-anisidine 
2.86 as the amine component with the objective of identifying the structural and electronic 
parameters that were tolerable in the aldehyde component. In general, electron-deficient 
aromatic aldehydes 2.85a-f produced excellent yields and enantioselectivities (Figure 2.24). 
The slower reaction rate for p-bromobenzaldehyde 2.85g might be due to the poor 
solubility of the corresponding imine; nevertheless, conventional heating for 24 h furnished 
the homoallylic amine product 2.79g in a practical yield. Electron-rich aromatic aldehydes 
2.85h-i were less reactive under the parent conditions, which was attributed to the 
diminished electrophilicity by the electron-donation from the phenyl ring. Higher yields 
for these substrates were obtained when catalyst loadings were increased (4 mol%) and 




naphthaldehyde 2.85j were also determined to be viable substrates for the asymmetric 
Petasis allylation. 
 
aConventional heating at 50 ℃ for 24 h. b4 mol% catalyst. PMP=p-methoxyphenyl group. 
Figure 2.24 Scope of Aromatic and Heteroaromatic Aldehydes in Asymmetric Petasis Allylation 
We next turned our attention to aliphatic substrates. The alkyl-substituted imines 
are notably challenging substrates using current allylation methodologies. Although α-




allylation, there are few methods that achieve high enantiocontrol for enolizable imines. 
The basic allyl-metal regents or metal-containing catalysts might induce enamine 
formation, which makes it more difficult to tolerate enolizable imines. To date the only 
suitable methods for aliphatic imines include allylboration of acyl imines developed by 
Schaus,31 allylboration of phosphinoyl imines reported by Hoveyda,61-62 and a three-
component coupling using allyltrimethylsilane from the List group.76 All of these reactions 
employed mild allyl-metal reagents and most of them adopted metal-free catalytic systems. 
Another issue with alkyl-substituted imines lies in their hygroscopic properties and 
susceptibility to hydrolysis, which makes them difficult to prepare and handle. Although 
N-aryl imines are significantly more stable than their N-acyl counterparts, aliphatic N-aryl 
imines such as hydrocinnamylimine are considerably less stable compared to aromatic 
imines and are difficult to chromatograph.77 We reasoned that this one-pot organocatalytic 
Petasis allylation methodology would be best suited for the aliphatic imines due to its mild 
conditions and exemption from isolating the substrates.  
We initiated our investigation by examining hydrocinnamaldehyde 2.85m using the 
same one-pot conditions (Figure 2.25). Gratifyingly, the desired product 2.79m was 
obtained with remarkable selectivity albeit in a modest yield. Other aliphatic aldehydes 
were next examined. Conjugated substrates such as alkenyl- or alkynyl-substituted 
aldehydes delivered 2.79n and 2.79o with good yields and excellent enantioselectivities. 
Cyclohexanecarboxaldehyde 2.85p afforded the homoallylic product 2.79p in the best 
yield and selectivity (93% yield, 99:1 e.r.). Notably, ethyl glyoxylate 2.85s could be 




an enantiomeric ratio of 97:3. Branched aliphatic aldehydes isovaleraldehyde 2.85t and 
pivaldehyde 2.85u, while challenging substrates for other methods, were also excellent 
substrates, affording the products 2.79t and 2.79u in great enantioselectivities (>97:3 e.r.) 
and good yields (70 and 57% isolated yield respectively). 
 
aConventional heating at 50 ℃ for 24 h. PMP=p-methoxyphenyl group 
Figure 2.25 Scope of Aliphatic Aldehydes in Asymmetric Petasis Allylation 
Substrate Scope of Amine Component 
Very few of asymmetric imine allylation methodologies had taken on the challenge 
of exploring imines with varying N-substitution under a set of standardized conditions. 




substitutions in the allylation of iminoesters and iminophosphonates;78 whereas the Schaus 
group studied a more expansive collection of acyl imines in the asymmetric allylboration 
reaction, which led to the synthesis of maraviroc.31 Yamamoto and Fernandes examined 
different N-alkyl substituted imines in their extended research of asymmetric allylation 
catalyzed by chiral π-allylpalladium complexes; however, the level of enantioseletivity was 
largely dependent on the substrate.79-82  
 
aConventional heating at 50 ℃ for 24 h. 
Figure 2.26 Scope of Aromatic Amines Using Cyclohexanecarboxaldehyde 
With respect to the challenge of accessing chiral homoallylic amines with varying 




nature of the Petasis borono-Mannich reaction. Cyclohexanecarboxaldehyde 2.85p was 
chosen as a representative aliphatic aldehyde, considering that incorporation of aliphatic 
imines was another challenge in this field. Aryl amines were first evaluated (Figure 2.26). 
Substitutions at the para-position with both electron-donating and electron-withdrawing 
groups resulted in similarly high levels of yield and enantioselectivity (2.88a-d). 
Substitutions at the meta-position led to comparable results in enantioselectivity (2.88e and 
2.88f), and 2-bromoaniline afforded ortho-substituted homoallyl amine 2.88h with 
excellent enantiomeric purity, which demonstrated the tolerance of substituents in different 
positions. 2-Naphthylamine also proved to be an excellent substrate in the Petasis allylation 
reaction (2.88g). 2-Amino pyridine afforded the desired product 2.88i in a largely 
compromised yield, even when conventional heating conditions were employed. This 
result might be ascribed to the interruption of the boronate-imine coordination by the 
Lewis-basic pyridyl group. However, the product was still isolated in a synthetically useful 





Figure 2.27 Crossover Study of Aromatic Aldehydes and Amines 
The Petasis allylation adducts derived from aromatic aldehydes and amines were 
identified as promising antifungal agents. A structure-activity relationship (SAR) study has 
been established for the corresponding racemic compounds.83-84 Cross experiments 
between aromatic aldehydes and amines with opposite electronic properties were thus 
performed and condensation products 2.89a and 2.89b were obtained with excellent yields 





Figure 2.28 Catalyst Screen for Asymmetric Petasis Allyation Using Benzyl Amine 
We next evaluated the use of aliphatic amines in the Petasis borono-Mannich 
allylation reaction. As previously disclosed, chiral homoallylic amine products derived 
from N-alkyl imines are challenging to access in high enantioselectivities,79-82 although 
they are important intermediates in the synthesis of natural products and bioactive 
molecules.85 The preliminary study uncovered that N-p-methoxybenzyl imine 
demonstrated good reactivity; however, there was a great room for the improvement of 




optimized conditions in the presence of 10 mol% of 2.19 (Figure 2.28), the desired product 
2.91 was obtained in excellent yield with promising enantioselectivity (96% yield, 91:9 
e.r.). A catalyst screen was carried out with regard to the 3,3’-substitutions of the BINOL 
catalysts. Biphenols with other phenyl-derived subtitutions failed to improve the selectivity 
(Figure 2.28). We postulated that the increased basicity of alkyl amines compared to that 
of aromatic amines might play an important part. The stoichiometry of benzyl amine was 
therefore reduced to one equivalent, which led to a significant increase in selectivity. 
Finally, the conditions were standardized by using an equimolar amount of aldehyde and 
amine with 4 mol% of Ph2-BINOL 2.19 as the catalyst (Figure 2.29). p-
Methoxybenzylamine and allylamine were subjected to the Petasis allylation reaction, 
affording the corresponding homoallylic amines 2.95a and 2.95b in excellent yields and 
enantioselectivities. Products such as the di-olefin 2.95b may serve as precursors for ring-
closing metathesis, utilized as important building blocks in synthesis.82, 86 Furthermore, 
aliphatic aldehydes were also successfully incorporated with benzylamine, producing 
enantioenriched homoallyllic amines 2.95c and 2.95d, further demonstrating the scope of 





a8 mol% of catalyst. 
Figure 2.29 Asymmetric Petasis Allylation with Aliphatic Amines 
Proposed Catalytic Cycle 
A rational catalytic cycle for the asymmetric Petasis allylation was proposed 
(Figure 2.30). The cyclic allylboronate 2.18 is less prone to undergo ligand exchange with 
the BINOL catalyst compared to acyclic boronates. The role of t-BuOH is postulated to 
promote the catalytic pathway by lowering the energy barrier for the transesterification 
process. In particular, t-BuOH acts as a Lewis base which coordinates to the cyclic 
boronate, forming a tetrahedral “ate” complex 2.96. This interaction disrupts the stable 
planar dioxaborinane ring, preventing the electron back-donation from nO to pB. The 




generating a highly reactive chiral boron complex 2.97. Brown’s study23 on allylboronate 
revealed that acyclic boronates and the catechol-derived boronate were more reactive 
nucleophiles. In this context, opening the dioxaborinane ring and substituting an electron-
withdrawing moiety provides a more nucleophilic boronate 2.97, which subsequently 
coordinates with the in situ generated imine via a six-membered Zimmerman-Traxler 
transition state. The BINOL ligand attached to the boron atom provides the facial bias, 
forcing the imine partner to be attacked from si face. After the asymmetric γ-addition, the 
catalyst is sequestered in a resting state 2.99. To regenerate the catalyst, the liberated 
alcohol (in R group) from the boronate intramolecularly attacks the boron atom to reform 
the thermodynamically favored dioxaborinane ring, which enables rapid catalyst turnover.  
 
Figure 2.30 Proposed Catalytic Cycle 
Diastereoselective Petasis Borono-Mannich Crotylation 
We next turned our attention to the asymmetric Petasis crotylation reaction. As 




2.102a with high diastereo- and enantioselectivity (Figure 2.31). Conversely, (Z)-
crotylboronate 2.101 afforded the syn-diastereomer 2.103a predominantly in lower yield 
and d.r. (Figure 2.31). The observed enantioselectivity and diastereoselectivity was 
consistent with the reaction of (E)-crotylboronate with N-acyl imines as previously 
disclosed.31 In contrast, the (Z)-crotylboronate afforded the expected syn product in the 
present study.69 The observed good enantioselectivity but lower diasteroselectivity and 
yield for (Z)-crotylboration can be attributed to a pseudo-diaxial interaction between the 
crotyl-methyl group on the boronate and the aryl substituent of in situ isomerized Z-imine 
(Figure 2.32). Benzyl amine was also evaluated in the multicomponent crotylboration 
reaction. The (E)- and (Z)-crotylboronate afforded the corresponding anti- and syn-
diastereomers with excellent diastereoselectivities and enantioselectivities (Figure 2.31). 
Of note, the syn-diastereomer 2.103b was achieved in enhanced diastereoselectivity in 
comparison to 2.103a. This could be attributed to the free rotation introduced by the 
additional methylene of the benzyl group, which reduced the steric interaction in the 






a4 mol% of catalyst. b8 mol% of catalyst. 
Figure 2.31 Asymmetric Petasis Crotylation 
 
Figure 2.32 Model for Selectivity: (E)- and (Z)-Crotylboronate 
Conclusion 
In summary, we have developed an asymmetric Petasis borono-Mannich allylation 
reaction that affords chiral homoallylic amines using a chiral biphenol catalyst.87 The 




aromatic or aliphatic groups. The reaction is operationally straightforward; a one-pot, two-
step procedure affords the chiral amine products expediently in excellent yields and 
enantioselectivities. Furthermore, the crotylboration reactions provide access to both syn- 
and anti-diastereomers bearing two vicinal stereogenic centers. The generality of the imine 
condensation step indicates a broader utility of the allylation products than has been 







All 1H NMR and 13C NMR spectra were recorded using Varian Unity Plus 500 MHz 
spectrometer at ambient temperature in CDCl3 (Cambridge Isotope Laboratories, Inc.). 
Chemical shifts in 1H NMR spectra are reported in parts per million from tetramethylsilane 
with the solvent resonance as the internal standard (deuterochloroform: δ 7.26 ppm). Data 
are reported as follows: chemical shift, multiplicity (app= apparent, br = broad, par obsc = 
partially obscure, ovrlp = overlapping, s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet), coupling constant (Hz), and integration. Chemical shifts in 13C NMR are 
reported in ppm from tetramethylsilane with the solvent resonance as the internal standard 
(deuterochloroform: δ 77.0 ppm). All 13C NMR spectra were recorded with complete 
proton decoupling. Infrared spectra were recorded on a Nicolet Nexus 670 FT-IR ESP 
spectrophotometer. High-resolution mass spectra were obtained in the Boston University 
Chemical Instrumentation Center using a Waters Q-TOF mass spectrometer. LC-MS 
experiments were performed using an Agilent Single-Quad LC/MSD VL with single-quad 
low resolution (1 decimal place) capable of both ESI positive and negative modes using 
flow injection analysis. GC-MS experiments were performed using an Agilent GC-MS 
6890N equipped with a MS detector up to 800 m/z. The ionization is electron impact (EI) 
and software is ChemStation. Optical rotations were recorded on an AUTOPOL III digital 
polarimeter at 589 nm, and were reported as [α]T °CD (concentration in grams/100 mL 
solvent). Chiral HPLC analysis was performed using an Agilent 1100 series HPLC System 




Inc., 25 cm×4.6 mm I.D.), Chiralpak®AD-H (Chiral Technologies Inc., 25 cm × 4.6 mm 
I.D.) and Chiralpak®IA (Chiral Technologies Inc., 25 cm × 4.6 mm I.D.). Analytical thin 
layer chromatography was performed using EMD 0.25 mm silica gel 60-F plates. Flash 
column chromatography was performed on Sorbent Technologies 60 Å silica gel. Yields 
refer to chromatographically and spectroscopically pure compounds, unless otherwise 
stated. Catalyst loadings were calculated with respect to the amount of boronate. All 
reactions were carried out in oven-dried glassware under an argon atmosphere unless 
otherwise noted. Microwave reactions were conducted using a CEM Discover SP® 
microwave synthesis system. HPLC grade THF, CH2Cl2, Et2O and toluene were purchased 
from Fisher and VWR and were purified and dried by passing through as PURE SOLV® 
solvent purification system (Innovative Technology Inc.). The chiral biphenols were 
purchased or prepared according to known literature procedures.88 Allylboronate and 
crotylboronates were prepared according to our previously reported procedure.73  All 
reagents were purchased from commercial suppliers and used without further purification. 
3 Å molecular sieves (powdered) were oven-dried before use. 






A 10-mL oven-dried microwave reaction vial equipped with a stir bar was charged with 
aldehyde 2.85a (42.4 mg, 0.4 mmol), p-anisidine 2.86 (98.5 mg, 0.8 mmol) and oven-dried 
powdered 3 Å molecular sieves (350 mg). To the vial was added 1 mL of CH2Cl2 and the 
mixture was allowed to stir at room temperature for 2 h, at which time the reaction mixture 
was concentrated first by rotary evaporation and then by static pressure vacuum (2 – 10 
Torr) for 10 min. To the residue were added allylboronate 2.18 (75.6 mg, 0.6 mmol) and 
racemic BINOL (34.4 mg, 0.12 mmol). The slurry was sonicated for 5 min and then 
subjected to microwave irradiation at 10 W (the internal temperature was measured to be 
50 ℃) for 1 h. The crude reaction mixture was then dissolved in CH2Cl2 and loaded directly 
onto a silica gel column. Purification using an elution of hexanes:EtOAc (99:1) afforded 
the homoallylic amine (±)-2.79a as a colorless oil. 
General Procedure for Asymmetric Petasis Allylation to Afford Enantioenriched 
Homoallylic Amines 
 
A 10-mL oven-dried microwave reaction vial equipped with a stir bar was charged with 
aldehyde 2.85a (42.4 mg, 0.4 mmol), p-anisidine 2.86 (98.5 mg, 0.8 mmol) and oven-dried 




mixture was allowed to stir at room temperature for 2 h, at which time the reaction mixture 
was concentrated first by rotary evaporation and then by static pressure vacuum (2 – 10 
Torr) for 10 min. To the residue were added allylboronate 2.18 (75.6 mg, 0.6 mmol), (R)-
3,3’-Ph2-BINOL 2.19 (5.3 mg, 0.012 mmol) and t-BuOH (88.9 mg, 1.2 mmol). The slurry 
was sonicated for 5 min and then subjected to microwave irradiation at 10 W (the internal 
temperature reached 50 ℃) for 1 h. The crude reaction mixture was then dissolved in 
CH2Cl2 and loaded directly onto a silica gel column. Purification using an elution of 
hexanes:EtOAc (99:1) afforded the homoallylic amine 2.79a as a colorless oil. 
Absolute Stereochemical Determination of Allylboration Products 
 
A solution of ammonium cerium nitrate (CAN) (3.0 mmol) in water (10 mL) was cooled 
to 0 ℃ and added slowly to a stirred solution of homoallyl amine 2.79a (0.6 mmol) in 
acetonitrile (12 mL) at 0 ℃.89 The reaction was allowed to slowly warm up to room 
temperature for 2 h, at which time saturated NaHCO3 solution was added to adjust pH of 
the solution to 6, then sodium sulfite was added to quench the excess CAN. The mixture 
was extracted with EtOAc (3 × 10 mL) and the combined organic phase was dried over 
MgSO4 and concentrated in vacuo. The residue was purified by column chromatography 
over silica gel to afford ent-2.5 in 60% yield. The optical rotation was in agreement with 




Analytical Data for Homoallylic Amines 
(S)-4-Methoxy-N-(1-phenylbut-3-en-1-yl)aniline (2.79a) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 91 mg, 90%. 
e.r.: 97:3. [α]D22 = +2.4 (c = 1.0, CHCl3). HPLC Analysis, tr major: 15.4 min., tr minor: 
16.1 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 0.5 
mL/min, 254 nm]. All spectra were in agreement with reported data.91 
 
(S)-N-(1-(4-Fluorophenyl)but-3-en-1-yl)-4-methoxyaniline (2.79b) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1 → 98:2 (hexanes:EtOAc). Yield: 76 mg, 
70%.  
e.r.: 97:3. [α]D22 = +18.0 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 43.4 min., tr major: 
45.0 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 0.2 
mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.27 – 7.22 (m, 2H), 6.96 – 6.90 (m, 2H), 6.61 (d, J = 8.8 
Hz, 2H), 6.35 (d, J = 8.8 Hz, 2H), 5.67 (dddd, J = 24.0, 10.0, 7.0, 7.0 Hz, 1H), 5.13 – 5.04 
(m, 2H), 4.21 (dd, J = 7.9, 5.2 Hz, 1H), 3.82 (s, 1H), 3.62 (s, 3H), 2.52 – 2.32 (m, 2H). 13C 
NMR (126 MHz, CDCl3) δ 161.8 (d, 1JCF=244.4), 152.1, 141.4, 139.4, 134.5, 127.8 (d, 
3JCF=7.6), 118.4, 115.3 (d, 2JCF=20.2), 114.7, 114.7, 57.3, 55.7, 43.5.  
HRMS m/z 272.1449 [(M + H+) calc’d for C17H18NOFH+: 272.1451].  





Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 94 mg, 87%. 
e.r.: 97:3. [α]D22 = +10.6 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 11.4 min., tr major: 
12.4 min., [Chiralpak®AD-H column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 
mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.23 – 7.11 (m, 1H), 7.08 – 7.03 (m, 1H), 7.02 – 6.96 (m, 
1H), 6.86 – 6.78 (m, 1H), 6.60 (dd, J = 8.8, 2.6 Hz, 2H), 6.35 (dd, J = 8.8, 2.6 Hz, 2H), 
5.73 – 5.55 (m, 1H), 5.13 – 5.03 (m, 2H), 4.23 – 4.17 (m, 1H), 3.82 (s, 1H), 3.59 (s, 3H), 
2.53 – 2.43 (m, 1H), 2.41 – 2.30 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 163.2 (d, 
1JCF=245.7), 152.2, 146.9 (d, 3JCF=6.3), 141.3, 134.3, 130.0 (d, 3JCF=7.6), 122.0 (d, 
4JCF=2.5), 118.6, 114.8, 114.6, 113.8 (d, 2JCF=21.4), 113.2 (d, 2JCF=21.4), 57.6, 55.7, 43.2.  
HRMS m/z 272.1450 [(M + H+) calc’d for C17H18NOFH+: 272.1451].  




Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 98:2 → 95:5, hexanes:EtOAc. Yield: 118 mg, 
99%. e.r.: 97:3. [α]D22 = –31.6 (c = 1.0, CHCl3). HPLC Analysis, tr major: 25.3 min., tr 
minor: 30.7 min., [Chiralpak®IA column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 





Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 93 mg, 72%.  
e.r.: 96:4. [α]D22 = +7.0 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 10.7 min., tr major: 
11.5 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 1.0 
mL/min, 210 nm].  
1H NMR (500 MHz, CDCl3) δ 7.50 (d, J = 8.1 Hz, 2H), 7.41 (d, J = 8.1 Hz, 2H), 6.61 (d, 
J = 8.8 Hz, 2H), 6.34 (d, J = 8.8 Hz, 2H), 5.71 – 5.61 (m, 1H), 5.17 – 5.01 (m, 2H), 4.28 
(dd, J = 7.9, 5.0 Hz, 1H), 3.87 (s, 1H), 3.61 (s, 3H), 2.58 – 2.30 (m, 2H). 13C NMR (126 
MHz, CDCl3) δ 152.2, 148.1, 141.1, 134.1, 129.2 (q, 2JCF = 33.6 Hz), 126.7, 125.6 (q, 3JCF 
= 3.8 Hz), 124.2 (q, 1JCF = 272.2 Hz), 118.8, 114.8, 114.6, 57.6, 55.7, 43.2.  
HRMS m/z 322.1417 [(M + H+) calc’d for C18H18NOF3H+: 322.1419].  
IR (thin film, cm-1): 3038, 2925, 2832, 1617, 1512, 1326, 1240, 1162, 1123, 1067, 1038, 
1016, 923, 819. 
 
(S)-4-Methoxy-N-(1-(3-trifluoromethylphenyl)but-3-en-1-yl)aniline (2.79f) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 98 mg, 76%.  
e.r.: 98:2. [α]D22 = +18.0 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 11.1 min., tr major: 
13.0 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 




1H NMR (500 MHz, CDCl3) δ 7.56 (s, 1H), 7.49 (d, J = 7.6 Hz, 1H), 7.42 (d, J = 7.6 Hz, 
1H), 7.36 (dd, J = 7.6, 7.6 Hz, 1H), 6.61 (d, J = 8.8 Hz, 2H), 6.35 (d, J = 8.8 Hz, 2H), 5.72 
– 5.62 (m, 1H), 5.15 – 5.07 (m, 2H), 4.27 (dd, J = 7.9, 5.1 Hz, 1H), 3.86 (s, 1H), 3.62 (s, 
3H), 2.56 – 2.34 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 151.2, 144.1, 140.2, 133.1, 130.2, 
130.0, 129.9 (q, 2JC-F = 32.1 Hz), 125.4 (q, 1JC-F = 272.3 Hz), 122.9 (q, 3JC-F = 3.7 Hz), 
122.1 (q, 3JCF = 3.7 Hz), 117.8, 113.7, 113.7, 56.8, 54.7, 42.3.  
HRMS m/z 322.1422 [(M + H+) calc’d for C18H18NOF3H+: 322.1419].  




Prepared according to the general procedure, but by conventional heating at 50 ℃ for 24 
h. The crude mixture was purified by flash column chromatography with elution by 99:1 
→ 98:2, hexanes:EtOAc. Yield: 93 mg, 70%. 
e.r.: 95:5. [α]D22 = –21.4 (c = 1.0, CHCl3). HPLC Analysis, tr major: 12.4 min., tr minor: 
13.2 min., [Chiralpak®IA column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 







Prepared according to the general procedure, but by conventional heating at 50 ℃ with 4 
mol% catalyst for 24 h. The crude mixture was purified by flash column chromatography 
with elution by 99:1, hexanes:EtOAc. Yield: 91 mg, 80%. 
e.r.: 97:3. [α]D22 = –10.6 (c = 1.0, CHCl3). HPLC Analysis, this 
compound was converted to its trifluoroacetamide, tr minor: 11.5 min., 
tr major: 12.7 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., 
hexanes:i-PrOH = 99.5:0.5, 1.0 mL/min, 254 nm].  
All spectra were in agreement with reported data.93  
 
(S)-N-(1-(Benzo[d][1,3]dioxol-5-yl)but-3-en-1-yl)-4-methoxyaniline (2.79i) 
Prepared according to the general procedure, but by conventional heating at 50 ℃ with 4 
mol% catalyst for 24 h. The crude mixture was purified by flash column chromatography 
with elution by 97:3, hexanes:EtOAc. Yield: 77 mg, 65%. 
e.r.: 98:2. [α]D22 = –12.9 (c = 1.0, CHCl3). HPLC Analysis, tr major: 10.7 min., tr minor: 
11.4 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 
mL/min, 254 nm]. All spectra were in agreement with reported data.91 
 
(S)-4-Methoxy-N-(1-(naphthalen-2-yl)but-3-en-1-yl)aniline (2.79j) 
Prepared according to the general procedure, but by conventional heating at 50 ℃ with 4 




with elution by 99:1 → 98:2, hexanes:EtOAc to afford the compound as a yellow oil. Yield: 
109 mg, 90%.  
e.r.: 97:3. [α]D22 = –27.9 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 15.4 min., tr major: 
16.1 min., [Chiralpak®IA column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 1.0 
mL/min, 254 nm]. All spectra were in agreement with reported data.92 
 
(S)-N-(1-(Furan-2-yl)but-3-en-1-yl)-4-methoxyaniline (2.79k) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 98:2, hexanes:EtOAc. Yield: 80 mg, 82%. 
e.r.: 98:2. [α]D22 = –87.8 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 10.0 min., tr major: 
10.7 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 
mL/min, 250 nm]. All spectra were in agreement with reported data.91 
 
(S)-4-Methoxy-N-(1-(thiophen-2-yl)but-3-en-1-yl)aniline (2.79l) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc to afford the compound as 
a yellow oil. Yield: 102 mg, 98%.  
e.r.: 98:2. [α]D22 = –6.8 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 13.1 min., tr major: 
14.9 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 
mL/min, 210 nm]. 
IR (thin film, cm-1): 3033, 2945, 1511, 1238, 1037, 819, 773, 701.  





Prepared according to the general procedure, but by conventional heating at 50 ℃ for 24 
h. The crude mixture was purified by flash column chromatography with elution by 98:2, 
hexanes:EtOAc. Yield: 70 mg, 62%.  
e.r.: 99:1. [α]D22 = +6.5 (c = 1.0, CHCl3). HPLC Analysis, tr major: 15.5 min., tr minor: 
17.0 min., [Chiralcel®OD column, 24cm×4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 
mL/min, 254 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.27 – 7.03 (m, 5H), 6.69 (d, J = 8.4 Hz, 2H), 6.44 (d, J = 
8.4 Hz, 2H), 5.73 (dq, J = 10.6, 7.3 Hz, 1H), 5.05 – 4.93 (m, 2H), 3.67 (s, 3H), 3.35 – 3.25 
(m, 1H), 3.19 (s, 1H), 2.75 – 2.56 (m, 2H), 2.30 – 2.16 (m, 2H), 1.88 – 1.67 (m, 2H). 13C 
NMR (126 MHz, CDCl3) δ 151.9, 142.1, 141.8, 134.7, 128.4, 128.4, 125.8, 117.7, 114.9, 
114.8, 55.8, 52.8, 38.5, 36.1, 32.4.  
HRMS m/z 282.1848 [(M + H+) calc’d for C19H23NOH+: 282.1581]. 
IR (thin film, cm-1): 3100, 3030, 2990, 2929, 1511, 1238, 1038, 818.  
 
(S,E)-4-Methoxy-N-(1-phenylhexa-1,5-dien-3-yl)aniline (2.79n) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 84 mg, 75%. 
e.r.: 97:3. [α]D22 = –105.1 (c = 1.0, CHCl3). HPLC Analysis, tr major: 24.2 min., tr minor: 
27.5 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 






Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 98:2, hexanes:EtOAc. Yield: 100 mg, 90%. 
e.r.: 97:3. [α]D22 = –206.3 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 11.5 min., tr major: 
33.0 min., [Chiralcel®OD column, 24cm×4.6 mm I.D., hexanes:i-PrOH = 98:2, 1.0 
mL/min, 254 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.28 (dd, J = 6.9, 2.7 Hz, 2H), 7.23 – 7.15 (m, 3H), 6.74 (d, 
J = 8.8 Hz, 2H), 6.67 (d, J = 8.8 Hz, 2H), 6.03 – 5.85 (m, 1H), 5.22 – 5.10 (m, 2H), 4.28 – 
4.20 (m, 1H), 3.68 (s, 3H), 3.54 (s, 1H), 2.67 – 2.46 (m, 2H). 13C NMR (126 MHz, CDCl3) 
δ 152.9, 140.6, 133.7, 131.7, 128.2, 128.1, 123.0, 118.8, 116.1, 114.7, 89.7, 83.4, 55.7, 
46.8, 40.1.  
HRMS m/z 278.1540 [(M + H+) calc’d for C19H19NOH+: 278.1545].  
IR (thin film, cm-1): 3100, 3030, 2990, 2832, 2300, 1597, 1521, 1238, 1037, 919, 820, 757, 
691.  
 
(S)-N-(1-Cyclohexylbut-3-en-1-yl)-4-methoxyaniline (2.79p)  
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 93 mg, 93%. 
e.r.: 99:1. [α]D22 = +16.1 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 17.9 min., tr major: 
19.1 min., [Chiralpak®IA column, 24cm×4.6 mm I.D., hexanes:i-PrOH = 99.9:0.1, 1.0 






Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 97:3, hexanes:EtOAc. Yield: 84 mg, 71%.  
e.r.: 95:5. [α]D22 = –23.2 (c = 1.0, CHCl3). HPLC Analysis, tr major: 20.9 min., tr minor: 
25.4 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 
mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.19 (m, 5H), 6.69 (d, J = 8.8 Hz, 2H), 6.51 (d, J = 
8.8 Hz, 2H), 5.86 – 5.56 (m, 1H), 5.06 – 4.96 (m, 2H), 4.49 – 4.40 (m, 2H), 3.67 (s, 3H), 
3.51 – 3.39 (m, 3H), 2.39 – 2.25 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 152.2, 141.4, 
138.2, 135.0, 128.4, 127.6, 127.6, 117.5, 115.2, 114.9, 73.3, 71.0, 55.8, 53.7, 36.1.  
HRMS m/z 298.1803 [(M + H+) calc’d for C19H23NO2H+: 298.1807].  
IR (thin film, cm-1): 3102, 2905, 2362, 1512, 1239, 1102, 1039, 916, 819, 740, 698.  
 
(R,Z)-N-(Deca-1,7-dien-4-yl)-4-methoxyaniline (2.79r) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 87 mg, 84%.  
e.r.: 96:4. [α]D22 = +6.1 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 13.7 min., tr major: 
14.5 min., [Chiralpak®AD-H column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 99.75:0.25, 
1.0 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 6.69 (d, J=8.9 Hz, 2H), 6.48 (d, J=8.9 Hz, 2H), 5.78 – 5.68 
(m, 1H), 5.35 – 5.22 (m, 2H), 5.05 – 4.93 (m, 2H), 3.66 (s, 3H), 3.34 – 3.23 (m, 1H), 3.17 




0.86 (dd, J=7.5, 7.5 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 151.8, 141.9, 134.9, 132.3, 
128.4, 117.5, 114.9, 114.8, 55.8, 53.0, 38.4, 34.3, 23.7, 20.5, 14.3.  
HRMS m/z 260.2009 [(M + H+) calc’d for C17H25NOH+: 260.2014].  
IR (thin film, cm-1): 3035, 2932, 2840, 1512, 1240, 1041, 818, 772.  
 
Ethyl (S)-2-((4-methoxyphenyl)amino)pent-4-enoate (2.79s) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 95:5, hexanes:EtOAc. Yield: 70 mg, 70%.  
e.r.: 97:3. [α]D22 = –36.8 (c = 1.0, CHCl3). HPLC Analysis, tr major: 10.9 min., tr minor: 
14.7 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 1.0 
mL/min, 230 nm].  
1H NMR (500 MHz, CDCl3) δ 6.69 (d, J = 7.9 Hz, 2H), 6.52 (d, J = 7.9 Hz, 2H), 5.78 – 
5.65 (m, 1H), 5.13 – 5.03 (m, 2H), 4.01 – 3.94 (m, 2H), 3.97 (t, J = 5.8 Hz, 1H), 3.83 (s, 
1H), 3.65 (s, 3H), 2.60 – 2.34 (m, 2H), 1.16 (t, J = 7.0 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 173.4, 152.6, 140.5, 132.8, 118.6, 115.2, 115.0, 115.0, 114.8, 114.7, 114.7, 60.8, 
57.0, 55.5, 37.0, 14.1.  
HRMS m/z 250.1450 [(M + H+) calc’d for C14H19NO3H+: 254.1545].  
IR (thin film, cm-1): 3030, 2990, 1733, 1515, 1239, 1037, 820. 
 
(R)-4-Methoxy-N-(6-methylhept-1-en-4-yl)aniline (2.79t) 
Prepared according to the general procedure. The crude mixture was purified by flash 




e.r.: 97:3. [α]D22 = +20.8 (c = 1.0, CHCl3). HPLC Analysis, tr major: 12.0 min., tr minor: 
13.2 min., [Chiralpak®AD-H column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.5:0.5, 
1.0 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 6.69 (d, J = 7.8 Hz, 1H), 6.48 (d, J = 7.8 Hz, 1H), 5.78 – 
5.70 (m, 1H), 5.07 – 4.90 (m, 2H), 3.67 (s, 3H), 3.42 – 3.19 (m, 1H), 3.10 (s, 1H), 2.19 (d, 
J = 6.2 Hz, 1H), 1.76 – 1.66 (m, 1H), 1.37 – 1.13 (m, 2H), 0.87 (d, J = 6.6 Hz, 2H), 0.83 
(d, J = 6.6 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 151.7, 142.0, 134.9, 117.5, 115.0, 
114.6, 55.8, 51.4, 44.0, 38.7, 24.9, 23.0, 22.6.  
HRMS m/z 234.1850 [(M + H+) calc’d for C15H23NOH+: 234.1858].  
IR (thin film, cm-1): 3030, 2990, 2954, 1511, 1241, 1041, 818.  
 
(S)-N-(2,2-Dimethylhex-5-en-3-yl)-4-methoxyaniline (2.79u) 
Prepared according to the general procedure, but by conventional heating at 50 ℃ for 24 
h. The crude mixture was purified by flash column chromatography with elution by 99:1, 
hexanes:EtOAc. Yield: 70 mg, 57%.  
e.r.: 99:1. [α]D22 = +12.9 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 12.5 min., tr major: 
13.1 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.9:0.1, 1.0 
mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 6.65 (d, J = 8.9 Hz, 2H), 6.46 (d, J = 8.9 Hz, 2H), 5.80 – 
5.64 (m, 1H), 4.96 (d, J = 17.1 Hz, 1H), 4.87 (d, J = 10.1 Hz, 1H), 3.66 (s, 3H), 3.10 (s, 




NMR (126 MHz, CDCl3) δ 151.2, 144.0, 137.1, 116.1, 114.8, 113.9, 63.1, 55.8, 36.6, 36.0, 
26.9.  
MS m/z 234 [(M + H) + calc’d for C15H23OH+: 234].  
IR (thin film, cm-1): 3015, 2954, 1512, 1237, 1041, 816.  
 
(S)-N-(1-Cyclohexylbut-3-en-1-yl)aniline (2.88a) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 77 mg, 84%.  
e.r.: 99:1. [α]D22 = +5.1 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 6.3 min., tr major: 7.0 
min., [Chiralpak®AD-H column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.9:0.1, 1.0 
mL/min, 250 nm].  
1H NMR (500 MHz, CDCl3) δ 7.14 – 6.94 (m, 2H), 6.59 – 6.52 (m, 1H), 6.51 – 6.44 (m, 
2H), 5.73 (dddd, J = 17.2, 10.2, 7.0, 7.0 Hz, 1H), 5.02 – 4.91 (m, 2H), 3.43 (s, 1H), 3.30 – 
3.07 (m, 1H), 2.35 – 2.21 (m, 1H), 2.21 – 2.05 (m, 1H), 1.84 – 1.53 (m, 5H), 1.48 – 1.39 
(m, 1H), 1.27 – 0.86 (m, 5H). 13C NMR (126 MHz, CDCl3) δ 148.4, 135.6, 129.2, 117.0, 
116.5, 113.0, 57.3, 41.3, 35.9, 29.4, 29.1, 26.6, 26.5, 26.4.  
HRMS m/z 230.1915 [(M + H+) calc’d for C16H23NH+: 230.1909].  
IR (thin film, cm-1): 3020, 2924, 2851, 1601, 1505, 1495, 1320, 746, 691.  
 
(S)-N-(1-Cyclohexylbut-3-en-1-yl)-4-fluoroaniline (2.88b) 
Prepared according to the general procedure. The crude mixture was purified by flash 




e.r.: 98:2. [α]D22 = +10.4 (c = 1.0, CHCl3). HPLC Analysis, this compound 
was converted to its trifluoroacetamide, tr minor: 7.8 min., tr major: 8.9 
min., [Chiralpak®IA column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 
99.9:0.1, 1.0 mL/min, 210 nm].  
1H NMR (500 MHz, CDCl3) δ 6.82 – 6.72 (m, 2H), 6.45 – 6.37 (m, 2H), 5.77 – 5.66 (m, 
1H), 5.01 – 4.94 (m, 2H), 3.31 (s, 1H), 3.13 – 3.04 (m, 1H), 2.30 – 2.22 (m, 1H), 2.17 – 
2.06 (m, 1H), 1.79 – 1.72 (m, 1H), 1.72 – 1.62 (m, 3H), 1.62 – 1.55 (m, 1H), 1.46 – 1.37 
(m, 1H), 1.20 – 0.90 (m, 5H). 13C NMR (126 MHz, CDCl3) δ 156.2, 154.3, 144.8, 144.8, 
135.5, 117.1, 115.7, 115.5, 113.9, 113.8, 58.3, 41.3, 35.8, 29.4, 29.1, 26.6, 26.4, 26.4.  
HRMS m/z 248.1822 [(M + H+) calc’d for C16H22NFH+: 248.1815].  
IR (thin film, cm-1): 3030, 2925, 2852, 1610, 1510, 1447, 1317, 1220, 914, 817, 766.  
 
(S)-4-Bromo-N-(1-cyclohexylbut-3-en-1-yl)aniline (2.88c) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 96 mg, 78%. 
e.r.: 99:1. [α]D22 = +10.9 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 12.3 min., tr major: 
14.6 min., [Chiralpak®AD-H column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 99.9:0.1, 
1.0 mL/min, 210 nm].  
1H NMR (500 MHz, CDCl3) δ 7.13 (d, J = 8.7 Hz, 1H), 6.36 (d, J = 8.7 Hz, 1H), 5.70 
(dddd, J = 17.4, 10.5, 7.1, 7.1 Hz, 1H), 5.00 – 4.95 (m, 1H), 3.46 (s, 1H), 3.15 – 3.11 (m, 




1.21 – 0.87 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 147.4, 135.3, 131.9, 117.3, 114.5, 
107.8, 57.5, 41.4, 35.9, 29.5, 29.1, 26.5, 26.4, 26.3.  
HRMS m/z 308.1010 [(M + H+) calc’d for C16H22NBrH+: 308.1014].  
IR (thin film, cm-1): 3030, 2924, 2851, 1593, 1497, 1446, 1319, 1177, 810.  
 
(S)-N-(1-Cyclohexylbut-3-en-1-yl)-4-methylaniline (2.88d) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 79 mg, 80%.  
e.r.: 99:1. [α]D22 = +9.5 (c = 1.0, CHCl3). HPLC Analysis, tr major: 40.2 min., tr major: 
42.6 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.9:0.1, 1.0 
mL/min, 254 nm]. 
1H NMR (500 MHz, CDCl3) δ 6.95 (d, J = 8.0 Hz, 2H), 6.49 (d, J = 8.0 Hz, 2H), 5.88 – 
5.69 (m, 1H), 5.14 – 4.95 (m, 2H), 3.39 (s, 1H), 3.25 – 3.15 (m, 1H), 2.41 – 2.26 (m, 1H), 
2.25 – 2.12 (m, 1H), 2.22 (s, 3H), 1.85 – 1.80 (m, 1H), 1.76 – 1.72 (m, 3H), 1.70 – 1.60 
(m, 1H), 1.52 – 1.42 (m, 1H), 1.24 – 1.03 (m, 5H). 13C NMR (126 MHz, CDCl3) δ 146.1, 
135.8, 129.7, 125.7, 116.9, 113.1, 57.7, 41.3, 36.0, 29.5, 29.1, 26.6, 26.5, 26.4, 20.3.  
HRMS m/z 244.2074 [(M + H+) calc’d for C17H25NH+: 244.2065].  
IR (thin film, cm-1): 3034, 2923, 2852, 1618, 1519, 1447, 1318, 1225, 806. 
 
(S)-N-(1-Cyclohexylbut-3-en-1-yl)-3-methoxyaniline (2.88e) 
Prepared according to the general procedure. The crude mixture was purified by flash 




e.r.: 95:5. [α]D22 = +7.0 (c = 1.0, CHCl3). HPLC Analysis, tr major: 16.6 min., tr minor: 
27.0 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.5:0.5, 1.0 
mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 6.96 (dd, J = 8.1, 8.1 Hz, 1H), 6.14 – 6.08 (m, 2H), 6.04 
(dd, J = 2.3, 2.3 Hz, 1H), 5.72 (dddd, J = 17.2, 10.2, 7.0, 7.0 Hz, 1H), 5.02 – 4.91 (m, 2H), 
3.68 (s, 3H), 3.46 (s, 1H), 3.20 – 3.12 (m, 1H), 2.32 – 2.18 (m, 1H), 2.18 – 2.04 (m, 1H), 
1.78 – 1.53 (m, 5H), 1.47 – 1.36 (m, 1H), 1.20 – 0.89 (m, 5H). 13C NMR (126 MHz, CDCl3) 
δ 160.9, 149.8, 135.6, 129.9, 117.1, 106.3, 101.5, 99.0, 57.4, 55.0, 41.4, 36.0, 29.5, 29.1, 
26.6, 26.4, 26.4.  
HRMS m/z 260.2009 [(M + H+) calc’d for C17H25NOH+: 260.2014].  
IR (thin film, cm-1): 3050, 2925, 2851, 1612, 1511, 1495, 1449, 1209, 1161, 1050, 825. 
 
(S)-N-(1-Cyclohexylbut-3-en-1-yl)-2,3-dihydrobenzo[b][1,4]dioxin-6-amine (2.88f) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 99 mg, 86%. 
e.r.: 96:4. [α]D22 = +7.9 (c = 1.0, CHCl3). HPLC Analysis, tr major: 50.0 min., tr minor: 
54.8 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.9:0.1, 1.0 
mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 6.59 (d, J = 8.5 Hz, 1H), 6.15 – 5.92 (m, 2H), 5.72 (dddd, 
J = 17.2, 10.2, 7.0, 7.0 Hz, 1H), 5.01 – 4.90 (m, 2H), 4.14 (dd, J = 5.5, 2.7 Hz, 2H), 4.09 
(dd, J = 5.5, 2.7 Hz, 2H), 3.17 (s, 1H), 3.07 – 3.00 (m, 1H), 2.33 – 2.18 (m, 1H), 2.14 – 




1.41 (dddd, J = 11.6, 8.4, 5.5, 3.0 Hz, 1H), 1.22 – 0.85 (m, 5H). 13C NMR (126 MHz, 
CDCl3) δ 144.0, 143.5, 135.7, 135.0, 117.6, 117.0, 107.1, 101.6, 64.8, 64.2, 58.3, 41.2, 
35.8, 29.4, 29.1, 26.6, 26.4, 26.4.  
HRMS m/z 288.1961 [(M + H+) calc’d for C18H25NO2H+: 288.1964].  
IR (thin film, cm-1): 3048, 2924, 2851, 1626, 1593, 1509, 1449, 1210, 1078, 921.  
 
(S)-N-(1-Cyclohexylbut-3-en-1-yl)naphthalen-2-amine (2.88g) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 105 mg, 94%.  
e.r.: 99:1. [α]D22 = +20.2 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to its trifluoroacetamide, tr minor: 15.8 min., tr major: 17.5 min., 
[Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 
99.9:0.1, 1.0 mL/min, 250 nm].  
1H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 8.1 Hz, 1H), 7.53 – 7.47 (m, 2H), 7.25 (ddd, J 
= 8.1, 6.8, 1.2 Hz, 1H), 7.07 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 6.76 (dd, J = 8.7, 2.4 Hz, 1H), 
6.68 (d, J = 2.4 Hz, 1H), 5.76 (dddd, J = 17.2, 10.2, 7.1, 7.1 Hz, 1H), 5.04 – 4.93 (m, 2H), 
3.61 (d, J = 6.6 Hz, 1H), 3.38 – 3.21 (m, 1H), 2.38 – 2.16 (m, 2H), 1.84 – 1.78 (m, 1H), 
1.76 – 1.65 (m, 3H), 1.62 – 1.56 (m, 1H), 1.54 – 1.43 (m, 1H), 1.22 – 0.98 (m, 5H). 13C 
NMR (126 MHz, CDCl3) δ 146.0, 135.5, 135.3, 128.9, 127.6, 127.1, 126.2, 125.7, 121.6, 
118.2, 117.2, 104.5, 57.3, 41.3, 35.8, 29.5, 29.2, 26.6, 26.4, 26.4.  
HRMS m/z 280.2062 [(M + H+) calc’d for C20H25NH+: 280.2065].  





Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by hexanes. Yield: 88 mg, 71%. 
e.r.: 99:1. [α]D22 = –4.8 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 10.2 min., tr major: 
11.5 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes, 0.8 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.42 (dd, J = 7.6, 1.5 Hz, 1H), 7.15 (ddd, J = 8.4, 7.6, 1.5 
Hz, 1H), 6.64 (dd, J = 8.4, 1.5 Hz, 1H), 6.52 (ddd, J = 8.4, 7.6, 1.5 Hz, 1H), 5.83 (dddd, J 
= 17.2, 10.2, 7.1, 7.1 Hz, 1H), 5.23 – 4.97 (m, 2H), 4.29 (d, J = 8.8 Hz, 1H), 3.44 – 3.17 
(m, 1H), 2.49 – 2.16 (m, 2H), 1.98 – 1.64 (m, 5H), 1.57 (dddd, J = 14.9, 8.3, 5.6, 2.9 Hz, 
1H), 1.37 – 0.96 (m, 5H). 13C NMR (126 MHz, CDCl3) δ 144.9, 135.1, 132.5, 128.4, 117.4, 
116.9, 111.6, 109.8, 57.8, 41.4, 36.1, 29.5, 28.9, 26.6, 26.4, 26.4.  
ESIMS m/z 308, 310 [(M + H+) calc’d for C16H22BrNH+: 308, 310].  
IR (thin film, cm-1): 3072, 2925, 2851, 1595, 1509, 1458, 1323, 1017, 914, 739.  
 
(S)-N-(1-Cyclohexylbut-3-en-1-yl)pyridin-2-amine (2.88i) 
Prepared according to the general procedure, but by conventional heating at 50 ℃ for 24 
h. The crude mixture was purified by flash column chromatography with elution by 
hexanes:EtOAc = 98:2. Yield: 62 mg, 50%.  
e.r.: 96:4. [α]D22 = +15.4 (c = 1.0, CHCl3). HPLC Analysis, tr major: 17.6 min., tr minor: 
20.3 min., [Chiralpak®IA-H column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 97:3, 0.5 




1H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 5.5 Hz, 1H), 7.36 (dd, J = 8.1, 7.0 Hz, 1H), 
6.50 (dd, J = 7.0, 5.5 Hz, 1H), 6.33 (d, J = 8.1 Hz, 1H), 5.89 – 5.69 (m, 1H), 5.17 – 4.94 
(m, 2H), 4.37 (d, J = 9.4 Hz, 1H), 3.67 – 3.55 (m, 1H), 2.44 – 2.10 (m, 2H), 1.89 – 1.55 
(m, 5H), 1.53 – 1.44 (m, 1H), 1.31 – 0.92 (m, 5H). 13C NMR (126 MHz, CDCl3) δ 158.9, 
148.1, 137.3, 135.3, 117.2, 112.2, 106.6, 55.5, 41.5, 36.4, 29.6, 28.8, 26.5, 26.3, 26.3.  
ESIMS m/z 231 [(M + H+) calc’d for C15H22N2H+: 231].  




Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by hexanes:EtOAc = 99:1. Yield: 117 mg, 98%.  
e.r.: 98:2. [α]D22 = +21.0 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 29.8 min., tr major: 
31.5 min., [Chiralpak®IA-H column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 
mL/min, 250 nm].  
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.27 (m, 2H), 7.00 (dd, J = 8.6, 8.6 Hz, 2H), 6.62 (d, 
J = 8.6 Hz, 1H), 6.04 (dd, J = 8.6, 2.7 Hz, 1H), 5.99 (d, J = 2.7 Hz, 1H), 5.73 (dddd, J = 
16.6, 10.2, 7.8, 6.3 Hz, 1H), 5.20 – 5.09 (m, 2H), 4.25 (dd, J = 8.1, 5.1 Hz, 1H), 4.19 – 
4.15 (m, 2H), 4.15 – 4.07 (m, 2H), 3.88 (s, 1H), 2.61 – 2.31 (m, 2H). 13C NMR (126 MHz, 
CDCl3) δ 161.8(d, 1JCF=244.4), 143.8, 142.2, 139.3, 139.3, 135.7, 134.4, 127.8(d, 3JCF=7.6), 
118.5, 117.5, 115.4, 115.4(d, 2JCF=21.4), 107.3, 102.2, 64.7, 64.1, 57.2, 43.4.  




IR (thin film, cm-1): 3073, 2977, 2925, 2872, 1627, 1509, 1214, 1069, 833.  
 
(S)-4-Fluoro-N-(1-(4-methoxyphenyl)but-3-en-1-yl)aniline (2.89b)  
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by hexanes:EtOAc = 99:1. Yield: 108 mg, 85%. 
e.r.: 98:2. [α]D22 = +7.6 (c = 1.0, CHCl3). HPLC Analysis, tr major: 30.4 min., tr minor: 
34.5 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.9:0.1, 1.0 
mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 8.4 Hz, 2H), 6.92 – 6.83 (m, 2H), 6.82 – 6.75 
(m, 2H), 6.46 – 6.38 (m, 2H), 5.86 – 5.65 (m, 1H), 5.24 – 5.10 (m, 2H), 4.28 (dd, J = 8.0, 
5.0 Hz, 1H), 4.03 (s, 1H), 3.80 (s, 3H), 2.63 – 2.41 (m, 2H). 13C NMR (126 MHz, CDCl3) 
δ 158.6, 155.7 (d, 1JCF=226.8), 143.7, 143.7, 135.3, 134.7, 127.3, 118.3, 115.4 (d, 
2JCF=21.4), 114.3 (d, 3JCF=7.6), 114.0, 57.1, 55.2, 43.4.  
ESIMS m/z 272 [(M + H+) calc’d for C18H18FNO2H+: 272].  
IR (thin film, cm-1): 3073, 2907, 2835, 1509, 1246, 1217, 1173, 1034, 919, 820.  
 
(S)-N-(4-Methoxybenzyl)-1-phenylbut-3-en-1-amine (2.95a) 
Prepared according to the general procedure, but with an equimolar amount of amine (0.4 
mmol) and with 4% catalyst. The crude mixture was purified by flash column 




e.r.: 96:4. [α]D22 = –44.8 (c = 1.0, CHCl3). HPLC Analysis, this compound 
was converted to its trifluoroacetamide, tr minor: 16.1 min., tr major: 17.9 
min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 
0.6 mL/min, 230 nm]. All spectra were in agreement with reported data.81 
 
(S)-N-Allyl-1-phenylbut-3-en-1-amine (2.95b) 
Prepared according to the general procedure, but with an equimolar amount of amine (0.4 
mmol) and with 4% catalyst. The crude mixture was purified by flash column 
chromatography with elution by hexanes:EtOAc = 95:5 → 90:10. Yield: 54 mg, 72%.  
e.r.: 96:4. [α]D22 = –31.0 (c = 1.0, CHCl3). HPLC Analysis, this compound 
was converted to its trifluoroacetamide, tr minor: 9.2 min., tr major: 9.8 min., 
[Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 0.6 
mL/min, 230 nm]. All spectra were in agreement with reported data.81 
 
(S)-N-Benzyl-1-cyclohexylbut-3-en-1-amine (2.95c) 
Prepared according to the general procedure, but with an equimolar amount of amine (0.4 
mmol) and with 8% catalyst. The crude mixture was purified by flash column 
chromatography with elution by hexanes:EtOAc = 95:5 → 90:10. Yield: 90 mg, 92%. 
e.r.: 95:5. [α]D22 = –5.0 (c = 1.0, CHCl3). HPLC Analysis, this compound 
was converted to its trifluoroacetamide, tr minor: 14.9 min., tr major: 16.3 
min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 999:1, 





Prepared according to the general procedure, but with an equimolar amount of amine (0.4 
mmol) and with 8% catalyst. The crude mixture was purified by flash column 
chromatography with elution by hexanes:EtOAc = 95:5 → 90:10. Yield: 99 mg, 89%.  
e.r.: 94:6. [α]D22 = –9.5 (c = 1.0, CHCl3). HPLC Analysis, this compound 
was converted to its trifluoroacetamide, tr minor: 11.9 min., tr major: 16.8 
min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 
99:1, 0.8 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.09 (m, 9H), 6.37 (s, 1H), 5.75 – 5.62 (m, 1H), 5.07 
– 4.94 (ovrlp, 2H), 3.71 (d, J = 13.3 Hz, 1H), 3.54 (d, J = 13.3 Hz, 1H), 3.17 (dd, J = 7.7, 
6.3 Hz, 1H), 2.33 – 2.15 (m, 2H), 1.80 (d, J = 1.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) 
δ 140.7, 139.1, 137.9, 135.6, 129.0, 128.3, 128.2, 128.1, 127.3, 126.8, 126.2, 117.1, 65.5, 
51.3, 39.2, 13.1. 
ESIMS m/z 278 [(M + H+) calc’d for C20H23NH+: 278]. 
IR (thin film, cm-1): 3062, 3025, 2975, 2923, 2855, 1640, 1600, 1495, 1358, 1117, 1074, 
1029, 993, 917. 





A 5-mL oven-dried flask was charged with stir bar and flushed with Ar. To the vial was 
added aldehyde 2.85a (42.4 mg, 0.4 mmol), p-anisidine 2.86 (98.5 mg, 0.8 mmol) and 
oven-dried powdered 3Å molecular sieves (350 mg). The mixture was then dissolved in 
CH2Cl2 (1 mL) and allowed to stir for 2 h at room temperature, at which time the reaction 
mixture was concentrated first by rotary evaporation and then by static pressure vacuum (2 
– 10 Torr) for 10 min. To the residue were added E-crotylboronate 2.100 (84.0 mg, 0.6 
mmol), (R)-3,3’-Ph2-BINOL 2.19 (5.3 mg, 0.012 mmol) and t-BuOH (88.9 mg, 1.2 mmol). 
The slurry was sonicated for 5 min and then heated at 50 ℃ for 24 h. The crude reaction 
mixture was then dissolved in CH2Cl2 and loaded directly onto a silica gel column. 
Purification using an elution of hexanes:EtOAc (99:1) afforded the homocrotyl amine 
2.102a as a colorless oil. The reaction with Z-crotylboronate 2.101 followed the same 
procedure.  
Procedure for Preparation of Racemic Crotylation Products 
 
A 5-mL oven-dried flask was charged with stir bar and flushed with Ar. To the vial was 
added aldehyde 2.85a (42.4 mg, 0.4 mmol), p-anisidine 2.86 (98.5 mg, 0.8 mmol) and 
oven-dried powdered 3Å molecular sieves (350 mg). The mixture was then dissolved in 
CH2Cl2 (1 mL) and allowed to stir for 2 h at room temperature, at which time the reaction 
mixture was concentrated first by rotary evaporation and then by static pressure vacuum (2 




mmol) and scandium triflate (39.4 mg, 0.08 mmol). The slurry was sonicated for 5 min and 
then heated at 50 ℃ for 24 h. The crude reaction mixture was then dissolved in CH2Cl2 and 
loaded directly onto a silica gel column. Purification using an elution of hexanes:EtOAc 
(99:1) afforded the racemic products 2.102a and 2.103a as an inseparable mixture with 3:2 
ratio. 
 
A 5-mL oven-dried flask was charged with stir bar and flushed with Ar. To the vial was 
added aldehyde 2.85a (42.4 mg, 0.4 mmol), benzylamine 2.90 (42.9 mg, 0.4 mmol) and 
oven-dried powdered 3Å molecular sieves (350 mg). The mixture was then dissolved in 
CH2Cl2 (1 mL) and allowed to stir for 2 h at room temperature, at which time the reaction 
mixture was concentrated first by rotary evaporation and then by static pressure vacuum (2 
– 10 Torr) for 10 min. To the residue were added E-crotylboronate 2.100 (84.0 mg, 0.6 
mmol), racemic 3,3’-Ph2-BINOL (35.3 mg, 0.08 mmol) and t-BuOH (88.9 mg, 1.2 mmol). 
The slurry was sonicated for 5 min and then heated at 50 ℃ for 36 h. The crude reaction 
mixture was then dissolved in CH2Cl2 and loaded directly onto a silica gel column. 
Purification using an elution of hexanes:EtOAc (99:1) afforded the racemic amine 2.102b 
as a colorless oil. The reaction with Z-crotylboronate 2.101 followed the same procedure 




Absolute Stereochemical Determination of Crotylboration Products 
 
A solution of ammonium cerium nitrate (3.0 mmol) in water (10 mL) was cooled to 0 ℃ 
and added slowly to a stirred solution of homocrotyl amine 2.102a (0.6 mmol) in 
acetonitrile (12 mL) at 0 ℃. The reaction slowly warmed up to room temperature for 2 
hours, at which time saturate NaHCO3 was added to adjust to pH 6 of the solution and then 
sodium sulfite was added. The mixture was extracted with EtOAc and the organic phase 
was dried over MgSO4 and concentrated in vacuo. The residue was purified by column 
chromatography over silica gel to afford 2.104 in 58% yield. The optical rotation was in 
agreement with literature value. [α]D22 = +71.0 (c = 1.0, CHCl3). Lit:96 [α]D22 = +76 (c = 
0.92, CHCl3). The stereochemistry of the syn-diastereomer 2.103a was deduced based on 
its NMR spectra and chiral HPLC trace compared to those of 2.102a.  
Analytical Data for Petasis Crotylboration Products 
4-Methoxy-N-((1S,2S)-2-methyl-1-phenylbut-3-en-1-yl)aniline (2.102a) 
Prepared according to the general procedure. The crude mixture was purified by flash 
column chromatography with elution by 99:1, hexanes:EtOAc. Yield: 89 mg, 83%.  
e.r.: 98:2. d.r.: >20:1. [α]D22 = –17.7 (c = 1.0, CHCl3). HPLC Analysis, tr major: 19.9 
min., tr minor: 22.7 min., [Chiralpak®IA column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 




1H NMR (500 MHz, CDCl3) δ 7.34 – 7.16 (m, 4H), 7.15 – 7.07 (m, 1H), 6.61 – 6.46 (m, 
2H), 6.40 – 6.23 (m, 2H), 5.67 (ddd, J = 17.2, 10.4, 3.6 Hz, 1H), 5.20 – 4.89 (m, 2H), 3.95 
– 3.85 (m, 2H), 3.55 (s, 3H), 2.46 – 2.36 (m, 1H), 0.95 – 0.85 (m, 3H). 13C NMR (126 
MHz, CDCl3) δ 150.9, 141.9, 141.0, 139.8, 127.3, 126.4, 126.0, 115.2, 113.7, 113.5, 62.3, 
54.7, 44.5, 16.4.  
HRMS m/z 268.1702 [(M + H+) calc’d for C18H21NOH+: 268.1701].  
IR (thin film, cm-1): 3052, 2923, 2851, 1628, 1522, 1238, 825. 
 
4-Methoxy-N-((1S,2R)-2-methyl-1-phenylbut-3-en-1-yl)aniline (2.103a) 
A 5-mL oven-dried flask was charged with stir bar and flushed with Ar. To the vial was 
added aldehyde 2.85a (42.4 mg, 0.4 mmol), p-anisidine 2.86 (98.5 mg, 0.8 mmol) and 
oven-dried powdered 3Å molecular sieves (350 mg). The mixture was then dissolved in 
CH2Cl2 (1 mL) and allowed to stir for 2 h at room temperature, at which time the reaction 
mixture was concentrated first by rotary evaporation and then by static pressure vacuum (2 
– 10 Torr) for 10 min. To the residue were added Z-crotylboronate 2.101 (84.0 mg, 0.6 
mmol), (R)-3,3’-Ph2-BINOL 2.19 (10.6 mg, 0.024 mmol) and t-BuOH (88.9 mg, 1.2 mmol). 
The slurry was sonicated for 5 min and then heated at 50 ℃ for 24 h. The crude reaction 
mixture was then dissolved in CH2Cl2 and loaded directly onto a silica gel column. 
Purification using an elution of hexanes:EtOAc (99:1) afforded the homocrotyl amine 
2.103a as a colorless oil. The crude mixture was purified by flash column chromatography 




e.r.: 96:4. d.r.: 9:1. [α]D22 = –14.7 (c = 1.0, CHCl3). HPLC Analysis, tr major: 24.1 min., 
tr minor: 25.4 min., [Chiralpak®IA column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 
99.6:0.4, 0.5 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.33 – 6.99 (m, 5H), 6.71 – 6.51 (m, 2H), 6.49 – 6.28 (m, 
2H), 5.83 – 5.54 (m, 1H), 5.16 – 4.94 (m, 2H), 4.21 (d, J = 4.8 Hz, 1H), 3.89 (s, 1H), 3.60 
(s, 3H), 2.65 – 2.55 (m, 1H), 0.99 – 0.80 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 151.8, 
141.6, 141.3, 140.5, 128.1, 127.5, 126.8, 114.7, 114.6, 114.5, 62.1, 55.7, 55.7, 43.9, 15.1.  
HRMS m/z 268.1702 [(M + H+) calc’d for C18H21NOH+: 268.1701].  
IR (thin film, cm-1): 3052, 2923, 2851, 1628, 1522, 1238, 825.  
 
(1S,2S)-N-Benzyl-2-methyl-1-phenylbut-3-en-1-amine (2.102b) 
A 5-mL oven-dried flask was charged with stir bar and flushed with Ar. To the vial was 
added aldehyde 2.85a (42.4 mg, 0.4 mmol), benzylamine 2.90 (42.9 mg, 0.4 mmol) and 
oven-dried powdered 3Å molecular sieves (350 mg). The mixture was then dissolved in 
CH2Cl2 (1 mL) and allowed to stir for 2 h at room temperature, at which time the reaction 
mixture was concentrated first by rotary evaporation and then by static pressure vacuum (2 
– 10 Torr) for 10 min. To the residue were added E-crotylboronate 2.100 (84.0 mg, 0.6 
mmol), (R)-3,3’-Ph2-BINOL 2.19 (21.2 mg, 0.048 mmol) and t-BuOH (88.9 mg, 1.2 mmol). 
The slurry was sonicated for 5 min and then heated at 50 ℃ for 24 h. The crude reaction 
mixture was then dissolved in CH2Cl2 and loaded directly onto a silica gel column. 
Purification using an elution of hexanes:EtOAc (99:1) afforded the homocrotyl amine 




e.r.: 95:5. d.r.: >20:1. [α]D22 = –6.8 (c = 1.0, CHCl3). HPLC Analysis, this compound was 
converted to its trifluoroacetamide, tr minor: 5.6 min., tr major: 6.4 min., 
[Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.6:0.4, 
1.0 mL/min, 230 nm]. All spectra were in agreement with reported data.97 
 
(1S,2R)-N-Benzyl-2-methyl-1-phenylbut-3-en-1-amine (2.103b) 
A 5-mL oven-dried flask was charged with stir bar and flushed with Ar. To the vial was 
added aldehyde 2.85a (42.4 mg, 0.4 mmol), benzylamine 2.90 (42.9 mg, 0.4 mmol) and 
oven-dried powdered 3Å molecular sieves (350 mg). The mixture was then dissolved in 
CH2Cl2 (1 mL) and allowed to stir for 2 h at room temperature, at which time the reaction 
mixture was concentrated first by rotary evaporation and then by static pressure vacuum (2 
– 10 Torr) for 10 min. To the residue were added Z-crotylboronate 2.101 (84.0 mg, 0.6 
mmol), (R)-3,3’-Ph2-BINOL 2.19 (21.2 mg, 0.048 mmol) and t-BuOH (88.9 mg, 1.2 mmol). 
The slurry was sonicated for 5 min and then heated at 50 ℃ for 24 h. The crude reaction 
mixture was then dissolved in CH2Cl2 and loaded directly onto a silica gel column. 
Purification using an elution of hexanes:EtOAc (99:1) afforded the homocrotyl amine 
2.103b as a colorless oil. Yield: 61 mg, 61%.  
e.r.: 99:1. d.r.: >20:1. [α]D22 = –5.4 (c = 1.0, CHCl3). HPLC Analysis, this compound was 
converted to its trifluoroacetamide, tr minor: 7.8 min., tr major: 9.8 min., 
[Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.6:0.4, 




Sample HPLC Traces 
 
Signal 2: MWD1 B, Sig=254,16 Ref=360,100 
Peak RetTime Type  Width     Area      Height     Area   
  #   [min]        [min]   [mAU*s]     [mAU]        % 
----|-------|----|-------|----------|----------|--------| 
   1  19.135 MM    0.3688 1353.00488   61.14547  31.3021 
   2  21.137 MF    0.4682 1326.61926   47.22167  30.6917 
   3  22.400 MF    0.4037  822.08112   33.93830  19.0190  
   4  23.127 FM    0.4427  820.70502   30.90025  18.9872 
Totals :                  4322.41028  173.20569 
  

















































Signal 2: MWD1 B, Sig=254,16 Ref=360,100 
Peak RetTime Type  Width     Area      Height     Area   
  #   [min]        [min]   [mAU*s]     [mAU]        % 
----|-------|----|-------|----------|----------|--------| 
   1  19.924 BB    0.3941 2.65917e4   963.08258  97.8992 
   2  22.661 PB    0.4193  570.63116   19.16848   2.1008 
Totals :                  2.71624e4   982.25106 
 
Signal 2: MWD1 B, Sig=254,16 Ref=360,100 
Peak RetTime Type  Width     Area      Height     Area   
  #   [min]        [min]   [mAU*s]     [mAU]        % 
----|-------|----|-------|----------|----------|--------| 
   1  20.470 BB    0.3795  574.39081   21.79113   7.9098 
   2  23.032 BV    0.4538  252.86507    8.06544   3.4822 
   3  24.149 VV    0.4643 6164.26758  191.13638  84.8870 
   4  25.350 VB    0.5095  270.21066    7.62421   3.7210 
Totals :                  7261.73412  228.61717  









































3Enantioselective Synthesis of Allenes by Catalytic Traceless Petasis Reactions 
Introduction 
Traceless Petasis reactions, a new class of Petasis borono-Mannich reactions 
featuring an eliminable reaction component, was first developed by Thomson and co-
workers (Figure 3.1).98 Alkynyl trifluoroborates were coupled with 2-
nitrobenzenesulfonylhydrazide 3.1 and α-hydroxyaldehydes or ketones, affording a 
transient propargylic hydrazide 3.2 as the Petasis adduct (Figure 3.1). Spontaneous loss of 
sulfinic acid 3.3 generated diazene species 3.4, which underwent a retro-ene pathway to 
produce the racemic allene product with concomitant extrusion of nitrogen. The scope of 
the carbonyl component in the traceless Petasis reaction was later expanded to include 
substrates lacking α-hydroxy substituents by using BF3·OEt2 as an activator.99  
 




The Myers lab demonstrated that enantioenriched propargylic diazene species 
underwent stereospecific retro-ene rearrangement in the transformation to optically active 
allenes.100 The chirality information of the diazene intermediate originated from 
enantioenriched propargylic alcohols via a Mitsunobu displacement reaction (Figure 3.2).  
 
Figure 3.2 Stereospecific Synthesis of Enantioenriched Allenes from Propargylic Alcohols 
We reasoned that if the propargylic hydrazide 3.2 could be accessed 
enantioselectively, we would be able to develop a direct asymmetric route to synthesizing 
enantioenriched allenes. An asymmetric Petasis borono-Mannich reaction had been 
revealed by Schaus and co-workers in the VAPOL-catalyzed coupling of alkenyl boronic 
esters, secondary amines and ethyl glyoxylate.14 Asymmetric synthesis of homoallylic 
amines by a catalytic Petasis allylation reaction between aldehydes, amines and 
allylboronate had also been demonstrated. We therefore envisaged two distinct approaches 
to producing the enantioenriched propargylic hydrazide as the Petasis product (Figure 3.3). 
In the first method, the propargylic hydrazide 3.6 could be generated from the assembly of 
glycolaldehyde, a sulfonylhydrazide and an alkynylboronate, which could be 
acknowledged as an enantioselective version of the original traceless Petasis reaction 
developed by Thomson’s group.98 The alternative method included the use of an alkynyl 
aldehyde and allylboronate, which closely resembled the aforementioned asymmetric 




chiral diol exchange with organoboronates, which proved to deliver high levels of 
asymmetric induction.32 Herein, we describe the successful development of both methods 
outlined in Figure 3.3, which enabled direct access to enantioenriched allenyl alcohols 3.5 
and allyl allenes 3.8.  
 
Figure 3.3 Development of Asymmetric Traceless Petasis Reactions to Afford Allenes 
Background 
Chiral Allenes in Natural Products and Pharmaceutical Agents 
Allenes, containing adjacent π-systems, are widely distributed in nature. 
Approximately 150 natural products comprise an allenic or cumulenic structure.101 Almost 
all allene-containing natural products reported to date are chiral and have been isolated in 
an enantioenriched form. Many of these chiral allenes have shown interesting biological 
activities.102 For example, methyl (R,E)-tetradeca-2,4,5-trienoate 3.9 was isolated from 
male “dried bean beetles” Acanthoscelides obtectus as an insect pheromone,103 which 
provides insight for crop protection. The allenic ester 3.10, isolated from Sapium 






Figure 3.4 Examples of Natural Products Containing Chiral Allenes 
Chiral allenes are also featured as key structural elements in pharmaceutical 
agents.105 For instance, 3.11 is a hydrolytically stable allenic prostacyclin analogue, which 
serves as a promising anti-thrombotic agent.106 Allenic nucleoside analogues such as 
cytallene and adenallene were originally developed by Zemlicka.107-108 These allenic 
compounds are now of high interest as cytotoxic and antiviral agents. Of note, (R)-cytallene 
3.12 is found to inhibit HIV-1109 as well as the replication of the hepatitis-B virus110, 
whereas the (S)-enantiomer is much less active.  
 




Chiral Allenes as Important Intermediates in Synthesis 
Allenes are highly versatile intermediates for synthesis since they participate in 
many chemical transformations such as cycloadditions and cyclizations.111-114 
Enantioenriched 1,1-divinylallene 3.17 served as a key precursor in the synthesis of 
pseudopterosins by Sherburn, Paddon-Row and co-workers.115 The Ni(0)-catalyzed 
Kumada coupling between the electrophile 3.15 and the Grignard reagent 3.16 proceeded 
with a high level of formal anti-SN2’ selectivity, thereby furnishing the chiral allene 
intermediate 3.17 in excellent enantiomeric purity (Figure 3.6). The divinyl allene 3.17 
subsequently underwent a Diels-Alder cycloaddition with the dienophile 3.18, giving a 
cyclic cross-conjugated cyclohexene 3.19 with good selectivity. This highly-functionalized 
triene 3.19 was then employed in the construction of the core structure 3.20 of 





Figure 3.6 Cycloaddition of Chiral Allenes in the Synthesis of Pseudopterosin 
Metal-catalyzed cyclizations of allenes bearing a nucleophilic functionality 
represent an attractive approach for the construction of heterocycles.116-118 A Pd-catalyzed 
domino cyclization of an enantioenriched allene 3.21 was developed by Fujii, Ohno and 
co-workers, which enabled direct construction of the ergot alkaloid skeleton 3.22 (Figure 
3.7).119 Of note, the installation of the C5 stereogenic center in 3.23 resulted from the 
transfer of the allenic axial chirality to the center chirality.  
 




Recent Advancements in the Catalytic Enantioselective Synthesis of Allenes 
The development of methods for the asymmetric synthesis of chiral allenes has 
been an area of intense research.120-121 Most of the methods rely on using enantioenriched 
starting materials or stoichiometric amounts of chiral reagents.122 Catalytic 
enantioselective methodologies for the synthesis of allenes had been sparse prior to 
2010.123 Most of these methodologies shared common mechanistic pathways, such as 
nucleophilic additions to chiral Pd-π-allyl complexes, which largely limited the structural 
scope of the allenes. The past few years (2010 - 2016) have seen significant developments 
of new methodologies with innovative mechanistic pathways, including a few examples of 
organocatalytic methods.124 Dynamic kinetic resolutions mediated by chiral catalysts have 
also been developed by groups of Ma125-126 and Feng.127-128 Herein, we examine the recent 
advancements in the catalytic asymmetric synthesis of allenes.  
A catalytic asymmetric amine-promoted synthesis of allenes was developed by Ma 
and co-workers.129 (R,R)-N-PINAP 3.24 was determined to be the optimal Cu(Ⅰ) chiral 
ligand, affording the 1,3-disubstituted allenes in good yields and high enantioselectivities 
(Figure 3.8).130 The alcohol unit in the terminal alkynes was found to play an important 





Figure 3.8 Catalytic Asymmetric Synthesis of 1,3-Disubstituted Chiral Allenes from Terminal Propargyl 
Alcohols and Aldedydes 
An asymmetric 1,6-addition of silyl groups to enynoates was developed by Xu, Loh 
and co-workers which afforded silyl-substituted enantioenriched allene products 3.28 in 
good yields and with high enantioselectivities (Figure 3.9).131 The combination of 5 mol% 
CuTC (copper(Ⅰ) thiophene-2-carboxylate) and 6 mol% chiral bisoxazoline ligand 3.27 was 
determined to be the most efficient catalytic system. Aromatic R1 groups in 3.25 were well 
tolerated; however, aliphatic substituents were unfavorable for this enantioselective 
hydrosilyation, providing good yields but moderate enantioselectivities. Notably, an 
example of chiral tetra-substituted substrates was demonstrated, albeit with an 
enantiomeric ratio of 68:32.  
 




Copper catalysts were also employed in the coupling of diazo compounds with 
terminal alkynes for the synthesis of enantioenriched allenes. The first asymmetric 
synthesis of allenes by C-H insertions of α-diazoesters to terminal alkynes was 
accomplished by the Feng group in 2015, using cationic guanidinium salts 3.27 and 
copper(Ⅰ) complexes (Figure 3.10).132 Enantioenriched 2,4-disubstituted allenoates were 
generated in high yields and enantioselectivities under mild conditions; however, the scope 
of the diazo component was limited to α-diazoesters.  
 
Figure 3.10 Synthesis of Chiral Allenoates by Asymmetric C-H Insertion of α-Diazoesters into Terminal Alkynes 
The scope for asymmetric Cu(Ⅰ)-catalyzed coupling reaction was expanded to 
include non-stabilized diazoalkanes by Wang and co-workers, which led to optically active 
hydrocarbon allenes (Figure 3.11).133 A new chiral bisoxazoline ligand 3.28 was designed 






Figure 3.11 Enantioselective Synthesis of Tri-Substituted Allenes via Cu(I)-Catalyzed Coupling of Diazoalkanes 
with Terminal Alkynes 
A mechanistically distinct approach to optically active allenes via an asymmetric 
β-hydride elimination was reported by Frantz and co-workers (Figure 3.12).134 A new class 
of chiral phosphite ligands IanPhos 3.29 and tert-butyl IanPhos 3.30 were designed, which 
not only achieved excellent asymmetric induction during the β-hydride elimination step 
but also minimized racemization of the allene products. Although there had been several 
approaches to enantioenriched allenoates,128, 132, 135-136 this methodology represented a 
welcome addition to the existing paradigm of chiral allene synthesis.  
 
Figure 3.12 Pd-Catalyzed Asymmetric β-Hydride Elimination for the Synthesis of Chiral Allenes 
Organocatalytic methodologies for the asymmetric synthesis of allenes are scarce 




achieved by the use of an organic catalyst in 1935 by Maitland and Mills.137 This 
asymmetric synthesis was realized by enantioselective dehydration of a racemic allyl 
alcohol in the presence of a catalytic amount of camphorsulfonic acid. Although the initial 
asymmetric induction only achieved an enantiomeric ratio lower than 53:47, the preferred 
enantiomer was enriched by repeated recrystallization.  
Organocatalytic methodologies to access allenes with synthetically useful 
enantiomeric purity did not appear until 2009, when a highly enantioselective 
isomerization reaction of 3-alkynoates was developed by Tan, Huang and co-workers.135 
Chiral bicyclic guanidine 3.31 was found to catalyze the transformation efficiently (Figure 
3.13). 
 
Figure 3.13 Enantioselective Synthesis of Allenoates by Guanidine-Catalyzed Isomerization of Alkynoates 
Asymmetric synthesis of optically active tetra-substituted allenes is one of the most 
demanding challenges in this field. One of the most elegant approaches to solving this 
problem was represented by Maruoka and co-workers.138 Their method featured the 
generation of a chiral ammonium cumulenolate via a tight ion pair with a BINOL-derived 
phase transfer catalyst 3.34, which then underwent nucleophilic addition to tosyl imines 
3.33 enantioselectively (Figure 3.14). The desired tetra-substituted allenes 3.35 were 




could also undergo asymmetric alkylation with simple alkyl halides; however, an 
inseparable mixture of allenes and undesired alkynoates was generated, which limited its 
practical utility.  
 
Figure 3.14 Organocatalytic Synthesis of Chiral Tetra-Substituted Allenes via Phase Transfer Catalysis 
Asymmetric synthesis of 2,3-allenoates was reported by Zhang, Sun and co-
workers through an asymmetric intermolecular addition of nitroalkanes to activated enynes 
(Figure 3.15).136 A bifunctional cinchona-based thiourea catalyst 3.38 was developed, 
which interacted with the ester and nitro functional groups from substrates 3.36 and 3.37 





Figure 3.15 Organocatalytic Enantioselective Synthesis of Allenoates by Addition of Nitroalkanes to Enynes 
A catalytic enantioselective alkynylogous Mukaiyama aldol reaction was 
developed by List and co-workers using a newly designed chiral disulfonimide 3.42 (Figure 
3.16).139 Chiral tetra-substituted allenes were obtained in high yields with excellent regio-, 
diastereo-, and enantioselectivities. The synthetic utility of the chiral allene products was 
showcased by further transformations to more functionalized enantioenriched building 
blocks.  
 




Results and Discussion 
Asymmetric Traceless Petasis Alkynylation 
We initiated our investigation into traceless Petasis alkynylation by screening 
biphenol catalysts under the conditions analogous to those employed in Thomson’s original 
discovery.98 The reaction between 2-nitrobenzenesulfonyl (o-Ns) hydrazide 3.1, 
glycolaldehyde dimer 3.44 and an alkynyl boronic ester 3.45a afforded the desired chiral 
allene 3.5a in a good yield and with promising enantioselectivity when catalyzed by 15 
mol% of 3,3’-Br2-BINOL 3.46a (Figure 3.17). Use of 3,3’-Ph2-BINOL catalyst 3.47 
achieved a similar level of yield and selectivity. Chiral diols with other backbones were 
subsequently examined. Vaulted biaryl diols were successfully employed as the optimal 
ligand in the first catalytic asymmetric Petasis reaction,14 whereas H8-BINOL derivatives 
proved to be the most suitable in systems involving alkynyl boronates.140 Unfortunately, 
neither 3.46b or  3.46c provided substantial improvement in stereoselectivity (Figure 3.17). 
We reasoned that biphenol catalysts substituted by electron-withdrawing units would form 
a more reactive boron “ate” complex, thus out-competing the uncatalyzed racemic pathway. 
Gratifyingly, 3,3’-(CF3)2-BINOL 3.48 accomplished a significant improvement in both 
yield and enantioselectivity. Inspired by this lead catalyst, we synthesized and tested other 
BINOL derivatives substituted by electron-deficient functional groups. Perfluorophenyl-
derived BINOL 3.46d afforded much lower yield compared to 3.47, which might be due 
to unfavorable steric effects. Smaller electron-withdrawing groups were thus evaluated; 
however, cyano- and carboxylic ester-substituted BINOLs 3.46e and 3.46f afforded the 




completely racemic mixture (Figure 3.17). It is likely that these catalysts form strong inter- 
or intramolecular hydrogen bonding, which prevents them from entering the ligand 
exchange process with the boronic esters. We were determined to optimize the biphenol 
catalyst based on the structure of the lead compound 3,3’-(CF3)2-BINOL 3.48. Replacing 
the trifluoromethyl group with a methyl group interestingly resulted in a comparatively 
high level of enantiocontrol, albeit with much lower conversion to the allene product. 
Methoxy-substituted BINOL 3.46h, on the other hand, afforded a nearly racemic outcome 
(Figure 3.17). These results revealed that both the steric and electronic properties of the 
trifluoromethyl groups at the 3,3’-positions are essential to the catalytic ability. We also 
investigated substitutions that closely resembled the trifluoromethyl group, such as 
thiotrifluoromethyl and pentafluoroethyl groups; unfortunately, no enhancement of 





Figure 3.17 Initial Catalyst Screen for the Traceless Petasis Alkynylation 
We next turned our attention to the hydrazide component in the Petasis alkynylation 
reaction. Although it was rendered traceless throughout the course of the reaction, we 
reasoned that the structural properties of the hydrazide unit would make an important 




determined the enantiomeric purity of the final allene product. When additional electron-
withdrawing groups were introduced to the phenyl ring of the o-Ns hydrazide, the desired 
product was isolated with nearly quantitative yields but with much lower selectivity, which 
implied an accelerated uncatalyzed reaction rate (Figure 3.18, 3.49 and 3.50a). p-Ns 
hydrazide 3.50b, however, resulted in minimal conversion to the allene product, although 
the Petasis adduct was isolated in a good yield. This matched Hünig’s observations in the 
thermal cleavage of arenesulfonyl hydrazide to generate sulfinic acid and diimide, in which 
p-Ns hydrazide 3.50b required elevated temperature compared to o-Ns hydrazide 3.1.141 
Halogenated hydrazides were subsequently evaluated. 2,6-Disubsitution was recognized as 
an unfavorable structural pattern, which resulted in poor enantioselectivity (Figure 3.18, 
3.50c). Conversely, 2,5-difluoro-substituted hydrazide 3.50d afforded the highest 
enantiomeric ratio at this stage, albeit with exceptionally low yield even after reacting for 
6 days. Replacing the fluorine atoms by chlorine or bromine significantly improved the 
yield of the reaction without comprising the enantioselectivity (Figure 3.18, 3.51 and 3.50f). 
Finally, 2,5-dibromobenzenesulfonyl hydrazide 3.51 was determined to be a suitable 
substrate given that useful yield was afforded after 48 hours, although the reactivity was 





aReaction was run for 6 days. b48 hours. c4 days. 
Figure 3.18 Evaluation of Hydrazides in the Asymmetric Traceless Petasis Alkynylation 
Extensive investigations were subsequently conducted on the effects of solvent as 
well as the concentration and temperature of the reaction, but no higher enantioselectivity 
was achieved. We decided to design and synthesize new BINOL-derived catalysts in 
pursuit of higher enantiomeric control. Although 3,3’-disubstituted BINOLs have been 
commonly used in catalytic methodologies, 6,6’-disubstituted BINOLs are much less 
explored.142 Kobayashi and co-workers revealed that introduction of strongly electron-




the Lewis acidity of the BINOL catalyst.143 In a later report, they further examined the 
effects of electron-withdrawing groups substituted at the 6,6′-positions of 3,3′-I2-BINOL 
in an enantioselective aldol reaction.144 When the 6,6′-positions were substituted by bromo, 
iodo, and pentafluoroethyl groups, the catalysts demonstrated higher activity. These 
observations encouraged us to synthesize 3,3’-(CF3)2-6,6’-Br2-BINOL 3.52 and 3,3’,6,6’-
(CF3)4-BINOL 3.53, which was not known to the literature (vide infra). A two-dimensional 
evaluation of the hydrazides and catalysts was carried out (Table 3.1). When o-Ns 
hydrazide 3.1 was selected, 3,3’,6,6’-(CF3)4-BINOL 3.53 displayed higher reactivity than 
3,3′-(CF3)2-BINOL 3.48 under lower temperature (Table 3.1, entry 3 and 4). The advantage 
of 3,3’,6,6’-(CF3)4-BINOL 3.53 became more discernible when 3.51 was used as the 
hydrazide component, reaching an enantiomeric ratio of 92:8 (Table 3.1, entry 6). 
Reducing the catalyst loading to 10 mol% did not influence the enantioselectivity. 
Moreover, it was found that the decomposition of the Petasis adduct for the allene 
formation could be facilitated by an aqueous work-up, which afforded higher and more 
reproducible yield (Table 3.1, entry 7). 3,3’-(CF3)2-6,6’-Br2-BINOL 3.52 was also tested 
using the optimized procedure but failed to achieve higher enantioselectivity. Finally, a 
solvent mixture of 1:1 toluene/mesitylene was revealed to attain the best yield and 






Entry Catalyst (mol%) Hydrazide Temperature/Time Yield(%)a e.r.b 
1 3.48 (15 mol%) 3.1 0 °C /24 h 85 86:14 
2 3.53 (15 mol%) 3.1 0 °C /24 h 85 87:13 
3 3.48 (15 mol%) 3.1 –10 °C /48 h 20 88:12 
4 3.53 (15 mol%) 3.1 –10 °C /48 h 50 90:10 
5 3.48 (15 mol%) 3.51 0 °C /48 h 68 88:12 
6 3.53 (15 mol%) 3.51 0 °C /48 h 72 92:8 
7c 3.53 (10 mol%) 3.51 0 °C /48 h 85 92:8 
8c 3.52 (10 mol%) 3.51 0 °C /48 h 51 85:15 
9c,d 3.53 (10 mol%) 3.51 0 °C /48 h 85 93:7 
Reaction conditions: hydrazide (0.4 mmol), glycolaldehyde dimer (0.2 mmol) and powdered 3 Å molecular sieves (400 
mg) were mixed in toluene (1 mL) at room temperature for 2 h and then cooled to the reaction temperature; catalyst, 
boronate (0.52 mmol), toluene were added successively. aIsolated yield. bEnantiomeric ratios determined by chiral HPLC 
analysis. cAfter the completion of the reaction, aqueous 10% NaOH was added and the reaction continued for overnight. 
dPhCH3/Mesitylene=1:1. 




Determination of the Petasis Adduct Intermediate 
We attempted to isolate and analyze the initial Petasis adduct intermediate 3.54 in 
order to garner further insight into the reaction mechanism (Figure 3.19). When the reaction 
was run at –5 ℃, the corresponding propargylic hydrazide 3.54 and the allenyl alcohol 
3.5a were formed as a separable mixture. Although NMR and ESIMS confirmed the 
structure of 3.54, attempts to directly determine the enantiopurity of 3.54 were unsuccessful. 
Subjecting hydrazide 3.54 to chiral HPLC analysis at room temperature resulted in diazene 
formation and sigmatropic rearrangement, giving rise to the corresponding allene product 
3.5a in a 92:8 enantiomeric ratio (Figure 3.19).  
 
Figure 3.19 Determination of the Petasis Adduct Intermediate 
Substrate Scope of Allenyl Alcohols 
With the optimized conditions in hand, we explored the scope of the traceless 
Petasis alkynylation reaction. Aryl-substituted alkynyl boronates were first assessed 
(Figure 3.20). The parent conditions proved successful for electron-poor aryl alkynyl 
boronates (Figure 3.20, 3.5c and 3.5d); however, the electron-rich substrate 3.5b required 
a higher catalyst loading and lower temperature in order to suppress the uncatalyzed 




boronate. The reaction of thiophen-alkynyl boronate 3.45e afforded the chiral allene in 70% 
isolated yield and 92:8 enantiomeric ratio. Naphthalene-alkynyl boronate 3.45f was also a 
viable substrate in the asymmetric traceless Petasis reaction. 
 
a20 mol% catalyst was used at -10 ℃. b72 h. 
Figure 3.20 Substrate Scope for Aryl-Substituted Alkynyl Boronates 
Similarly, alkyl-substituted alkynyl boronates could be used in the reaction (3.45g 
– 3.45k) achieving commensurate levels of enantioselectivities, although longer reaction 
time was necessary to afford moderate to good yields. The trialkyl silyl alkynyl boronate 
3.45m revealed to be one of the most suitable substrates, achieving the highest 





Figure 3.21 Substrate Scope for Alkyl-Substituted Alkynyl Boronates 
α-Hydroxyacetone (3.55) could also be incorporated into the asymmetric traceless 
Petasis reaction, affording tri-substituted allene 3.56 in 91% yield and with an enantiomeric 
ratio of 90:10 (Figure 3.22, eq 1). However, 2-hydroxyacetophenone 3.57 resulted in the 
corresponding tri-substituted allene in substantially lower yield and selectivity, even when 





Figure 3.22 Traceless Petasis Alkynylation with α-Hydroxy Ketones to Afford Tri-Substituted Allenes 
Development of Traceless Petasis Alkynylation Using Cyclic Boronates 
Cyclic alkynyl boronic esters were next investigated. These are appealing 
nucleophiles as they are stable to chromatographic conditions and thereby more 
synthetically practical when accessing more complex allene compounds. Nonetheless, they 
are known to be less reactive towards ligand exchange with the biphenol catalysts. We 
discovered that addition of sub-stoichiometric amount of trialkoxyborate significantly 
facilitated the ligand exchange process of the cyclic boronate 3.59, achieving similar level 
of yield and enantioselectivity compared to the acyclic substrate (Figure 3.23).  
 






Figure 3.24 Proposed Catalytic Cycle 
A rational catalytic cycle for the asymmetric traceless Petasis alkynylation was 
proposed based on our previous knowledge of BINOL-promoted nucleophilic boronate 
additions and Thomson’s original mechanistic proposal (Figure 3.24).98 Ligand exchange 
occurred between the alkynyl boronate 3.45a and the biphenol catalyst 3.53, generating a 
highly reactive chiral boron species 3.60. The hydrazone intermediate 3.61 was formed by 
condensation of glycolaldehyde and hydrazide in the presence of molecular sieves. The α-
hydroxy group in the electrophile provided a handle for the boronate-ligand complex, 
creating a boron “ate” intermediate 3.62, which facilitated the asymmetric delivery of the 
alkynyl group to the C=N bond. Concomitant to formation of the new C-C bond, the 




Stereospecific retro-ene rearrangement afforded the desired allene product 3.5a by a point-
to-axial chirality transfer.  
Ag-Catalyzed Cyclization of Enantioenriched Allenols 
The enantioenriched allenols accessed by the traceless Petasis alkynylation are 
versatile intermediates that may be further functionalized. For example, AgNO3 on silica 
gel145 induced cycloetherification of phenyl-substituted allene 3.5a with no erosion of 
enantiomeric ratio (Figure 3.25, eq 1). Interestingly, AuCl3-catalyzed cyclization146 of 3.5a 
led to significant decrease of enantiopurity (85:15 e.r.), which was due to the formation of 
an epimerizable π-complex intermediate.147 In another example, cyclization of 3.5g was 
achieved with no compromise to enantiopurity by the use of AgNO3 (20 mol%) in 
acetone/water.148 
 
Figure 3.25 Ag-Catalyzed Cyclization of Enantioenriched Allenols 
Asymmetric Traceless Petasis Allylation 
The success in asymmetric traceless Petasis alkynylation prompted us to investigate 




Phenylpropiolaldehyde 3.67a was selected as a model substrate, which was subjected to 
the allylation conditions developed in the synthesis enantioenriched homoallylic amines as 
described in the last chapter. As a proof-of-concept study, the desired allyl allene product 
3.8a was produced in 39% yield and with high enantioselectivity (96:4) after reacting for 
92 h in the presence of 15 mol% of 3,3’-Ph2-BINOL 3.47 (Table 3.2, entry 1). The addition 
of t-BuOH improved both yield and selectivity (Table 3.2, entry 2), as we observed in the 
previous Petasis allylation studies. We next evaluated different thermal conditions (Table 
3.2, entry 3-5), with the catalyst loading set at 7 mol%. Unfortunately, no improvement of 







Entry Catalyst loading (mol%) Conditions Yield(%)a e.r.b 
1c 15 PhCH3 (0.5 M), r.t., 92 h 39 96:4 
2 15 PhCH3 (0.5 M), r.t., 92 h 47 99:1 
3 7 PhCH3 (1.5 M), r.t., 53 h 26 99:1 
4 7 PhCH3 (1.5 M), 50 °C, 43 h 6 96:4 
5 7 PhCH3 (1.5 M), μwave 10 W, 1 h 15 98:2 
Reaction conditions: aldehyde (0.4 mmol), hydrazide (0.4 mmol) and powdered 3 Å molecular sieves (200 mg) were 
mixed in CH2Cl2 (1 mL) at room temperature for 2 h; CH2Cl2 was removed; allylboronate (0.6 mmol), catalyst, t-BuOH, 
toluene were added succesively. aIsolated yield. bDetermined by chiral HPLC analysis. cWith no t-BuOH. 
Table 3.2 Preliminary Optimization of Traceless Petasis Allylation 
We decided to assess other arenesulfonyl hydrazides possessing more electron-
withdrawing groups in an attempt to enhance the reactivity of the hydrazone intermediate. 
o-Ns hydrazides substituted by trifluomethyl and chloro groups were considered since their 
corresponding hydrazones are highly electrophilic and the resulting sulfinites are better 
leaving groups, which is essential for the formation of the diazene intermediate. Indeed, 
hydrazide 3.49 and 3.50a afforded improved yields with desirable enantioselectivities 
(Table 3.3, entry 1-2). Shortening the reaction time to 24 h provided the best yield (Table 




allene product. Further lowering the temperature to 4 °C had detrimental effects on both 





Conditions Yield(%)a e.r.b 
1 3.49 15 PhCH3 (2 M), r.t., 70 h 65 98:2 
2 3.50a 15 PhCH3 (2 M), r.t., 70 h 60 98:2 
3 3.49 7 PhCH3 (2 M), r.t., 24 h 87 99:1 
4 3.49 7 PhCH3 (2 M), 4 °C, 27 h 38 85:15 
Reaction conditions: aldehyde (0.4 mmol), hydrazide (0.4 mmol) and powdered 3 Å molecular sieves (200 mg) were 
mixed in CH2Cl2 (1 mL) at room temperature for 2 h; CH2Cl2 was removed; allylboronate (0.6 mmol), catalyst, t-BuOH, 
toluene were added successively. aIsolated yield. bDetermined by chiral HPLC analysis.  




Substrate Scope of Allyl Allenes 
 
a3 Equivalents of boronate were used. 
Figure 3.26 Substrate Scope for Aryl Alkynyl Aldehydes in the Traceless Petasis Allylation 
We first explored the scope of arylpropiolaldehyde substrates (Figure 3.26). The 
reaction proved general for both electron-rich and electron-poor aldehydes, affording the 
enantioenriched allene products in >98:2 enantiomeric ratio. Of note, ortho-substitution 
was tolerated as demonstrated by 3.8e, albeit with compromised isolated yield. 
Heterocyclic propiolaldehydes were also good substrates for the reaction (>98:2 e.r.), 




increased amount of allylboronate was employed, presumably due to the nitrogenated 
heterocycle acting as a Lewis base to inhibit the reaction (Figure 3.26, 27% yield, 98:2 e.r.). 
 
aReaction for 40 hours. 
Figure 3.27 Substrate Scope for Alkyl Alkynyl Aldehydes in the Traceless Petasis Allylation 
Alkyl-substituted propiolaldehydes were next investigated (Figure 3.27). 
Substrates containing cyclic or acyclic aliphatic moieties were good substrates for the 
reaction (Figure 3.27, 3.8i and 3.8j). Silylpropiolaldehyde afforded the corresponding 
allenylsilane 3.8k in a good yield and with excellent enantioselectivity, which could be 
used in further asymmetric synthesis.149-152 Propargylic propiolaldehydes bearing 
heteroatoms (3.67l – 3.67n) were also good substrates for the reaction. Notably, the basicity 
of nitrogen in 3.67n was mitigated by the adjacent ester group compared to that of 3.67m, 




Total Synthesis of Laballenic Acid 
The synthetic utility of the asymmetric traceless Petasis allylation was showcased 
by the total synthesis of laballenic acid 3.73, a natural product isolated from Leonotis 
nepetaefolia seed oil.153 The first synthesis of laballenic acid was an 8-step enantioselective 
reduction-based approach starting from propargyl alcohol. This natural product was 
obtained in very low enantiomeric purity.154 Ma’s group displayed two new routes to this 
natural product. In the first one, a 6-step synthesis was applied starting from a TBS-
protected propargyl alcohol, n-dodecanal, and by using (R)-α,α-diphenylprolinol as a 
stoichiometric chiral source.155 Laballenic acid was furnished in 12% overall yield with an 
enantiomeric ratio of 99:1. In the other route, the synthesis of laballenic acid was achieved 
in only two steps by starting from methyl 5-hexynoate and dodecanal.156 Stoichiometric 
amount of (R)-α,α-diphenylprolinol was again employed as the chirality inducer, reaching 
a similarly high level of enantiomeric purity (96.5:3.5 e.r.).  
We decided to apply our newly-developed traceless Petasis allylation methodology 
to the synthesis of laballenic acid. A key transformation that demonstrated the utility of the 
allyl allene products was the chemoselective hydroboration of the unhindered terminal 
alkene over the less reactive internal adjacent -systems using 9-BBN. Thus, allene 3.70 
was transformed to alcohol 3.71 in 75% yield with no erosion of enantiomeric purity 
(Figure 3.28). Subsequent Mitsunobu-type cyanation and hydrolysis delivered laballenic 
acid (3.73) in a highly efficient manner.157 This was marked as the first catalytic 





Figure 3.28 Catalytic Asymmetric Synthesis of Laballenic Acid 
Diastereodivergent Traceless Petasis Crotylations 
We next turned our attention to the traceless Petasis crotylation reaction. With 
regard to the observations we made in the Petasis borono-Mannich crotylations of 
benzaldehyde and primary amines as discussed in Chapter 2, we anticipated to achieve a 
diastereodivergent outcome regulated by (E)- or (Z)-crotyldioxaborinane. The reaction of 
propionaldehyde 3.67a with the 2-nitro-4-(trifluoromethyl)-substituted hydrazide 3.49 
using (E)-crotyldioxaborinane 3.75 provided a syn-diastereomer 3.77a with excellent 
enantio- and diastereoselectivity under standard conditions. Disappointingly, under the 
same conditions, (Z)-crotyldioxaborinane 3.76 afforded the anti-diastereomer 3.78a with 




interaction between the crotyl-methyl group and the arenesulfonyl N-substitution arising 
from a chair-like transition state. Nonetheless, truncating the hydrazide structure had a 
remarkable impact on the reaction generality. The use of 2-nitrobenzenesulfonohydrazide 
3.1 with phenyl propionaldehye 3.67a and catalyst (R)-3.47 allowed for highly 
stereoselective reactions with both (E)-crotylboronate 3.75 and (Z)-crotylboronate 3.76 to 
deliver crotyl allene diastereomers (Ra,S)-3.77a and (Ra,R)-3.78a, respectively (Figure 
3.29). The reactions also worked well for hept-2-ynal 3.74 to produce the corresponding 
aliphatic allenes, (Ra,S)-3.77b or (Ra,R)-3.78b. Thus, under a standard set of reaction 
conditions, either diastereomeric product (Ra,S)-3.77 or (Ra,R)-3.78 could be obtained by 
simply switching the olefin geometry of the boronate. These divergent results indicate that 
transfer of chirality from the catalyst to the product most likely proceeded through a closed, 





Figure 3.29 Diastereodivergent Traceless Petasis Crotylations 
The utility of the traceless Petasis crotylation reaction was demonstrated by a 
formal synthesis of a naturally-occurring lactone (+)-cis-3-methyl-4-decanolide (3.81) 
(Figure 3.30). The crotylboration product 3.78b was converted to the terminal alcohol 3.79 
by hydroboration with 9-BBN, and then to carboxylic acid 3.80 after treatment with Jones 
reagent. Ma and coworkers previously demonstrated that acid 3.80 could be transformed 
in two steps to an odor-active lactone 3.81 through a stereoselective iodolactonization 
reaction.158 Access to carboxylic acid 3.80 through our methodology thus completed a six-





Figure 3.30 Use of Traceless Petasis Crotylation Products in Formal Synthesis 
Conclusion 
Catalytic asymmetric synthesis of allenes is still in its infancy, and reactions that 
generate the chiral allene moiety with the simultaneous formation of carbon–carbon bonds 
are exceptionally rare. The two catalytic enantioselective traceless Petasis borono-Mannich 
reactions described in this chapter are powerful new examples of asymmetric synthesis of 
chiral allenes from readily available achiral precursors.160 Both reaction manifolds utilize 
boron nucleophiles that add to in situ generated sulfonylhydrazones to afford chiral 
propargylic hydrazides, which decompose to form unstable diazene intermediates. Retro-
ene fragmentation of the enantioenriched diazene intermediates results in a stereospecific 
point-to-axial transfer of chirality, generating the allene products with concomitant loss of 
dinitrogen. Two classes of allene products, allenol and allyl allene, are accessed in good 
yields and with high enantioselectivities. Both allene products can be further elaborated 
into more functionalized products, including enantioenriched dihydrofurans, and natural 




the crotylation pathway, which provides α-methyl substituted allenes with excellent 







All 1H NMR and 13C NMR spectra were recorded using Varian Unity Plus 500 MHz 
spectrometer at ambient temperature in CDCl3 (Cambridge Isotope Laboratories, Inc.). 
Chemical shifts in 1H NMR spectra are reported in parts per million from tetramethylsilane 
with the solvent resonance as the internal standard (deuterochloroform: δ 7.26 ppm). Data 
are reported as follows: chemical shift, multiplicity (app = apparent, br = broad, par obsc 
= partially obscure, ovrlp = overlapping, s = singlet, d = doublet, t = triplet, q = quartet, m 
= multiplet), coupling constant (Hz), and integration. Chemical shifts in 13C NMR are 
reported in ppm from tetramethylsilane with the solvent resonance as the internal standard 
(deuterochloroform: δ 77.0 ppm). All 13C NMR spectra were recorded with complete 
proton decoupling. Chemical shifts in 19F NMR spectra are reported in parts per million 
using 0.05% α, α, α-trifluorotoluene in deuterobenzene as the external standard. Infrared 
spectra were recorded on a Nicolet Nexus 670 FT-IR ESP spectrophotometer. High-
resolution mass spectra were obtained using a Waters Q-TOF mass spectrometer. LC-MS 
experiments were performed using an Agilent Single-Quad LC/MSD VL with single-quad 
low resolution (1 decimal place) capable of both ESI positive and negative modes using 
flow injection analysis. GC-MS experiments were performed using an Agilent GC-MS 
6890N equipped with a MS detector up to 800 m/z. The ionization is electron impact (EI) 
and software is ChemStation. Optical rotations were recorded on an AUTOPOL III digital 
polarimeter at 589 nm, and were reported as [α]T °CD (concentration in grams/100 mL 




with a diode array detector. Chiral columns include Chiralcel®OD (Chiral Technologies 
Inc., 25cm×4.6mm I.D.), Chiralpak®AD-H (Chiral Technologies Inc., 25cm × 4.6 mm I.D.) 
and Chiralpak®IA-H (Chiral Technologies Inc., 25cm × 4.6 mm I.D.). Analytical thin layer 
chromatography was performed using EMD 0.25 mm silica gel 60-F plates. Flash column 
chromatography was performed on Sorbent Technologies 60 Å silica gel. Yields refer to 
chromatographically and spectroscopically pure compounds, unless otherwise stated. 
Catalyst loadings were calculated with respect to the amount of boronates. All reactions 
were carried out in oven-dried glassware under an argon or nitrogen atmosphere unless 
otherwise noted. HPLC grade THF, dichloromethane, Et2O and toluene were purchased 
from Fisher and VWR and were purified and dried by passing through as PURE SOLV® 
solvent purification system (Innovative Technology Inc.). Triethyl borate was distilled over 
CaH2 before use in the preparation of alkynyl boronates. Mesitylene was dried by and 
stored with 3 Å molecular sieves beads. The chiral biphenols were purchased or prepared 
according to known literature procedures.88 Allylboronate and crotylboronates were 
prepared according to our previously reported procedure.73 All other reagents were 








To a solution of 3.82 (S)-2,2’-bis(methoxymethyloxy)-6,6’-bis(trifluoromethyl)-1,1’-
binaphthyl143 (3.17 g, 5.19 mmol) in dry THF (60 mL) was added a hexane-cyclohexane 
solution of s-butyllithium (1.02 M, 20.8 mL, 21.2 mmol) at –78 °C under argon and the 
resulting mixture was stirred for 1 h at the same temperature. Iodine (7.92 g, 31.2 mmol) 
in dry THF (25 mL) was then added by a cannula and the reaction mixture was stirred for 
an additional 3 h at the same temperature. The reaction was quenched with water and 
diluted with EtOAc. The organic layer was separated and the aqueous layer was extracted 
with EtOAc. The organic layers were combined and treated with aqueous 10% Na2SO3 to 
destroy excess iodine, washed with brine, and dried over anhydrous sodium sulfate. After 
filtration and concentration under reduced pressure, the crude product was purified by silica 




bis(methoxymethoxy)-6,6’-bis(trifluoromethyl)-1,1’-binaphthalene 3.83 as an amorphous 
oil in 65% yield.  
[α]D22= +3.1 (c=1.1, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 8.67 (s, 2H), 8.11 (s, 2H), 7.48 (d, J = 8.9 Hz, 2H), 7.25 (d, 
J = 8.9 Hz, 2H), 4.91 – 4.71 (m, 4H), 2.55 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 154.5, 
141.1, 134.9, 130.8, 127.9 (q, J = 32.6 Hz), 127.5, 125.8, 125.0, 124.5 (q, J = 4.5 Hz), 
122.9 (q, J = 3.2 Hz), 99.8, 94.2, 56.5. 19F NMR (470 MHz, CDCl3) δ –62.5. 
ESIMS found 762.9 (calculated for [C26H19F6I2O4]+: 762.9) 
IR (thin film, cm-1): 3015, 2948, 2902, 2827, 1570, 1328, 1164, 1069, 957.  
 
(S)-3,3’,6,6’-Tetrakis(trifluoromethyl)-[1,1’-binaphthalene]-2,2’-diol (3.53) 
A mixture of (S)-3,3’-diiodo-2,2’-bis(methoxymethoxy)-6,6’-bis(trifluoromethyl)-1,1’-
binaphthalene (3.83) (0.56g, 1 mmol) and FSO2CF2CO2Me (0.51 mL, 4 mmol), CuI (0.46 
g, 2.4 mmol), HMPA (0.70 mL, 4 mmol) in NMP (20 mL) was stirred under argon 
atmosphere at 80 °C and monitored by TLC. When the starting material vanished, the 
reaction was cooled to room temperature and diluted with dichloromethane (50 mL). The 
solution was washed with water (3 × 100 mL), dried over sodium sulfate, and concentrated 
to afford a syrup. The crude product was then dissolved in THF:MeOH (1:1, 25 mL/25 mL) 
mixture. 1 gram of Amberlyst 15 was added and the mixture was heated to 50 °C for 3 h. 
The Amberlyst powder was filtered off and the filtrate was concentrated and subjected to 
column chromatography (hexanes:EtOAc, 50:1) to directly afford the deprotected product 




[α]D22= +4.0 (c=1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 8.51 (s, 2H), 8.34 (s, 2H), 7.63 (d, J = 9.0, 2H), 7.19 (d, J 
= 9.0 Hz, 2H), 5.53 (s, 2H). 13C NMR (126 MHz, CDCl3) δ 151.1, 136.1, 131.4 (q, J = 5.4 
Hz), 127.9 (q, J = 33.0 Hz), 127.4 (q, J = 4.3 Hz), 126.7, 125.9 (q, J = 3.0 Hz), 124.9, 124.4 
(q, J = 119.0 Hz), 122.2 (q, J = 119.8 Hz), 120.4 (q, J = 31.9 Hz), 112.3. 19F NMR (470 
MHz, CDCl3) δ –62.6, –62.7. 
ESIMS found 557.0 (calculated for [C24H9F12O2]–: 557.0) 
IR (thin film, cm-1): 3549, 1639, 1467, 1338, 1144.  
Preparation of Hydrazides 
2-Nitrobenzenesulfonylhydrazide (3.1) was synthesized according to the procedure 
reported by Myers and coworkers.161 
 
2,5-Dibromobenzenesulfonohydrazide (3.51) 
Hydrazine monohydrate (6.1 mL, 125 mol, 2.5 equiv) was added dropwise to a solution of 
2,5-dibromobenzenesulfonyl chloride (16.7 g, 50 mmol, 1 equiv) in THF (20 mL) at –30 ℃ 
under an argon atmosphere. During the addition, a white precipitate of hydrazine 
hydrochloride was deposited. After stirring at –30 ℃ for 1 h, EtOAc (30 mL, 23 ℃) was 
added to the cold reaction solution and the mixture was washed repeatedly with ice-cold 
10% aqueous sodium chloride solution (5 × 100 mL). The organic layer was dried over 
sodium sulfate at 0 ℃ and then was added slowly to a stirring solution of hexanes (500 




as an off-white solid and was collected by vacuum filtration. The filter cake was washed 
with hexanes (2 × 20 mL, 23 ℃) and then recrystallized by dichloromethane to afford an 
off-white crystal (11.7 g, 71% yield). The hydrazide was stored at –8 ℃ without exposure 
to light.  
Caution: During the reaction one equivalent of hydrazine hydrochloride was generated as 
a white precipitate. Stirring might be impeded and the rate of stirring should be adjusted. 
Hydrazine hydrochloride is extremely hazardous in case of skin contact (irritant), of eye 
contact (irritant), of ingestion or inhalation. After the aqueous work-up it remained in the 
water layer, which should be disposed to a separate container as a hazardous waste.  
1H NMR (500 MHz, DMSO-d6) δ 8.80 (br, 1H), 8.04 (d, J = 2.4 Hz, 1H), 7.79 – 7.68 (m, 





Hydrazine monohydrate (6.1 mL, 125 mol, 2.5 equiv) was added dropwise to a solution of 
2-nitro-4-(trifluoromethyl)benzenesulfonyl chloride (14.5 g, 50 mmol, 1 equiv) in THF (20 
mL) at –30 ℃ under an argon atmosphere. During the addition, a white precipitate of 
hydrazine hydrochloride was deposited. After stirring at –30 ℃ for 30 min, EtOAc (30 mL, 
23 ℃) was added to the cold reaction solution and the mixture was washed repeatedly with 




over sodium sulfate at 0 ℃ and then was added slowly to a stirring solution of hexanes 
(500 mL) at 23 ℃ over 5 min. 2-Nitro-4-(trifluoromethyl)benzenesulfonohydrazide 
precipitated within 10 min as a yellow solid and was collected by vacuum filtration. The 
filter cake was washed with hexanes (2 × 20 mL, 23 ℃) and then recrystallized by 
dichloromethane to afford a pale white solid (10.7 g, 75% yield). The hydrazide was stored 
at –8 ℃ without exposure to light.  
Caution: see above.  
1H NMR (500 MHz, Acetonitrile-d3) δ 8.26 (d, J = 8.2 Hz, 1H), 8.22 (q, J = 1.0 Hz, 1H), 
8.13 (dq, J = 8.3, 1.0 Hz, 1H), 7.15 (br, 1H), 2.74 (br, 2H). 13C NMR (126 MHz, 
Acetonitrile-d3) δ 148.7, 135.0 (q, J = 34.5 Hz), 133.9, 133.5, 129.3 (q, J = 3.8 Hz), 122.5 
(q, J = 272.7 Hz), 122.3 (q, J = 4.0 Hz). 19F NMR (470 MHz, Acetonitrile-d3) δ –63.9. 
Preparation of Acyclic Alkynyl Boronates 
 
Acyclic alkynyl boronates were synthesized in a modified procedure based on the 
published method.140 To flask A charged with argon was added 25 mL diethyl ether and 
alkyne (15 mmol, 1 equiv). Solution was cooled to –78 ℃ and to it was added n-BuLi (9.4 
mL, 15 mmol, 1.6 M in hexane). Solution was allowed to stir at this temperature for 1 h. 
To a second flask B charged with argon was added 25 mL diethyl ether and freshly distilled 
triethyl borate (2.55 mL, 15 mmol). Solution was cooled to –78 ℃ and to flask B was 
added via cannula the solution of lithium-acetylene from flask A. Reaction was allowed to 




2 M solution sure-sealed in diethyl ether, 15 mmol). Reaction was removed from the dry 
ice-acetone bath and allowed to warm to room temperature for 1 h, during which time 
precipitate started to form. A third flask C was flamed-dried and to it was added 5 mL dry 
toluene. The crude boronate solution with precipitate from flask B was quickly filtered 
under nitrogen through an over-dried funnel and dry Celite® to flask C. The boronate 
solution in flask C was concentrated in vacuo to less than 5 mL volume without exposure 
to the air, and made into a 1M solution in toluene stored in a sealed vial at –8 ℃. The 
boronates were allowed to be stored for up to 2 weeks and were used directly without 
further purification.  
 
5,5-dimethyl-2-(prop-2-yn-1-yl)-1,3-dioxane (3.84l) 
To a stirred solution of carbon tetrabromide (6.6 g, 20 mmol) in dichloromethane (100 mL) 
was added triphenylphosphine (7.9 g, 30 mmol) in CH2Cl2 (50 mL) at 0 ℃. The reaction 
mixture was stirred at 0 °C for 30 min, before a solution of 2-(5,5-dimethyl-1,3-dioxan-2-
yl)acetaldehyde162 3.85 (1.6 g, 10 mmol) in anhydrous CH2Cl2 (5 mL) was added. The 
resulting mixture was stirred for 1 h at 0 ℃ before an addition of H2O (40 mL) to partition 
the organic layer. The resulting mixture was extracted with CH2Cl2 (3 × 50 mL); the 
combined organic layer was washed with brine, dried over Na2SO4, and concentrated under 
reduced pressure. The crude mixture was dissolved in 5 mL CH2Cl2 and filtered through a 
silica gel column by hexane/ether (10:1, 500 mL) to afford 2-(3,3-dibromoallyl)-5,5-




purification. To a stirred solution of 2-(3,3-dibromoallyl)-5,5-dimethyl-1,3-dioxane (3.1 g, 
10 mmol) in THF (30 mL) was added n-BuLi (15.6 mL, 1.6 M in hexane, 25 mmol) 
dropwise at –78 ℃ for 30 min. The resulting solution was stirred for 30 min at –78 ℃, 
before it was quenched with aqueous sat. NH4Cl (5 mL) at –78 ℃. The aqueous layer was 
extracted with EtOAc (3 × 50 mL). The organic layer was washed with brine (50 mL), 
dried over Na2SO4, and concentrated under reduced pressure. The residue was eluted 
through a silica column by hexanes:EtOAc (10:1) to afford compound 5,5-dimethyl-2-
(prop-2-yn-1-yl)-1,3-dioxane (3.84l) (1.0 g, 65 % over two steps) as a colorless liquid.  
1H NMR (500 MHz, C6D6) δ 4.35 (t, J = 5.1 Hz, 1H), 3.31 (d, J = 11.2, 2H), 3.02 (d, J = 
10.7, 2H), 2.45 (dd, J = 5.1, 2.7 Hz, 2H), 1.83 (t, J = 2.7 Hz, 1H), 1.01 (s, 3H), 0.25 (s, 3H). 
13C NMR (126 MHz, C6D6) δ 99.6, 79.2, 76.5, 70.1, 29.4, 25.5, 22.6, 21.1. 
Preparation of Cyclic Alkynyl Boronate 
 
2-(Phenylethynyl)-1,3,2-dioxaborolane (3.59) 
Cyclic alkynyl boronates were synthesized according to the modified procedure by 
Yamamoto.163 To a solution of the potassium trifluoro(phenylethynyl)borate (2.07 g, 10.0 
mmol) and 2,2,7,7-tetramethyl-3,6-dioxa-2,7-disilaoctane164 (2.06 g, 10.0 mmol) in dry 
acetone (10 mL) was added chlorotrimethylsilane (2.17 g, 20.0 mmol) at room temperature, 
and the solution was stirred overnight. The precipitates were removed by filtration under 




neutral alumina column by hexanes and the resulting 2-(phenylethynyl)-1,3,2-
dioxaborolane 3.59 solution was concentrated and stored as 1 M solution in toluene.  
1H NMR (500 MHz, CDCl3) δ 7.57 – 7.50 (m, 2H), 7.41 – 7.34 (m, 1H), 7.36 – 7.29 (m, 
2H), 4.32 (s, 4H). 
Preparation of Ynals 
3.67a-m and 3.74 are known compounds and were synthesized following the disclosed 
literature procedures.165-173 
 
Methyl phenyl(prop-2-yn-1-yl)carbamate (3.87) 
To the solution of N-(prop-2-yn-1-yl)aniline174 3.86 (2.2 g, 17 mmol, 1.0 equiv) in CH2Cl2 
(35 mL) was added DIPEA (4.4 mL, 1.5 equiv) and methyl chloroformate (1.4 mL, 1.1 
equiv) at 0 ℃. The reaction was allowed to warm up to room temperature and stir overnight, 
after which moment the mixture was diluted with CH2Cl2, washed with 1 M HCl solution 
and extracted with CH2Cl2 (3 × 100 mL). The combined organic layer was then washed 
with saturated NaHCO3 solution and brine, dried over Na2SO4, filtered and concentrated 
to give a residue, which was purified by flash chromatography with hexanes:EtOH (10:1) 
to afford methyl phenyl(prop-2-yn-1-yl)carbamate (3.87) as a light yellow liquid in 90% 




1H NMR (500 MHz, CDCl3) 7.40 – 7.28 (m, 4H), 7.30 – 7.22 (m, 1H), 4.39 (d, J = 2.5 Hz, 
2H), 3.70 (s, 3H), 2.27 (t, J = 2.5 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 155.5, 141.4, 
129.0, 127.1, 126.7, 79.5, 72.3, 53.2, 40.2. 
 
Methyl (4-oxobut-2-yn-1-yl)(phenyl)carbamate (3.67n) 
Dry THF (25 mL) and methyl phenyl(prop-2-yn-1-yl)carbamate (3.87) (1.9 g, 10 mmol, 
1.0 equiv) were added to an oven dried nitrogen purged flask. The flask was then cooled 
to –78 ℃ using a dry ice-acetone cold bath. Next, n-butyllithium (6.3 mL, 1.6 M in hexanes, 
1.0 equiv) was added dropwise to the flask and allowed to stir for 10 minutes at the same 
temperature. To the flask, dry dimethylformamide (DMF) (1.5 mL, 2.0 equiv) was then 
slowly added. The reaction temperature was allowed to warm to room temperature in 10 
min. The reaction was then poured into a vigorously stiired biphasic solution prepared from 
a 10% aqueous solution of KH2PO4 (100 mL) and Et2O (80 mL) at 0 ℃. The organic layer 
was washed with water (2 × 100 mL). The combined aqueous layers were then extracted 
with Et2O (200 mL). The combined organic layers were dried over MgSO4, filtered and 
concentrate. The residue was purified by flash chromatography on silica gel using 
hexanes:EtOAc (8:1) to afford methyl (4-oxobut-2-yn-1-yl)(phenyl)carbamate (3.67n) in 
45% yield (1.0 g) as a light yellow liquid.  
1H NMR (500 MHz, CDCl3) 9.18 (s, 1H), 7.39 (t, J = 7.7 Hz, 2H), 7.34 – 7.24 (m, 3H), 
4.61 (s, 2H), 3.73 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 176.3, 155.5, 140.9, 129.3, 127.5, 




General Procedure for Racemic Petasis Alkynylation to Afford Racemic Allenols 
 
2-Nitrobenzenesulfonohydrazide 3.1 (87 mg, 0.4 mmol), glycolaldehyde dimer 3.44 (24 
mg, 0.2 mmol), and 3 Å oven-dried powdered molecular sieves (400 mg) were added to a 
10-mL oven-dried reaction vial equipped with a magnetic stir bar. Racemic BINOL catalyst 
(15 mg, 0.052 mmol) was added and rinsed into the solution with dry toluene (0.48 mL). 
The mixture was stirred for 5 min, at which moment to it was subjected the alkynyl 
boronate 3.45 (0.52 mmol, stored as 1 M solution in toluene). The reaction was stirred at 
room temperature for 18 h. The racemic allenyl alcohol product 3.5 was isolated directly 
by silica gel chromatography.  
General Procedure for Asymmetric Petasis Alkynylation to Afford Enantioenriched 
Allenols 
 
2,5-Dibromobenzenesulfonohydrazide 3.51 (132 mg, 0.4 mmol), glycolaldehyde dimer 
3.44 (24 mg, 0.2 mmol), and oven-dried 3 Å powdered molecular sieves (400 mg) were 




mesitylene (1.0 mL) was added to the vial and the reaction mixture was stirred at room 
temperature for 2 h, at which time (S)-(CF3)4-BINOL catalyst 3.53 (29 mg, 0.052 mmol, 
10 mol%) was added and rinsed into the solution with dry toluene (0.48 mL). The mixture 
was cooled to 0 ℃ for 10 min under argon, at which moment to it was subjected the alkynyl 
boronate 3.45 (0.52 mmol, 1 M solution in toluene). The reaction was allowed to stir at 0 ℃ 
for 48 h and then quenched by 1 mL aqueous 10% NaOH solution and allowed to warm up 
to room temperature overnight. The reaction mixture was transferred to a separatory funnel 
using EtOAc (5 mL) and H2O (5 mL). The organic layer was collected and the aqueous 
layer was extracted by EtOAc (3 × 5 mL). The combined organic layers were dried with 
Na2SO4. Concentration under reduced pressure followed by flash column chromatography 
on silica gel afforded the desired compound. 
Analytical Data for Allenyl Alcohols 
(S)-4-Phenylbuta-2,3-dien-1-ol (3.5a) 
Prepared from glycolaldehyde dimer 3.44 (0.2 mmol) and the corresponding alkynyl 
boronate 3.45a (0.52 mmol) according to the general procedure. The product was purified 
by flash column chromatography with elution by hexanes:EtOAc (8:1) to afford the pure 
product as a colorless oil. Yield: 50 mg, 85%.  
e.r.: 93:7. [α]D22 = +103.0 (c = 0.49, CH3CN). In lit:175 [α]D22 = +105.9 (c = 0.49, CH3CN). 
The absolute stereochemistry was assigned as (S). HPLC Analysis, tr major: 43.7 min., tr 
minor: 46.9 min., [Chiralpak®AD-H column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 






2,5-Dibromobenzenesulfonohydrazide 3.51 (132 mg, 0.4 mmol), glycolaldehyde dimer 
3.44 (24 mg, 0.2 mmol), and 3 Å oven-dried powdered molecular sieves (400 mg) were 
added to a 10-mL oven-dried reaction vial equipped with a magnetic stir bar. Dry 
mesitylene (1.0 mL) was added to the vial and the reaction mixture was stirred at room 
temperature for 2 h, at which time (S)-(CF3)4-BINOL catalyst 3.53 (58 mg, 0.104 mmol, 
20 mol%) was added and rinsed into the solution with dry toluene (0.48 mL). The mixture 
was cooled to –10 ℃ under argon for 10 min, at which moment to it was subjected the 
alkynyl boronate 3.45b (0.52 mmol, 1 M solution in toluene). The reaction was allowed to 
stir at –10 ℃ for 48 h and then quenched by 1 mL aqueous 10% NaOH solution and 
allowed to warm up to room temperature overnight. The reaction mixture was transferred 
to a separatory funnel using EtOAc (5 mL) and H2O (5 mL). The organic layer was 
collected and the aqueous layer was extracted by EtOAc (3 × 5 mL). The combined organic 
layers were dried with Na2SO4. Concentration under reduced pressure followed by flash 
column chromatography on silica gel with elution by hexanes:EtOAc (8:1) afforded the 
desired compound as a clear oil. Yield: 56 mg, 80%.  
e.r.: 91:9. [α]D22 = +27.1 (c = 1.0, CHCl3). HPLC Analysis, tr major: 39.5 min., tr minor: 
42.9 min., [Chiralpak®AD-H column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 1.0 
mL/min, 250 nm]. The absolute stereochemistry was assigned by analogy. All spectra were 






Prepared from glycolaldehyde dimer 3.44 (0.2 mmol) and the corresponding alkynyl 
boronate 3.45c (0.52 mmol) according to the general procedure. The product was purified 
by flash column chromatography with elution by hexanes:EtOAc (8:1) to afford the pure 
product as a colorless oil. Yield: 51 mg, 78%.  
e.r.: 93:7. [α]D22 = +53.8 (c = 1.0, CHCl3). HPLC Analysis, tr major: 30.6 min., tr minor: 
31.7 min., [Chiralpak®IA column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 0.8 
mL/min, 254 nm]. The absolute stereochemistry was assigned by analogy. All spectra were 
in agreement with reported data.98 
 
(S)-4-(2-(Trifluoromethyl)phenyl)buta-2,3-dien-1-ol (3.5d) 
Prepared from glycolaldehyde dimer 3.44 (0.2 mmol) and the corresponding alkynyl 
boronate 3.45d (0.52 mmol) according to the general procedure. The crude mixture was 
purified by flash column chromatography with hexanes:EtOAc (10:1) to afford the pure 
product as a colorless oil. Yield: 61 mg, 71% 
e.r.: 93:7. [α]D22 = +72.6 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 43.4 min., tr major: 
45.7 min., [Chiralpak®IA-H column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 99.6:0.4, 
1.0 mL/min, 254 nm]. The absolute stereochemistry was assigned by analogy. 
1H NMR (500 MHz, CDCl3) δ 7.65 – 7.59 (m, 2H), 7.47 (dd, J = 7.7, 7.7 Hz, 1H), 7.30 
(dd, J = 7.7, 7.7 Hz, 1H), 6.69 (dddd, J = 6.0, 4.3, 2.0, 2.0 Hz, 1H), 5.84 (ddd, J = 6.1, 6.1, 
6.0 Hz, 1H), 4.34 – 4.24 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 205.5, 132.4 (q, 4JC-F = 
1.3 Hz), 131.8, 128.7, 127.0, 126.2 (q, 1JC-F = 239.4 Hz), 126.8 (q, 2JC-F = 30.5 Hz), 126.0 




HRMS found 215.0690 (calculated for [C11H10F3O]+: 215.0684) 
IR (thin film, cm-1): 3377, 3082, 2940, 1955, 1731, 1495, 1316, 1162, 1121, 1060, 766.  
 
(S)-4-(Thiophen-3-yl)buta-2,3-dien-1-ol (3.5e) 
Prepared from glycolaldehyde dimer 3.44 (0.2 mmol) and the corresponding alkynyl 
boronate 3.45e (0.52 mmol) according to the general procedure. The crude mixture was 
purified by flash column chromatography with hexanes:EtOAc (6:1) to afford the pure 
product as a colorless oil. Yield: 43 mg, 70%. 
e.r.: 92:8. [α]D22 = +116.4 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 21.4 min., tr major: 
23.9 min., [Chiralpak®IA-H column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 1.0 
mL/min, 254 nm]. The absolute stereochemistry was assigned by analogy. 
1H NMR (500 MHz, CDCl3) δ 7.27 (ddd, J = 5.1, 3.0, 0.6 Hz, 1H), 7.12 – 7.09 (m, 1H), 
7.07 (dd, J = 5.1, 1.2 Hz, 1H), 6.40 (ddd, J = 6.4, 3.0, 2.9 Hz, 1H), 5.73 (ddd, J = 6.4, 5.8, 
5.8, 1H), 4.28 – 4.20 (m, 2H), 1.54 (t, J = 6.1 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 
204.5, 135.0, 126.2, 126.1, 121.3, 95.1, 91.8, 60.4. 
HRMS found 153.0370 (calculated for [C8H9OS]+: 153.0374) 







2,5-Dibromobenzenesulfonohydrazide 3.51 (132 mg, 0.4 mmol), glycolaldehyde dimer 
3.44 (24 mg, 0.2 mmol), and 3 Å oven-dried powdered molecular sieves (400 mg) were 
added to a 10-mL oven-dried reaction vial equipped with a magnetic stir bar. Dry 
mesitylene (1.0 mL) was added to the vial and the reaction mixture was stirred at room 
temperature for 2 h, at which time (S)-(CF3)4-BINOL catalyst 3.53 (29 mg, 0.052 mmol, 
10 mol%) was added and rinsed into the solution with dry toluene (0.48 mL). The mixture 
was cooled to 0 ℃ for 10 min, at which moment to it was subjected the alkynyl boronate 
3.45f (0.52 mmol, 1 M solution in toluene). The reaction was allowed to stir at 0 ℃ for 72 
h and then quenched by 1 mL aqueous 10% NaOH solution and allowed to warm up to 
room temperature overnight. The reaction mixture was transferred to a separatory funnel 
using EtOAc (5 mL) and H2O (5 mL). The organic layer was collected and the aqueous 
layer was extracted by EtOAc (3 × 5 mL). The combined organic layers were dried with 
Na2SO4. Concentration under reduced pressure followed by flash column chromatography 
on silica gel with elution by hexanes:EtOAc (8:1) afforded the desired compound 3.5f as a 
clear oil. Yield: 67 mg, 85%.  
e.r.: 90:10. [α]D22 = +116.8 (c = 1.0, CHCl3). HPLC Analysis, tr major: 40.5 min., tr minor: 
47.2 min., [Chiralpak®IA column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 1.0 
mL/min, 254 nm]. The absolute stereochemistry was assigned by analogy. All spectra were 







2,5-Dibromobenzenesulfonohydrazide 3.51 (132 mg, 0.4 mmol), glycolaldehyde dimer 
3.44 (24 mg, 0.2 mmol), and 3 Å oven-dried powdered molecular sieves (400 mg) were 
added to a 10-mL oven-dried reaction vial equipped with a magnetic stir bar. Dry 
mesitylene (1.0 mL) was added to the vial and the reaction mixture was stirred at room 
temperature for 2 h, at which time (S)-(CF3)4-BINOL catalyst 3.53 (29 mg, 0.052 mmol, 
10 mol%) was added and rinsed into the solution with dry toluene (0.48 mL). The mixture 
was cooled to 0 ℃ under argon for 10 min, at which moment to it was subjected the alkynyl 
boronate 3.45g (0.52 mmol, 1 M solution in toluene). The reaction was allowed to stir at 
0 ℃ for 72 h and then quenched by 1 mL aqueous 10% NaOH solution and allowed to 
warm up to room temperature overnight. The reaction mixture was transferred to a 
separatory funnel using EtOAc (5 mL) and H2O (5 mL). The organic layer was collected 
and the aqueous layer was extracted by EtOAc (3 × 5 mL). The combined organic layers 
were dried with Na2SO4. Concentration under reduced pressure followed by flash column 
chromatography on silica gel with elution by hexanes:EtOAc (8:1) afforded the desired 
compound as a clear oil. Yield: 54 mg, 72%.  
e.r.: 92:8. [α]D22 = +10.5 (c = 1.0, CHCl3). In lit for (R)-6-phenylhexa-2,3-dien-1-ol:148 
[α]D20 = –38.7 (c = 1.05, CHCl3, 96% ee). HPLC Analysis, tr minor: 27.6 min., tr major: 
44.8 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 0.8 







2,5-Dibromobenzenesulfonohydrazide 3.51 (132 mg, 0.4 mmol), glycolaldehyde dimer 
3.44 (24 mg, 0.2 mmol), and 3 Å oven-dried powdered molecular sieves (400 mg) were 
added to a 10-mL oven-dried reaction vial equipped with a magnetic stir bar. Dry 
mesitylene (1.0 mL) was added to the vial and the reaction mixture was stirred at room 
temperature for 2 h, at which time (S)-(CF3)4-BINOL catalyst 3.53 (29 mg, 0.052 mmol, 
10 mol%) was added and rinsed into the solution with dry toluene (0.48 mL). The mixture 
was cooled to 0 ℃ under argon for 10 min, at which moment to it was subjected the alkynyl 
boronate 3.45g (0.52 mmol, 1 M solution in toluene). The reaction was allowed to stir at 
0 ℃ for 72 h and then quenched by 1 mL aqueous 10% NaOH solution and allowed to 
warm up to room temperature overnight. The reaction mixture was transferred to a 
separatory funnel using EtOAc (5 mL) and H2O (5 mL). The organic layer was collected 
and the aqueous layer was extracted by EtOAc (3 × 5 mL). The combined organic layers 
were dried with Na2SO4. Concentration under reduced pressure followed by flash column 
chromatography on silica gel with elution by hexanes:EtOAc (8:1) afforded the desired 
compound as a clear oil. Yield: 49 mg, 71%.  
e.r.: 90:10. [α]D22 = +29.2 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 43.4 min., tr major: 
54.0 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 1.0 
mL/min, 254 nm]. The absolute stereochemistry was assigned by analogy.  







Prepared from glycolaldehyde dimer 3.44 (0.2 mmol) and the corresponding alkynyl 
boronate 3.45i (0.52 mmol) according to the general procedure, but for 72 hours. The 
product was purified by flash column chromatography with elution by hexanes:EtOAc (8:1) 
to afford the pure product as a colorless oil. Yield: 38 mg, 63%.  
e.r.: 90:10. [α]D22 = +80.5 (c = 1.0, CHCl3). In lit:148 [α]D21 = +100.9 (c = 1.04, CHCl3, 99% 
ee). HPLC Analysis, tr minor: 19.0 min., tr major: 19.8 min., [Chiralpak®IA column, 
24cm × 4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 mL/min, 230 nm].  
All spectra were in agreement with reported data.148  
 
(S)-Deca-2,3-dien-1-ol (3.5j) 
Prepared from glycolaldehyde dimer 3.44 (0.2 mmol) and the corresponding alkynyl 
boronate 3.45j (0.52 mmol) according to the general procedure but for 96 hours. The 
product was purified by flash column chromatography with elution by hexanes:EtOAc (8:1) 
to afford the pure product as a colorless oil. Yield: 45 mg, 73%.  
e.r.: 90:10. [α]D22 = +60.7 (c = 1.0, CHCl3). In lit for (R)-deca-2,3-dien-1-ol:177 [α]D20 = –
72.5 (c = 1.02, CHCl3, 94% ee). HPLC Analysis, tr minor: 18.3 min., tr major: 19.5 min., 
[Chiralpak®IA-H column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.6:0.4, 1.0 mL/min, 







Prepared from glycolaldehyde dimer 3.44 (0.2 mmol) and the corresponding alkynyl 
boronate 3.45k (0.52 mmol) according to the general procedure but for 96 hours. The 
product was purified by flash column chromatography with elution by hexanes:EtOAc (8:1) 
to afford the pure product as a colorless oil. Yield: 46 mg, 60%.  
e.r.: 90:10. [α]D22 = +33.2 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 37.1 min., tr major: 
39.2 min., [Chiralpak®IA column, 24cm × 4.6 mm I.D., hexanes:EtOH = 99:1, 1.0 mL/min, 
250 nm]. The absolute stereochemistry was assigned by analogy.  
All spectra were in agreement with reported data.98  
 
(S)-5-(5,5-Dimethyl-1,3-dioxan-2-yl)penta-2,3-dien-1-ol (3.5l) 
Prepared from glycolaldehyde dimer 3.44 (0.2 mmol) and the corresponding alkynyl 
boronate 3.45l (0.52 mmol) according to the general procedure but for 72 hours. The crude 
mixture was purified by flash column chromatography with hexanes:EtOAc (10:1) to 
afford the pure product as a colorless oil. Yield: 56 mg, 70%. 
e.r.: 85:15. [α]D22 = –19.6 (c = 1.0, CHCl3). HPLC Analysis, tr major: 13.0 min., tr minor: 
13.9 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 97:3, 1.0 
mL/min, 210 nm]. The absolute stereochemistry was assigned by analogy. 
1H NMR (500 MHz, CDCl3) δ 5.42 – 5.31 (m, 2H), 4.51 (dd, J = 4.8, 4.8 Hz, 1H), 4.13 – 
4.07 (m, 2H), 3.61 (d, J = 11.0 Hz, 2H), 3.43 (d, J = 10.9 Hz, 2H), 2.39 – 2.35 (m, 2H), 
2.19 (t, J = 5.9 Hz, 1H), 1.18 (s, 3H), 0.71 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 203.6, 




ESIMS found 199.1 (calculated for [C11H19O3]+: 199.1) 
IR (thin film, cm-1): 3370, 2956, 2849, 1969, 1472, 1392, 1131, 1090, 1020.  
 
(S)-4-(tert-Butyldimethylsilyl)buta-2,3-dien-1-ol (3.5m) 
Prepared from glycolaldehyde dimer 3.44 (0.2 mmol) and the corresponding alkynyl 
boronate 3.45m (0.52 mmol) according to the general procedure, but for 96 hours. The 
product was purified by flash column chromatography with elution by hexanes:EtOAc (8:1) 
to afford the pure product as a colorless oil. Yield: 46 mg, 62%.  
e.r.: 95:5. [α]D22 = +116.9 (c = 1.0, CHCl3). HPLC Analysis, tr major: 14.9 min., tr minor: 
16.8 min., [Chiralcel®OD column, 24cm × 4.6 mm I.D., hexanes:EtOH = 99.6:0.4, 1.0 
mL/min, 210 nm]. The absolute stereochemistry was assigned by analogy.  
All spectra were in agreement with reported data.178 
 
(S)-2-Methyl-4-phenylbuta-2,3-dien-1-ol (3.56) 
2,5-Dibromobenzenesulfonohydrazide 3.51 (132 mg, 0.4 mmol), hydroxyacetone 3.55 (30 
mg, 0.4 mmol), and oven-dried 3 Å powdered molecular sieves (400 mg) were added to a 
10-mL oven-dried reaction vial equipped with a magnetic stir bar. Dry mesitylene (1.0 mL) 
was added to the vial and the reaction mixture was stirred at room temperature for 2 h, at 
which time (S)-(CF3)4-BINOL catalyst 3.53 (29 mg, 0.052 mmol, 10 mol%) was added and 
rinsed into the solution with dry toluene (0.48 mL). The mixture was cooled to 0 ℃ under 
argon for 10 min, at which moment to it was subjected the alkynyl boronate 3.45a (0.52 




quenched by 1 mL aqueous 10% NaOH solution and allowed to warm up to room 
temperature overnight. The reaction mixture was transferred to a separatory funnel using 
EtOAc (5 mL) and H2O (5 mL). The organic layer was collected and the aqueous layer was 
extracted by EtOAc (3 × 5 mL). The combined organic layers were dried with Na2SO4. 
Concentration under reduced pressure followed by flash column chromatography on silica 
gel with elution by hexanes:EtOAc (8:1) afforded the desired compound as a clear oil. 
Yield: 58 mg, 91%.  
e.r.: 90:10. [α]D22 = +9.8 (c = 1.0, CHCl3). In lit for (R)-2-methyl-4-phenylbuta-2,3-dien-
1-ol:179 [α]D20 = –10.9 (c = 0.5, CHCl3, 99% ee). HPLC Analysis, tr major: 14.3 min., tr 
minor: 15.7 min., [Chiralpak®IA column, 24cm × 4.6 mm I.D., hexanes:EtOH = 98:2, 1.0 
mL/min, 210 nm]. All spectra were in agreement with reported data.179 
General Procedure for Asymmetric Petasis Alkynylation Using Cyclic Alkynyl Boronate 
 
2,5-Dibromobenzenesulfonohydrazide 3.51 (132 mg, 0.4 mmol), glycolaldehyde dimer 
3.44 (24 mg, 0.2 mmol), and oven-dried 3 Å powdered molecular sieves (400 mg) were 
added to a 10-mL oven-dried reaction vial equipped with a magnetic stir bar. Dry 
mesitylene (1.0 mL) was added to the vial and the reaction mixture was stirred at room 




20 mol%) was added and rinsed into the solution with triethyl borate (38 mg, 0.26 mmol) 
and dry toluene (0.48 mL). The mixture was cooled to 4 °C for 10 min, at which moment 
to it was subjected 2-(phenylethynyl)-1,3,2-dioxaborolane 3.59 (0.52 mmol, 1 M solution 
in toluene). The reaction was allowed to stir at 0 ℃ for 46 h and then quenched by 1 mL 
aqueous 10% NaOH solution and allowed to warm up to room temperature overnight. The 
reaction mixture was transferred to a separatory funnel using EtOAc (5 mL) and H2O (5 
mL). The organic layer was collected and the aqueous layer was extracted by EtOAc (3 × 
5 mL). The combined organic layers were dried with Na2SO4. Concentration under reduced 
pressure followed by flash column chromatography on silica gel afforded 3.5a in 91:9 e.r. 
and 71% yield.  
Isolation of the Propargylic Hydrazide Intermediate 3.54 
 
2,5-Dibromobenzenesulfonohydrazide 3.51 (132 mg, 0.4 mmol), glycolaldehyde dimer 
3.44 (24 mg, 0.2 mmol), and oven-dried 3 Å powdered molecular sieves (400 mg) were 
added to a 10-mL oven-dried reaction vial equipped with a magnetic stir bar. Dry 
mesitylene (1.0 mL) was added to the vial and the reaction mixture was stirred at room 
temperature for 2 h, at which time (S)-(CF3)4-BINOL catalyst 3.53 (29 mg, 0.104 mmol, 
10 mol%) was added and rinsed into the solution with dry toluene (0.48 mL). The mixture 




3.45a (0.52 mmol, 1 M solution in toluene). The reaction was allowed to stir at the same 
temperature for 48 h, at which moment the reaction mixture was subjected to flash column 
chromatography on silica gel using pentane/Et2O (10:1 → 1:2) to afford allenol product 6a 
and intermediate 3a. 3a was condensed by a high-vac pump without allowing the 
temperature to exceed 10 ℃.  
1H NMR (500 MHz, CDCl3) 8.32 (s, 1H), 7.64 – 7.53 (m, 2H), 7.45 – 7.39 (m, 2H), 7.38 
– 7.28 (m, 3H), 6.81 (s, 1H), 3.95 – 3.87 (m, 2H), 3.72 (par obsc, 1H), 2.82 (br, 1H). 13C 
NMR (126 MHz, CDCl3) δ 138.7, 137.4, 136.3, 135.6, 131.9, 129.0, 128.4, 122.1, 121.7, 
118.2, 87.0, 83.7, 61.7, 54.7. 
ESIMS found 472.9, 474.9, 476.9 (calculated for 3a [C16H15Br2N2O3S]+: 474.9) 
Cycloetherification of Enantioenriched Allenols 
(R)-2-Phenyl-2,5-dihydrofuran (3.65) 
(S)-4-Phenylbuta-2,3-dien-1-ol (3.5a) (44 mg, 0.3 mmol, 92:8 e.r.) was dissolved in 3 mL 
hot pentane. Silver nitrate on silica gel (51 mg, 10% wt, 0.1 equiv) was added in and the 
reaction flask was wrapped with aluminum foil and allowed to stir for 26 hours at room 
temperature. After the allenol was consumed (as monitored by TLC), the reaction mixture 
was subjected directly to column chromatography on silica gel eluting with hexanes to 
afford the cyclized product 3.65 as a colorless oil. Yield: 35 mg, 79%.  
e.r.: 92:8. [α]D22 = +111.8 (c = 0.42, CHCl3). In lit:180 [α]D22 = +248 (c = 0.59, CHCl3, 93% 
ee). HPLC Analysis, tr minor: 12.9 min., tr major: 17.2 min., [Chiralpak®IA column, 
24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.95:0.05, 1.0 mL/min, 210 nm].  





(S)-6-Phenylhexa-2,3-dien-1-ol (3.5g) (52 mg, 0.3 mmol, 92:8 e.r.) was dissolved in a 
mixture of acetone/water (1.2 mL/0.8 mL). Silver nitrate (10 mg, 0.2 equiv) was added in 
and the reaction flask was wrapped with aluminum foil and allowed to stir for 48 hours at 
room temperature. After the allenol was consumed (as being monitored by TLC), the 
solvent was removed under reduced pressure and the crude reaction mixture was subjected 
to column chromatography using hexanes to give cyclized product 3.66 as a colorless oil. 
Yield: 35 mg, 67%.  
e.r.: 92:8. [α]D22 = +74.6 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 11.5 min., tr major: 
12.2 min., [Chiralpak®IA column, 24cm × 4.6 mm I.D., hexanes:i-PrOH = 99.9:0.1, 0.8 
mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.23 (m, 2H), 7.24 – 7.09 (m, 3H), 5.91 (ddt, J = 6.0, 
1.8, 1.8 Hz, 1H), 5.79 (dtd, J = 6.0, 2.4, 1.4 Hz, 1H), 4.90 – 4.83 (m, 1H), 4.76 – 4.57 (m, 
2H), 2.78 – 2.61 (m, 2H), 1.95 – 1.79 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 142.2, 129.5, 
128.4, 128.3, 126.7, 125.7, 85.4, 75.1, 37.7, 31.5. 
ESIMS found 175.1 (calculated for [C12H15O]+: 175.1).  
IR (thin film, cm-1): 3081, 3061, 3027, 2924, 2848, 1603, 1496, 1454, 1354, 1079, 1018.  
Absolute Stereochemistry Determination for Allenols 
The absolute stereochemistry of allenols was determined unambiguously by direct 
comparison of the optical rotations of 3.5a,175 3.5g,148  3.5i,148 3.5j,177 3.56,179 with those 
reported for the same compounds or their enantiomers.  




General Procedure for Racemic Petasis Allylation to Afford Racemic Allyl Allenes 
 
2-Nitro-4-(trifluoromethyl)benzenesulfonohydrazide 3.49 (114 mg, 0.4 mmol), ynal 3.67 
(0.4 mmol), and oven-dried 3 Å powdered molecular sieves (200 mg) were added to a 10 
mL reaction vial equipped with a magnetic stir bar. Dichloromethane (1.0 mL) was added 
to the vial and the reaction mixture was stirred at room temperature for 2 h, at which time 
the reaction mixture was concentrated first by rotary evaporation and then by static pressure 
vacuum (2 – 10 Torr) for 10 min. Racemic BINOL catalyst (17 mg, 0.06 mmol, 10 mol%), 
tert-butanol (89 mg, 1.2 mmol) and allylboronate 3.68 (76 mg, 0.6 mmol) was added and 
rinsed into the solution with dry toluene (0.2 mL). The reaction was applied to sonication 
for 10 min to facilitate dissolution. The vial was sealed with a rubber septum and attached 
to a balloon filled with argon. The mixture was allowed to stir at room temperature for 24 
h, at which time the crude mixture was chromatographed on silica gel to afford the desired 




General Procedure for Asymmetric Petasis Allylation to Afford Enantioenriched Allyl 
Allenes 
 
2-Nitro-4-(trifluoromethyl)benzenesulfonohydrazide 3.49 (114 mg, 0.4 mmol), ynal 3.67 
(0.4 mmol), and oven-dried 3 Å powdered molecular sieves (200 mg) were added to a 10 
mL oven dried reaction vial equipped with a magnetic stir bar. Dichloromethane (1.0 mL) 
was added to the vial and the reaction mixture was stirred at room temperature for 2 h, at 
which time the reaction mixture was concentrated first by rotary evaporation and then by 
static pressure vacuum (2 – 10 Torr) for 10 min. (R)-Ph2-BINOL catalyst 3.47 (18 mg, 0.04 
mmol, 7 mol%), tert-butanol (89 mg, 1.2 mmol) and allylboronate 3.68 (76 mg, 0.6 mmol) 
was added and rinsed into the solution with dry toluene (0.2 mL). The reaction was applied 
to sonication for 10 min to facilitate dissolution. The vial was sealed with a rubber septum 
and attached to a balloon filled with argon. The mixture was allowed to stir at room 
temperature for 24 h, at which time the crude mixture was chromatographed on silica gel 
to afford the desired product.  





The allyl allene 3.8 (0.3 mmol) was dissolved in dry THF (0.4 mL) under argon and cooled 
to 0 ℃. 9-BBN (0.5 M in THF, 0.45 mL, 1.5 equiv) was added dropwise to the reaction, 
and the reaction was allowed to warm up to room temperature naturally. After one hour, 
the reaction was cooled to 0 ℃. 3 M NaOH solution (0.1 mL) was added slowly to the 
reaction, followed by dropwise addition of H2O2 (35% in water, 0.3 mL). The reaction was 
warmed to room temperature in 5 min. The reaction mixture was transferred to a separatory 
funnel using Et2O (5 mL) and H2O (5 mL). The organic layer was collected and the aqueous 
layer was extracted by Et2O (3 × 5 mL). The combined organic layers were dried with 
Na2SO4. Concentration under reduced pressure followed by flash column chromatography 
on silica gel afforded the desired terminal alcohol. Crotyl allene compounds 3.77 and 3.78 
followed the same procedure.  
Analytical Data for Allyl Allenes 
(R)-(Hexa-1,2,5-trien-1-yl)benzene (3.8a) 
Prepared from the corresponding ynal 3.67a (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 52 mg, 
83%. 
e.r.: 99:1. [α]D22 = –227.6 (c = 1.0, CHCl3). HPLC Analysis, tr major: 6.1 min., tr minor: 
6.7 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes, 1.0 mL/min, 250 nm]. 
Absolute stereochemistry as consistent with Lowe’s rule.182 






Prepared from the corresponding ynal 3.67b (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes:EtOAc (50:1) to afford the pure product as a colorless oil. 
Yield: 66 mg, 88%. 
e.r.: 98:2. [α]D22 = –248.7 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding alcohol 3.88b following the hydroboration/oxidation procedure, tr 
major: 21.9 min., tr minor: 33.0 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., 
hexanes:i-PrOH = 97:3, 1.0 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.22 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 6.13 (ddd, 
J = 6.0, 2.9, 2.9 Hz, 1H), 5.97 – 5.85 (m, 1H), 5.56 (ddd, J = 6.7, 6.7, 6.7 Hz, 1H), 5.15 
(dddd, J = 17.1, 1.6, 1.6, 1.6 Hz, 1H), 5.05 (dddd, J = 10.2, 1.6, 1.5, 1.5 Hz, 1H), 3.80 (s, 
3H), 2.91 – 2.85 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 204.9, 158.6, 136.3, 127.7, 127.0, 
115.5, 114.1, 94.4, 93.0, 55.3, 33.3. 
GCMS found 186.1 (calculated for C13H14O: 186.1). 
IR (thin film, cm-1): 3072, 3005, 2935, 2836, 1608, 1511, 1303, 1172, 1035, 833.  
 
(R)-6-(4-Methoxyphenyl)-hexa-4,5-dien-1-ol (3.88b) 
3.88b was prepared following the general hydroboration/oxidation procedure in 0.2 mmol 
scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (5:1) to afford the pure product as a colorless oil. Yield: 17 mg, 42%. 




1H NMR (500 MHz, CDCl3) δ 7.21 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 6.12 (ddd, 
J = 6.3, 3.1, 3.1 Hz, 1H), 5.58 (ddd, J = 6.5, 6.5, 6.5 Hz, 1H), 3.80 (s, 3H), 3.72 (t, J = 6.5 
Hz, 2H), 2.21 (dddd, J = 12.8, 6.5, 3.1, 1.7 Hz, 2H), 1.76 (ddt, J = 9.5, 7.8, 6.5 Hz, 2H), 
1.25 (br, 1H). 13C NMR (126 MHz, CDCl3) δ 204.5, 127.6, 127.1, 114.1, 113.9, 94.5, 94.3, 
62.4, 55.3, 31.9, 25.1. 
HRMS found 205.1239 (calculated for [C13H17O2]+: 205.1229). 
IR (thin film, cm-1): 3412, 2989, 2934, 2875, 1605, 1512, 1467, 1249, 1172, 1034, 836.  
 
(R)-1-Fluoro-4-(hexa-1,2,5-trien-1-yl)benzene (3.8c) 
Prepared from the corresponding ynal 3.67c (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes:EtOAc (200:1) to afford the pure product as a colorless oil.  
Yield: 61 mg, 87%. 
e.r.: 99:1. [α]D22 = –246.6 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding alcohol 3.88c following the hydroboration/oxidation procedure, tr 
major: 18.4 min., tr minor: 20.3 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., 
hexanes:i-PrOH = 98:2, 1.0 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.29 – 7.21 (m, 2H), 7.03 – 6.94 (m, 2H), 6.14 (ddd, J = 
6.2, 2.9, 2.9 Hz, 1H), 5.90 (dddd, J = 16.7, 10.2, 6.4, 6.4 Hz, 1H), 5.59 (ddd, J = 6.7, 6.7, 
6.7 Hz, 1H), 5.15 (dddd, J = 17.0, 1.7, 1.7, 1.6 Hz, 1H), 5.06 (dddd, J = 10.2, 1.6, 1.5, 1.5 
Hz, 1H), 2.92 – 2.85 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 205.3 (d, J = 2.4 Hz), 162.8, 




J = 21.7 Hz), 93.7 (d, J = 84.3 Hz), 33.1. 19F NMR (470 MHz, CDCl3) δ –115.7 (ddd, J = 
14.2, 9.1, 5.6 Hz). 
GCMS found 174.1 (calculated for C12H11F: 174.1). 
IR (thin film, cm-1): 3062, 2976, 2918, 1950, 1640, 1604, 1508, 1229, 1156, 837. 
 
(R)-6-(4-Fluorophenyl)-hexa-4,5-dien-1-ol (3.88c) 
3.88c was prepared following the general hydroboration/oxidation procedure in 0.3 mmol 
scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (4:1) to afford the pure product as a colorless oil. Yield: 20 mg, 35%. 
e.r.: 99:1. [α]D22 = –117.4 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.25 – 7.21 (m, 2H), 7.01 – 6.95 (m, 2H), 6.12 (ddd, J = 
6.5, 3.1, 3.1 Hz, 1H), 5.61 (ddd, J = 6.6, 6.6, 6.6 Hz, 1H), 3.76 – 3.67 (m, 2H), 2.22 (td, J 
= 7.2, 3.1 Hz, 2H), 1.81 – 1.70 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 204.9, 162.8, 
160.8, 130.8, 127.9 (d, J = 8.0 Hz), 115.5 (d, J = 21.7 Hz), 94.4 (d, J = 68.0 Hz), 62.3, 31.8, 
24.9. 19F NMR (470 MHz, CDCl3) δ –115.8 (ddd, J = 13.9, 8.9, 5.5 Hz). 
ESIMS found 175.1, 193.1 (calculated for [C12H14FO]+: 193.1). 
IR (thin film, cm-1): 3360, 3045, 2937, 1951, 1604, 1508, 1226, 1156, 840.  
 
(R)-1-(Hexa-1,2,5-trien-1-yl)-4-nitrobenzene (3.8d) 
Prepared from the corresponding ynal 3.67d (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 




chromatography with hexanes:EtOAc (100:1) to afford the pure product as a yellow oil. 
Yield: 70 mg, 87%.  
e.r.: 98:2. [α]D22 = –318.4 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 14.8 min., tr major: 
16.3 min., [Chiralpak®IA column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH =800:1, 1.0 
mL/min, 230 nm].  
1H NMR (500 MHz, CDCl3) δ 8.15 (d, J = 8.3 Hz, 2H), 7.40 (d, J = 8.3 Hz, 2H), 6.26 – 
6.20 (m, 1H), 5.89 (dddd, J = 16.7, 10.2, 6.4, 6.4 Hz, 1H), 5.71 (ddd, J = 6.7, 6.7, 6.7 Hz, 
1H), 5.17 (dddd, J = 17.1, 1.5, 1.4, 1.4 Hz, 1H), 5.09 (dddd, J = 10.1, 1.5, 1.4, 1.4 Hz, 1H), 
2.96 – 2.89 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 207.4, 146.4, 142.2, 135.4, 127.0, 
124.0, 116.2, 94.2, 32.6. 
GCMS found 201.1 (calculated for C12H11NO2: 201.1). 
IR (thin film, cm-1): 3078, 2979, 2843, 1949, 1640, 1595, 1516, 1494, 1342, 1110, 874.  
 
(R)-1-Bromo-2-(hexa-1,2,5-trien-1-yl)benzene (3.8e) 
Prepared from the corresponding ynal 3.67e (0.26 mmol) and allyl boronate 3.68 (0.4 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes:EtOAc (100:1) to afford the pure product as a colorless oil.  
Yield: 35 mg, 60%. 
e.r.: 99:1. [α]D22 = –148.4 (c = 1.0, CHCl3). HPLC Analysis, tr major: 7.4 min., tr minor: 
9.3 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes, 1.0 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.52 (dd, J = 8.0, 1.2 Hz, 1H), 7.46 (dd, J = 7.9, 1.7 Hz, 




Hz, 1H), 5.91 (dddd, J = 16.9, 10.1, 6.4, 6.4 Hz, 1H), 5.63 (ddd, J = 6.7, 6.4, 6.4 Hz, 1H), 
5.17 (dddd, J = 16.9, 1.7, 1.7, 1.6 Hz, 1H), 5.08 (dddd, J = 10.1, 1.6, 1.4, 1.4 Hz, 1H), 2.96 
– 2.86 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 206.5, 135.9, 134.2, 132.9, 128.3, 128.1, 
127.4, 122.4, 115.8, 94.1, 93.3, 32.9. 
GCMS found 234.1, 236.1 (calculated for C12H11Br: 234.0). 
IR (thin film, cm-1): 3078, 2928, 1953, 1600, 1563, 1474, 1439, 1022, 917. 
 
(R)-2-(-Hexa-1,2,5-trien-1-yl)naphthalene (3.8f)  
Prepared from the corresponding ynal 3.67f (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 73 mg, 
89%.  
e.r.: 98:2. [α]D22 = –236.4 (c = 1.0, CHCl3). HPLC Analysis, tr major: 16.1 min., tr minor: 
16.9 min., [Chiralpak®IA column, 24 cm × 4.6 mm I.D., hexanes, 1.0 mL/min, 250 nm].  
1H NMR (500 MHz, CDCl3) δ 7.82 – 7.74 (m, 3H), 7.66 (dd, J = 1.8, 0.9 Hz, 1H), 7.51 
(dd, J = 8.5, 1.7 Hz, 1H), 7.49 – 7.39 (m, 2H), 6.36 (ddd, J = 6.1, 2.9, 2.9 Hz, 1H), 5.95 
(dddd, J = 16.6, 10.1, 6.4, 6.4 Hz, 1H), 5.67 (ddd, J = 6.6, 6.6, 6.6 Hz, 1H), 5.20 (dddd, J 
= 17.1, 1.7, 1.7, 1.6 Hz, 1H), 5.09 (dddd, J = 10.1, 1.6, 1.5, 1.5 Hz, 1H), 2.98 – 2.91 (m, 
2H). 13C NMR (126 MHz, CDCl3) δ 206.1, 136.1, 133.7, 132.6, 132.3, 128.2, 127.7, 127.7, 
126.2, 125.5, 125.4, 124.6, 115.7, 95.4, 93.4, 33.2. 
GCMS found 206.1 (calculated for C16H14: 206.1). 





Prepared from the corresponding ynal 3.67g (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 56 mg, 
87%.  
e.r.: 99:1. [α]D22 = –267.4 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding alcohol 3.88g following the hydroboration/oxidation procedure, tr 
major: 44.6 min., tr minor: 50.0 min., [Chiralpak® AD-H column, 24 cm × 4.6 mm I.D., 
hexanes:EtOH=99:1, 1.0 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.29 – 7.22 (m, 1H), 7.09 – 7.04 (m, 2H), 6.24 (ddd, J = 
6.1, 2.7, 2.7 Hz, 1H), 5.90 (dddd, J = 16.6, 10.9, 6.5, 6.5 Hz, 1H), 5.52 (ddd, J = 6.7, 6.7, 
6.7 Hz, 1H), 5.15 (dd, J = 17.2, 2.2 Hz, 1H), 5.06 (d, J = 10.1 Hz, 1H), 2.91 – 2.84 (m, 2H). 
13C NMR (126 MHz, CDCl3) δ 205.8, 136.2, 136.1, 126.3, 125.8, 120.4, 115.6, 92.3, 89.6, 
33.2. 
GCMS found 162.1 (calculated for C10H10S: 162.1). 
IR (thin film, cm-1): 3079, 2978, 2911, 1952, 1791, 1639, 1435, 1258, 993, 787.  
 
(R)-6-(Thiophen-3-yl)-hexa-4,5-dien-1-ol (3.88g) 
3.88g was prepared following the general hydroboration/oxidation procedure in 0.3 mmol 
scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (5:1) to afford the pure product as a colorless oil. Yield: 32 mg, 59%. 




1H NMR (500 MHz, CDCl3) δ 7.27 – 7.22 (m, 1H), 7.08 – 7.03 (m, 2H), 6.22 (ddd, J = 
6.3, 3.1, 3.1 Hz, 1H), 5.54 (ddd, J = 6.5, 6.5, 6.5 Hz, 1H), 3.71 (t, J = 6.5 Hz, 2H), 2.24 – 
2.17 (m, 2H), 1.80 – 1.70 (m, 2H), 1.39 (br, 1H). 13C NMR (126 MHz, CDCl3) δ 205.4, 
136.2, 126.2, 125.8, 120.4, 93.6, 89.7, 62.3, 31.8, 25.0. 
ESIMS found 181.1 (calculated for [C10H13OS]+: 181.1). 
IR (thin film, cm-1): 3463, 3056, 2944, 1951, 1057, 788.  
 
(R)-3-(Hexa-1,2,5-trien-1-yl)pyridine (3.8h) 
2-Nitro-4-(trifluoromethyl)benzenesulfonohydrazide 3.49 (114 mg, 0.4 mmol), 3-(pyridin-
3-yl)propiolaldehyde 3.67h (52 mg, 0.4 mmol), and oven-dried 3 Å powdered molecular 
sieves (200 mg) were added to a 10 mL reaction vial equipped with a magnetic stir bar. 
Dichloromethane (0.5 mL) was added to the vial and the reaction mixture was stirred at 
room temperature for 2 h, at which time the reaction mixture was concentrated first by 
rotary evaporation and then by static pressure vacuum (2 – 10 Torr) for 10 min. (R)-Ph2-
BINOL catalyst 3.47 (36 mg, 0.08 mmol, 7 mol%), tert-butanol (89 mg, 1.2 mmol) and 
allylboronate 3.68 (152 mg, 1.2 mmol) was added and rinsed into the solution with dry 
toluene (0.2 mL). The reaction was applied to sonication for 10 min to facilitate dissolution. 
The vial was sealed with a rubber septum and attached to a balloon filled with argon. The 
mixture was allowed to stir at room temperature for 24 h, at which time the crude mixture 
was chromatographed on silica gel with hexanes:EtOAc (50:1) to afford the pure product 




e.r.: 98:2. [α]D22 = –222.4 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 11.0 min., tr major: 
11.5 min., [Chiralpak®IA column, 24 cm × 4.6 mm I.D., hexanes:EtOH=99:1, 1.0 mL/min, 
250 nm].  
1H NMR (500 MHz, CDCl3) δ 8.51 (s, 1H), 8.41 (d, J = 4.6 Hz, 1H), 7.58 (ddd, J = 7.9, 
1.9, 1.9 Hz, 1H), 7.21 (dd, J = 7.8, 4.8 Hz, 1H), 6.14 (ddd, J = 6.1, 2.9, 2.9 Hz, 1H), 5.89 
(dddd, J = 16.7, 10.1, 6.4, 6.4 Hz, 1H), 5.65 (ddd, J = 6.8, 6.8, 6.8 Hz, 1H), 5.15 (dddd, J 
= 17.0, 1.6, 1,6, 1.5 Hz, 1H), 5.07 (dddd, J = 10.1, 1.5, 1.4, 1.4 Hz, 1H), 2.93 – 2.87 (m, 
2H). 13C NMR (126 MHz, CDCl3) δ 206.0, 148.2, 147.9, 135.7, 133.4, 130.7, 123.4, 116.0, 
93.9, 91.8, 32.8. 
HRMS found 158.0979 (calculated for [C11H12N]+: 158.0970). 
IR (thin film, cm-1): 3057, 2982, 1951, 1640, 1571, 1481, 1431, 1025, 916, 810, 748.  
 
(R)-Octadeca-1,4,5-triene (3.8i) 
Prepared from the corresponding ynal 3.67i (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 97 mg, 
98%. 
e.r.: 98:2. [α]D22 = –39.5 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding alcohol 3.88i following the hydroboration/oxidation procedure, tr 
minor: 28.3 min., tr major: 30.9 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., 




1H NMR (500 MHz, CDCl3) δ 5.85 (dddd, J = 16.7, 10.5, 6.3, 6.3 Hz, 1H), 5.16 – 5.03 (m, 
3H), 5.01 (ddd, J = 10.3, 1.7, 1.7 Hz, 1H), 2.77 – 2.71 (m, 2H), 2.02 – 1.92 (m, 2H), 1.43 
– 1.36 (m, 2H), 1.36– 1.18 (m, 18H), 0.88 (t, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) 
δ 204.2, 136.8, 115.0, 91.4, 88.9, 33.5, 31.9, 29.7, 29.7, 29.7, 29.5, 29.4, 29.1, 29.1, 28.8, 
22.7, 14.1. 
GCMS found 248.3 (calculated for C18H32: 248.3). 
IR (thin film, cm-1): 3082, 2956, 2854, 1963, 1641, 1467, 1261, 991, 912, 870.  
 
(R)-Octadeca-4,5-dien-1-ol (3.88i) 
3.88i was prepared following the general hydroboration/oxidation procedure in 0.3 mmol 
scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (100:10) to afford the pure product as a colorless oil. Yield: 58 mg, 72%. 
e.r.: 98:2. [α]D22 = –41.2 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 5.13 – 5.06 (m, 2H), 3.69 (dt, J = 6.1, 6.1 Hz, 2H), 2.11 – 
2.04 (m, 2H), 2.02 – 1.91 (m, 2H), 1.69 (tt, J = 6.9, 6.9 Hz, 1H), 1.41 – 1.35 (m, 2H), 1.26 
(m, 18H), 1.35 – 1.15 (t, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 203.8, 91.6, 90.1, 
62.4, 32.0, 31.9, 29.7, 29.7, 29.6, 29.5, 29.4, 29.2, 29.1, 29.0, 25.2, 22.7, 14.1. 
ESIMS found 267.3 (calculated for [C18H35O]+: 267.3).  







Prepared from the corresponding ynal 3.67j (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 40 mg, 
62%.  
e.r.: 99:1. [α]D22 = –57.0 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding alcohol 3.88j following the hydroboration/oxidation procedure, tr 
minor: 40.4 min., tr major: 53.8 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., 
hexanes:i-PrOH =800:1, 1.0 mL/min, 210 nm].  
1H NMR (500 MHz, CDCl3) δ 5.84 (dddd, J = 16.6, 10.1, 6.4, 6.4 Hz, 1H), 5.16 – 5.03 (m, 
3H), 5.00 (dddd, J = 10.1, 1.5, 1.5, 1.5 Hz, 1H), 2.78 – 2.68 (m, 2H), 2.00 – 1.90 (m, 1H), 
1.74 – 1.57 (m, 4H), 1.33 – 1.06 (m, 6H). 13C NMR (126 MHz, CDCl3) δ 203.1, 136.8, 
115.0, 97.5, 89.8, 37.1, 33.6, 33.1, 33.0, 26.2, 26.0, 26.0. 
GCMS found 162.1 (calculated for C12H18: 162.1).  
IR (thin film, cm-1): 3078, 2925, 2853, 1960, 1640, 1449, 1261, 992, 913, 761.  
 
(R)-6-Cyclohexyl-hexa-4,5-dien-1-ol (3.88j) 
3.88j was prepared following the general hydroboration/oxidation procedure in 0.25 mmol 
scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (100:10) to afford the pure product as a colorless oil. Yield: 27 mg, 59%. 




1H NMR (500 MHz, CDCl3) δ 5.05 – 5.29 (m, 2H), 3.68 (tt, J = 6.3, 2.9 Hz, 2H), 2.06 (tdd, 
J = 6.8, 5.4, 2.0 Hz, 2H), 1.94 (m, 1H), 1.75 – 1.60 (m, 8H), 1.21 – 1.10 (m, 4H). 13C NMR 
(126 MHz, CDCl3) δ 202.6, 97.6, 91.1, 62.4, 37.2, 33.1, 33.1, 32.0, 26.2, 26.0, 25.3. 
ESIMS found 181.2 (calculated for [C12H21O]+: 181.2). 
IR (thin film, cm-1): 2923, 2850, 1469, 1053.  
 
(R)-(Hexa-1,2,5-trien-1-yl)dimethyl(phenyl)silane (3.8k) 
Prepared from the corresponding ynal 3.67k (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 62 mg, 
73%.  
e.r.: 98:2. [α]D22 = –50.0 (c = 1.0, CHCl3). HPLC Analysis, tr major: 9.9 min., tr minor: 
10.9 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes, 0.5 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.58 – 7.52 (m, 2H), 7.40 – 7.32 (m, 3H), 5.82 (dddd, J = 
16.6, 10.1, 6.4, 6.4 Hz, 1H), 5.13 – 5.03 (m, 2H), 5.00 (dddd, J = 10.1, 1.5, 1.5, 1.5 Hz, 
1H), 4.86 (ddd, J = 6.9, 6.9, 6.9 Hz, 1H), 2.77 – 2.71 (m, 2H), 0.38 – 0.34 (m, 6H). 13C 
NMR (126 MHz, CDCl3) δ 211.1, 138.5, 136.9, 133.7, 129.1, 127.7, 115.0, 82.1, 81.5, 
32.3, –2.2, –2.3. 
GCMS found 214.1 (calculated for C14H18Si: 214.1).  







Prepared from the corresponding ynal 3.67l (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes:EtOAc (50:1) to afford the pure product as a colorless oil. 
Yield: 72 mg, 90%.  
e.r.: 98:2. [α]D22 = –58.6 (c = 1.0, CHCl3). HPLC Analysis, tr major: 14.9 min., tr minor: 
15.8 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH =800:1, 0.8 
mL/min, 210 nm].  
1H NMR (500 MHz, CDCl3) δ 7.40 – 7.32 (m, 4H), 7.34 – 7.27 (m, 1H), 5.87 (dddd, J = 
16.6, 10.1, 6.4, 6.4 Hz, 1H), 5.35 – 5.21 (m, 2H), 5.12 (dddd, J = 17.1, 1.7, 1.7, 1.6 Hz, 
1H), 5.06 (dddd, J = 10.1, 1.6, 1.5, 1.5 Hz, 1H), 4.55 (d, J = 2.2 Hz, 2H), 4.13 – 4.02 (m, 
2H), 2.84 – 2.79 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 205.4, 138.2, 136.2, 128.4, 127.8, 
127.6, 115.5, 90.0, 88.9, 71.6, 68.4, 32.9. 
GCMS found 200.1 (calculated for C14H16O: 200.1) 
IR (thin film, cm-1): 3064, 3030, 2978, 2857, 1964, 1640, 1496, 1454, 1351, 1095, 1029, 
915, 736.  
 
(R)-N-(Hepta-2,3,6-trien-1-yl)-N-methylaniline (3.8m) 
Prepared from the corresponding ynal 3.67m (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure, but for 40 hours. The crude mixture was purified by 
flash column chromatography with hexanes:EtOAc (100:5) to afford the pure product as a 




e.r.: 99:1. [α]D22 = +3.5 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 8.8 min., tr major: 9.2 
min., [Chiralpak®IA column, 24 cm × 4.6 mm I.D., hexanes, 1.0 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.28 – 7.17 (m, 2H), 6.75 (d, J = 8.2 Hz, 2H), 6.71 (t, J = 
7.3 Hz, 1H), 5.77 (dddd, J = 16.7, 10.1, 6.4, 6.4 Hz, 1H), 5.19 – 5.11 (m, 2H), 5.10 – 4.94 
(m, 2H), 4.05 – 3.87 (m, 2H), 2.95 (s, 3H), 2.73 – 2.67 (m, 2H). 13C NMR (126 MHz, 
CDCl3) δ 205.0, 149.1, 136.3, 129.0, 116.6, 115.3, 112.9, 90.4, 87.2, 51.9, 38.1, 33.1. 
HRMS found 200.1433 (calculated for [C14H18N]+: 200.1439) 
IR (thin film, cm-1): 3006, 2979, 2908, 1965, 1600, 1506, 1342, 748.  
 
(R)-Methyl(hepta-2,3,6-trien-1-yl)(phenyl)carbamate (3.8n) 
Prepared from the corresponding ynal 3.67n (0.4 mmol) and allyl boronate 3.68 (0.6 mmol) 
according to the general procedure, but for 40 hours. The crude mixture was purified by 
flash column chromatography with hexanes:EtOAc (100:5) to afford the pure product as a 
colorless oil. Yield: 83 mg, 85%.  
e.r.: 99:1. [α]D22 = –23.2 (c = 1.0, CHCl3). HPLC Analysis, tr major: 45.5 min., tr minor: 
49.7 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH =800:1, 1.0 
mL/min, 210 nm].  
1H NMR (500 MHz, CDCl3) δ 7.38 – 7.30 (m, 2H), 7.28 – 7.20 (m, 3H), 5.71 (dddd, J = 
16.9, 10.1, 6.4, 6.4 Hz, 1H), 5.27 – 5.21 (m, 1H), 5.17 (ddddd, J = 6.6, 6.6, 6.6, 2.6, 2.6 Hz, 
1H), 5.02 (dddd, J = 16.9, 1.7, 1.7, 1.6 Hz, 1H), 4.97 (dddd, J = 10.1, 1.6, 1.5, 1.5 Hz, 1H), 




2H). 13C NMR (126 MHz, CDCl3) δ 204.9, 155.8, 136.1, 128.8, 126.9, 126.5, 115.4, 110.0, 
91.0, 88.3, 52.9, 49.9, 32.9. 
HRMS found 244.1338 (calculated for [C15H18NO2]+: 244.1331).  
IR (thin film, cm-1): 3292, 2958, 1700, 1596, 1497, 1446, 1381, 1280, 1218. 
Synthesis of Laballenic Acid 
(R)-Heptadeca-1,4,5-triene (3.70) 
Prepared from the corresponding ynal 3.69 (2.0 mmol) and allyl boronate 3.68 (3.0 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 399 mg, 
85%.  
e.r.: 99:1. [α]D22 = –38.3 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding alcohol (see below) following the hydroboration/oxidation procedure, 
tr minor: 32.5 min., tr major: 34.3 min., [Chiralpak®IA column, 24 cm × 4.6 mm I.D., 
hexanes:i-PrOH =800:1, 1.0 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 5.85 (dddd, J = 16.6, 10.1, 6.4, 6.4 Hz, 1H), 5.16 – 5.04 (m, 
3H), 5.01 (ddd, J = 10.1, 1.5, 1.5 Hz, 1H), 2.80 – 2.71 (m, 2H), 2.03 – 1.92 (m, 2H), 1.46 
– 1.35 (m, 2H), 1.35 – 1.19 (m, 16H), 0.89 (t, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) 
δ 204.2, 136.8, 115.0, 91.5, 88.9, 33.5, 31.9, 29.7, 29.6, 29.5, 29.4, 29.1, 29.1, 28.8, 22.7, 
14.1. 
GCMS found 234.2 (calculated for C17H30: 234.2).  






The product was prepared in 1.0 mmol scale following the general procedure for 
hydroboration/oxidation and the crude mixture was purified by flash column 
chromatography with hexanes:EtOAc (100:5) to afford the pure product as a colorless oil. 
Yield: 189 mg, 75%.  
e.r.: 99:1. [α]D22 = –43.7 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 5.13 – 5.07 (m, 2H), 3.74 – 3.62 (m, 2H), 2.12 – 2.03 (m, 
2H), 2.01 – 1.93 (m, 2H), 1.69 (tt, J = 7.3, 6.5 Hz, 2H), 1.43 – 1.34 (m, 2H), 1.33 – 1.21 
(m, 16H), 0.91 – 0.85 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 203.8, 91.6, 90.1, 62.4, 
32.0, 31.9, 29.7, 29.7, 29.5, 29.3, 29.2, 29.1, 25.2, 22.7, 14.1. 
ESIMS found 253.2 (calculated for [C17H33O]+: 253.2).  
IR (thin film, cm-1): 3354, 2853, 1467, 1057, 930.  
 
(R)-Octadeca-5,6-dienenitrile (3.72) 
(R)-Heptadeca-4,5-dien-1-ol 3.71 (131 mg, 0.5 mmol) was dissolved in Et2O (5 mL) and 
cooled to 0 ℃. Triphenylphosphine (262 mg, 1 mmol) and diisopropyl azodicarboxylate 
(202 mg, 1 mmol) were added followed by the addition of acetone cyanohydrin (85 mg, 1 
mmol). The reaction mixture was allowed to stir at the same temperature for 1 h and warm 
up to room temperature. After 24 hours, the reaction mixture was flashed through a short 
pad of silica gel and the solvent was removed under vacuum. The crude product was 
purified by column chromatography with hexanes:EtOAc (50:1) to afford the pure product 




[α]D22 = –47.5 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 5.14 (dddt, J = 6.5, 6.5, 6.4, 3.0 Hz, 1H), 5.05 (dddt, J = 
6.4, 6.3, 6.3, 3.0 Hz, 1H), 2.39 (t, J = 7.3 Hz, 2H), 2.16 – 2.10 (m, 2H), 2.01 – 1.94 (m, 
2H), 1.82 – 1.74 (m, 2H), 1.38 (q, J = 7.3 Hz, 2H), 1.34 – 1.20 (m, 16H), 0.88 (t, J = 6.9 
Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 204.1, 119.6, 92.3, 88.6, 31.9, 29.7, 29.6, 29.5, 
29.3, 29.2, 29.1, 28.9, 27.6, 24.6, 22.7, 16.4, 14.1. 
ESIMS found 262.2 (calculated for [C18H32N]+: 262.2). HRMS found 284.2364 
(calculated for [C18H31NNa]+: 284.2354).  
IR (thin film, cm-1): 2924, 2854, 2250, 1963, 1465, 880.  
 
(R)-Octadeca-5,6-dienoic acid, laballenic acid (3.73) 
(R)-Octadeca-5,6-dienenitrile 3.72 (115 mg, 0.44 mmol) was dissolved in EtOH (0.5 mL). 
To this solution was added a solution of NaOH (120 mg, 3 mmol) in H2O (0.16 mL). The 
reaction mixture was stirred at 80 ℃ for 5 h. The reaction was acidified with HCl (2 M) to 
pH=1, and extracted with Et2O (3 × 5 mL). The combined organic layers were dried over 
anhydrous Na2SO4, filtered and concentrated under vacuum. The crude mixture was 
purified by column chromatography with hexanes:EtOAc:AcOH (100:10:0.1) to afford the 
pure product as a colorless oil with acidic smell. Yield: 107 mg, 87%.  
[α]D22 = –45.0 (c = 1.0, CHCl3). In lit: [α]D29 = –42.7 (c = 0.96, CHCl3).155 [α]D27 = –50.6 
(c = 1.025, CHCl3).156  
1H NMR (500 MHz, CDCl3) δ 5.14 – 5.00 (m, 2H), 2.41 (t, J = 7.5 Hz, 2H), 2.04 (qd, J = 




7.1, 7.1 Hz, 2H), 1.34 – 1.21 (m, 16H), 0.88 (t, J = 6.8 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 204.0, 179.9, 91.6, 89.6, 33.3, 31.9, 29.7, 29.6, 29.5, 29.4, 29.2, 29.1, 28.9, 28.2, 
24.0, 22.7, 14.1. 
ESIMS found 279.2 (calculated for [C18H31O2]–: 279.2). HRMS found 279.2325 
(calculated for [C18H31O2]–: 279.2324).  
IR (thin film, cm-1): 2923, 2854, 1710, 1457, 1254, 878.  
All spectra were in agreement with reported data.155-156 
General Procedure for Racemic Traceless Petasis Crotylations to Afford Racemic but 
Diastereomerically Pure Crotyl Allenes 
 
2-Nitrobenzenesulfonohydrazide 3.1 (87 mg, 0.4 mmol), ynal 3.67a or 3.74 (0.4 mmol), 
and oven-dried 3 Å powdered molecular sieves (200 mg) were added to a 10-mL reaction 
vial equipped with a magnetic stir bar. CH2Cl2 (0.5 mL) was added to the vial and the 
reaction mixture was stirred at room temperature for 2 h, at which time the reaction mixture 
was concentrated first by rotary evaporation and then by static pressure vacuum (2 – 10 
Torr) for 10 min. Racemic Ph2-BINOL catalyst (±)-3.47 (18 mg, 0.04 mmol, 7 mol%), tert-
butanol (89 mg, 1.2 mmol) and crotylboronate 3.75 or 3.76 (84 mg, 0.6 mmol) were added 




sonication for 10 min to facilitate dissolution. The vial was sealed with a rubber septum 
and attached to a balloon filled with argon. The mixture was allowed to stir at room 
temperature for 48 h, at which time the crude mixture was chromatographed on silica gel 
to afford the desired product.  
General Procedure for Asymmetric Traceless Petasis Crotylations to Afford Crotyl 
Allenes 
 
2-Nitrobenzenesulfonohydrazide 3.1 (87 mg, 0.4 mmol), ynal 3.67a or 3.74 (0.4 mmol), 
and oven-dried 3 Å powdered molecular sieves (200 mg) were added to a 10-mL reaction 
vial equipped with a magnetic stir bar. Dichloromethane (1.0 mL) was added to the vial 
and the reaction mixture was stirred at room temperature for 2 h, at which time the reaction 
mixture was concentrated first by rotary evaporation and then by static pressure vacuum (2 
– 10 Torr) for 10 min. (R)-Ph2-BINOL catalyst 3.47 (18 mg, 0.04 mmol, 7 mol%), tert-
butanol (89 mg, 1.2 mmol) and crotylboronate 3.75 or 3.76 (84 mg, 0.6 mmol) were added 
and rinsed into the solution with dry toluene (0.2 mL). The reaction was applied to 
sonication for 10 min to facilitate dissolution. The vial was sealed with a rubber septum 




temperature for 48 h, at which time the crude mixture was chromatographed on silica gel 
to afford the desired product. 
Analytical Data for Crotyl Allenes 
(Ra,S)-(4-Methyl-hexa-1,2,5-trien-1-yl)benzene (3.77a) 
Prepared from the corresponding ynal 3.67a (0.4 mmol) and crotyl boronate 3.75 (0.6 
mmol) according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 53 mg, 
78%. 
e.r.: 98:2. d.r.: >20:1. [α]D22 = –163.4 (c = 1.0, CHCl3). HPLC Analysis, tr major: 6.2 
min., tr minor: 6.6 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 
800:1, 1.0 mL/min, 254 nm].  
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.31 (m, 4H), 7.23 – 7.17 (m, 1H), 6.23 (dd, J = 6.4, 
2.9 Hz, 1H), 5.90 (ddd, J = 17.0, 10.2, 6.7 Hz, 1H), 5.62 (dd, J = 6.4, 6.3 Hz, 1H), 5.13 
(ddd, J = 17.2, 1.5, 1.4 Hz, 1H), 5.03 (ddd, J = 10.2, 1.4, 1.3 Hz, 1H), 3.07 – 2.97 (m, 1H), 
1.21 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 204.3, 142.4, 134.9, 128.6, 126.8, 
126.5, 113.3, 99.5, 96.0, 37.5, 19.8. 
GCMS found 170.1 (calculated for C13H14: 170.1).  
IR (thin film, cm-1): 3084, 3030, 2970, 2930, 1950, 1495, 1458, 915, 776.  
 
(Ra,R)-(4-Methyl-hexa-1,2,5-trien-1-yl)benzene (3.78a) 
Prepared from the corresponding ynal 3.67a (0.4 mmol) and crotyl boronate 3.76 (0.6 




chromatography with hexanes to afford the pure product as a colorless oil. Yield: 36 mg, 
53%.  
e.r.: 98:2. [α]D22 = –120.8 (c = 1.0, CHCl3). HPLC Analysis, tr major: 27.7 min., tr minor: 
30.0 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 800:1, 0.2 
mL/min, 254 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.28 (m, 4H), 7.24 – 7.18 (m, 1H), 6.23 (dd, J = 6.4, 
2.8 Hz, 1H), 5.90 (ddd, J = 17.1, 10.2, 6.8 Hz, 1H), 5.62 (dd, J = 6.4, 6.3 Hz, 1H), 5.14 
(ddd, J = 17.1, 1.5, 1.5 Hz, 1H), 5.03 (ddd, J = 10.2, 1.3, 1.3 Hz, 1H), 3.11 – 2.97 (m, 1H), 
1.22 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 204.3, 142.4, 134.9, 128.6, 126.8, 
126.6, 113.3, 99.5, 96.0, 37.5, 19.8. 
GCMS found 170.1 (calculated for C13H14: 170.1). 
IR (thin film, cm-1): 3065, 3032, 2973, 1726, 1495, 1262, 919, 698.  
 
(Ra,S)-3-Methyl-deca-1,4,5-triene (3.77b) 
Prepared from the corresponding ynal 3.74 (0.5 mmol) and crotyl boronate 3.75 (0.75 
mmol) according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 57 mg, 
76%. 
e.r.: 99:1. d.r.: >20:1. [α]D22 = +34.1 (c = 1.0, CHCl3). HPLC Analysis, this compound 
was converted to the corresponding alcohol 3.89 following the hydroboration/oxidation 
procedure, tr major: 28.3 min., tr minor: 33.7 min., [Chiralpak®AD-H column, 24 cm × 




1H NMR (500 MHz, CDCl3) δ 5.81 (ddd, J = 17.1, 10.2, 6.8 Hz, 1H), 5.18 (dddd, J = 6.5, 
6.5, 6.4, 2.9 Hz, 1H), 5.10 (dddd, J = 6.4, 6.2, 3.0, 3.0 Hz, 1H), 5.04 (ddd, J = 17.1, 1.7, 
1.6 Hz, 1H), 4.96 (ddd, J = 10.2, 1.7, 1.1 Hz, 1H), 2.90 – 2.78 (m, 1H), 2.00 (dtd, J = 7.4, 
6.6, 3.0 Hz, 2H), 1.45 – 1.30 (m, 4H), 1.11 (d, J = 6.9 Hz, 3H), 0.95 – 0.85 (m, 3H). 13C 
NMR (126 MHz, CDCl3) δ 202.9, 143.0, 112.6, 95.4, 92.5, 37.3, 31.3, 28.6, 22.2, 19.7, 
13.9. 
GCMS found 150.1 (calculated for C11H18: 150.1). 
IR (thin film, cm-1): 2960, 2872, 1683, 1590, 1456, 917, 875.  
 
(Ra,S)-3-Methyl-deca-4,5-dien-1-ol (3.89) 
The substrate was run in 0.2 mmol scale following the hydroboration/oxidation procedure 
and the crude mixture was purified by flash column chromatography with hexanes:EtOAc 
(8:1) to afford the pure product as a colorless oil. Yield: 19 mg, 56%.  
e.r.: 99:1. d.r.: >20:1. [α]D22 = –15.7 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 5.12 (dddd, J = 6.6, 6.6, 6.5, 2.5 Hz, 1H), 5.04 (dddd, J = 
6.4, 6.3, 3.0, 3.0 Hz, 1H), 3.70 (t, J = 6.5 Hz, 2H), 2.33 – 2.23 (m, 1H), 2.02 – 1.94 (m, 
2H), 1.64 – 1.55 (m, 2H), 1.40 – 1.31 (m, 4H), 1.03 (d, J = 6.8 Hz, 3H), 0.89 (t, J = 7.1 Hz, 
3H). 13C NMR (126 MHz, CDCl3) δ 202.6, 96.4, 92.1, 61.2, 39.8, 31.3, 30.4, 28.7, 22.2, 
20.7, 13.9. 
HRMS found 169.1593 (calculated for [C11H21O]+: 169.1592). 






Prepared from the corresponding ynal 3.74 (1.0 mmol) and crotyl boronate 3.76 (1.5 mmol) 
according to the general procedure. The crude mixture was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 100 mg, 
67%.  
e.r.: 99:1. d.r.: >20:1. [α]D22 = –124.4 (c = 1.0, CHCl3). HPLC Analysis, this compound 
was converted to the corresponding alcohol 3.79 following the hydroboration/oxidation 
procedure, tr major: 32.3 min., tr minor: 39.7 min., [Chiralpak®AD-H column, 24 cm × 
4.6 mm I.D., hexanes:i-PrOH = 99.9:0.1, 1.0 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 5.81 (ddd, J = 17.2, 10.2, 6.7 Hz, 1H), 5.17 (dddd, J = 6.5, 
6.5, 6.5, 2.8 Hz, 1H), 5.13 – 5.08 (m, 1H), 5.04 (ddd, J = 17.2, 1.7, 1.6 Hz, 1H), 4.96 (ddd, 
J = 10.2, 1.7, 1.2 Hz, 1H), 2.90 – 2.79 (m, 1H), 2.04 –1.97 (m, 2H), 1.48 – 1.29 (m, 4H), 
1.11 (d, J = 6.9 Hz, 3H), 0.91 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 202.9, 
142.9, 112.6, 95.3, 92.5, 37.2, 31.3, 28.6, 22.1, 19.7, 13.9. 
GCMS found 150.1 (calculated for C11H18: 150.1). 
IR (thin film, cm-1): 2959, 2928, 2872, 1683, 1590, 1456, 917, 875, 760.  
 
(Ra,R)-3-Methyl-deca-4,5-dien-1-ol (3.79) 
The substrate was run in 0.67 mmol scale following the general procedure of 
hydroboration/oxidation and the crude mixture was purified by flash column 
chromatography with hexanes:EtOAc (8:1) to afford the pure product as a colorless oil. 




e.r.: 99:1. d.r.: >20:1. [α]D22 = –71.0 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 5.13 (dddd, J = 6.6, 6.6, 6.6, 2.4 Hz, 1H), 5.05 (dt, J = 6.5, 
3.1 Hz, 1H), 3.71 (td, J = 6.4, 3.5 Hz, 2H), 2.33 – 2.22 (m, 1H), 2.03 – 1.94 (m, 2H), 1.63 
– 1.55 (m, 2H), 1.42 – 1.31 (m, 4H), 1.04 (d, J = 6.8 Hz, 3H), 0.90 (t, J = 7.1 Hz, 3H). 13C 
NMR (126 MHz, CDCl3) δ 202.6, 96.4, 92.2, 61.3, 39.7, 31.4, 30.5, 28.8, 22.2, 20.8, 13.9. 
HRMS found 169.1586 (calculated for [C11H21O]+: 169.1592) 
IR (thin film, cm-1): 3353, 2958, 2929, 2872, 1961, 1457, 1053.  
Absolute Stereochemistry Determination for Crotyl Allenes and Allyl Allenes 
(Ra,S)-3-Methyldeca-4,5-dienoic acid (3.90) 
(Ra,S)-3-methyl-deca-4,5-dien-1-ol (3.89) (73 mg, 0.4 mmol) was dissolved in 3 mL 
acetone and cooled to –20 ℃. Jones reagent (2.5 equiv), prepared from CrO3 (100 mg, 1.0 
mmol), concentrated H2SO4 (0.09 mL, 1.6 mmol), and water (0.4 mL), was added slowly 
to the reaction and the reaction was allowed to warm to 0 ℃ in 2 h before quenched by 
addition of 1 mL i-PrOH, and the mixture was filtered and concentrated down to 1 mL. 
The residue was then purified by flash column chromatography with hexanes:EtOAc (8:1) 
to afford the pure product as a colorless oil. Yield: 39 mg, 53%.  
[α]D22 = –50.9 (c = 1.0, CHCl3). In lit:184 its enantiomer (Sa,R)-3-methyldeca-4,5-dienoic 
acid [α]D22 = +45 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 5.23 – 5.11 (m, 2H), 2.71 – 2.61 (m, 1H), 2.46 (dd, J = 15.6, 
7.0 Hz, 1H), 2.30 (dd, J = 15.6, 7.4 Hz, 1H), 2.02 – 1.93 (m, 2H), 1.41 – 1.28 (m, 4H), 1.08 
(d, J = 6.8 Hz, 3H), 0.89 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 202.4, 178.2, 




(Ra,R)-3-Methyldeca-4,5-dienoic acid (3.80) 
(Ra,R)- 3-Methyl-deca-4,5-dien-1-ol (3.79) (73 mg, 0.4 mmol) was dissolved in 3 mL 
acetone and cooled to 0 ℃. Jones reagent (2.5 equiv), prepared from CrO3 (100 mg, 1.0 
mmol), concentrated H2SO4 (0.09 mL, 1.6 mmol), and water (0.4 mL), was added slowly 
to the reaction and the reaction remained at the same temperature for 2 h before quenched 
by addition of 1 mL i-PrOH, and the mixture was filtered and concentrated down to 1 mL. 
The residue was then purified by flash column chromatography with hexanes:EtOAc (8:1) 
to afford the pure product as a colorless oil. Yield: 41 mg, 56%.  
[α]D22 = –80.5 (c = 1.34, CHCl3). In lit:184 [α]D22 = –74.9 (c = 1.34, CHCl3). 
1H NMR (500 MHz, CDCl3) δ 5.24 – 5.08 (m, 2H), 2.71 – 2.58 (m, 1H), 2.45 (dd, J = 15.6, 
7.0 Hz, 1H), 2.29 (dd, J = 15.6, 7.4 Hz, 1H), 2.02 – 1.94 (m, 2H), 1.43 – 1.28 (m, 4H), 1.09 
(d, J = 6.8 Hz, 3H), 0.90 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 202.4, 178.9, 
95.5, 93.4, 41.1, 31.3, 29.8, 28.6, 22.2, 20.3, 13.9. 
 
The absolute stereochemistry of 3.90 and 3.80 was confirmed by their NMR and optical 
rotations compared to those that had been reported by Ma’s group.184 Therefore the 
absolute stereochemistry of crotyl allenes 3.77 and 3.78 was determined.  






4Asymmetric Reductive Petasis Allylation/Crotylation of Enals via Sigmatropic 
Diazene Rearrangement to Afford Enantioenriched 1,4-Dienes 
Introduction 
 
Figure 4.1 Asymmetric Petasis Allylation/Crotylation of Enals to Afford 1,4-Dienes 
The success of the asymmetric synthesis of allyl allenes by traceless Petasis 
allylation reactions encouraged us to expand the aldehyde substrate scope to include allylic 
aldehydes. We postulate that the Petasis adduct 4.1 formed by sulfonylhydrazides, enals 
and allylboronate, will disintegrate to form an enantioenriched diazene intermediate 4.2 
(Figure 4.1). Subsequent enantiospecific diazene rearrangement, presumably via a chair-
like transition state,185 will furnish the chiral 1,4-diene product with high enantiomeric 
purity. When γ-substituted allylboronates are employed as the nucleophile, the traceless 




A diastereoselective strategy to access both syn- and anti-diastereomers is thereby 
achievable based on our previous observations in asymmetric Petasis crotylations.  
Background 
Allylic Diazene Rearrangement 
The addition of an alkene bearing an allylic hydrogen (ene) to an unsaturated 
compound (enophile) is named the ene reaction.186-189 The retro-ene reaction, also known 
as the alkene walk pathway, is the reverse process of the ene reaction (Figure 4.2, eq 1).190-
192 They are both believed to proceed in a concerted and stereospecific mechanism.  
 
Figure 4.2 Retro-Ene Reaction and Diazene Rearrangement 
The diazene rearrangement is a typical class of retro-ene reactions. The elimination 
of dinitrogen serves as a driving force, which allows it to take place readily at room 
temperature (Figure 4.2, eq 2).193 Early mechanistic studies were pioneered by Sato and 
Homma, in which allylic tosylhydrazides were prepared and subjected to warm acetic acid, 
which exclusively afforded sigmatropically rearranged products.194-195  
 




The first nucleophilic addition/diazene rearragenment sequence was developed by 
reducing unsaturated tosylhydrazones to the corresponding alkenes (Figure 4.3).196-197 
Notably in all examples studied in these reports, the alkene products were resulted from a 
migration of the double bond and predominately took the trans-geometry, which was 
strong evidence for the concerted 1,5-sigmatropic rearrangement.  
 
Figure 4.4 Alkylation/Diazene Rearrangement Sequence in Stereoselectvie Synthesis of Olefins 
N-tert-Butyldimethylsilyl-substituted tosylhydrazones were demonstrated to 
undergo 1,2-addition with equimolar amounts of organolithium reagents.198 Elimination of 
p-toluenesulfinic acid produced the allylic diazene 4.3, which spontaneously lost 
dinitrogen to form the alkene products (Figure 4.4). The selective formation of (E)-4.4 over 
(Z)-4.5 was rationalized by considering allylic 1,3-strain arising from a boat-like six-
membered cyclic transition state. 
Allylic Diazene Rearrangement in Asymmetric Synthesis 
 




The stereospecific nature of the allylic diazene rearrangement was later exploited 
by the Myers group.199 Optically active allylic alcohols were converted to the 
corresponding allylic sulfonylhydrazides 4.6 via a Mitsunobu reaction, which then resulted 
in formation of enantioenriched allylic diazene intermediates 4.7 (Figure 4.5). The 
stereospecific sigmatropic rearrangement provided the transposed products with excellent 
enantiomeric purity. Overall the reaction demonstrated a 1,3-transfer of stereochemistry 
from the hydroxylic center to the prochiral β-olefinic carbon (Figure 4.5). 
 
Figure 4.6 1,4-Stereocontrol via Allylic Diazene Rearrangement 
There are very few documented examples of asymmetric methodologies that take 
advantage of the stereospecificity of the allylic diazene rearrangement. McIntosh and co-
workers investigated a tandem hydride reduction/diazene rearrangement reaction that 
afforded 1,4-syn- or 1,4-anti-products in high yields and diastereoselectivities (Figure 
4.6).200 The chiral α-alkoxy group was crucial to the stereochemistry of the hydride 
addition. Notably, the stereochemical outcome of either syn- or anti-products was 





Figure 4.7 Palladium-Catalyzed Synthesis of Diazenes Followed by Stereospecific Rearrangement 
The first example of a transition-metal-catalyzed conversion of allylic electrophiles 
to access enantioenriched diazenes followed by stereospecific retro-ene rearrangement was 
reported by Movassaghi and co-workers in 2008 (Figure 4.7).201 Optically active Z-allylic 
epoxide 4.9 resulted in a 1,4-anti diazene intermediate 4.10, which upon rearrangement 
furnished syn-homoallylic alcohol 4.11 in a formally 1,2-stereocontrolled manner (Figure 
4.7).  
Diels-Alder reactions were utilized as another approach to allylic diazenes. 
Sorenson and co-workers developed a stereoselective Diels-Alder reaction which afforded 
an allylic sulfonylhydrazide 4.14 (Figure 4.8).202 Aldehyde protection followed by 
deprotection of the Alloc and the sulfonyl groups generated the diazene intermediate 4.15, 
which underwent stereospecific rearrangement to yield the desired trans-fused decalin 4.16. 
The suprafacial nature of the diazene rearrangement enabled a 1,3-transfer of 





Figure 4.8 Diels-Alder Reaction/Allylic Diazene Rearrangement Sequence 
An asymmetric variant of the Diels-Alder reaction was reported in 2011 by the 
Sorenson group, which provided the allylic sulfonylhydrazide 4.20 in excellent enantio- 
and diastereoselectivity (Figure 4.9).203 Palladium-catalyzed cleavage of the Alloc group 
followed by removal of the sulfonyl group under protic conditions produced the putative 
diazene intermediate 4.21, which through retro-ene rearrangement transferred the chirality 
to a prochiral β-olefinic carbon. This reaction marked the first catalytic asymmetric 






Figure 4.9 Asymmetric Diels-Alder Reaction/Allylic Diazene Rearrangement Sequence 
Results and Discussion 
Asymmetric Traceless Petasis Allylation of β,β-Disubstituted Enals 
We initiated our studies of reductive Petasis allylation by subjecting β-methyl enals 
to the optimized conditions of the traceless Petasis allylation which was described in 
Chapter 3. To our delight, the reaction with β-methyl cinnamaldehyde 4.24a, sulfonyl 
hydrazide 4.23 and allylboronate 4.26 in the presence of biphenol catalyst 4.25 afforded 
the desired 1,4-diene with excellent yield and enantioselectivity (Figure 4.10). Other β-
methyl branched enals were subsequently examined. β-Aryl-β-methyl enals with different 
substitutions (4.24b-4.24d) were in general good substrates in this enantioselective 





aReaction concentration was 1 M in toluene. b5 equivalents of t-BuOH were employed under neat conditions. 
Figure 4.10 Enantioselective Traceless Petasis Allylation of β-Methyl Enals 
β-Silyl-β-methyl enal 4.24g was also a viable substrate, providing the 
corresponding silylated product 4.27g in good enantiomeric purity under neat conditions. 
β-Alkyl-β-methyl enals such as geranial 4.24k were less suitable in this method, affording 
the desired products in good yield albeit with modest enantioselectivity. We reasoned that 
the facile E/Z isomerization of the hydrazone intermediate was the cause for the observed 




hydrazone derived from geranial and 2-nitro-4-(trifluoromethyl)benzenesulfonohydrazide 
existed as a mixture of E/Z isomers with a 4:1 ratio, which was consistent with the detected 
enantiomeric ratio of the resulting product. This means that the catalyzed rate for 
allylboration of the (E)-isomer [k(E)] was not fast enough to outcompete [k(Z)]. This 
observation is in stark contrast with the enantioconvergent results reported by the 
MacMillan204 and the List205-206 groups, where both (E)- and (Z)-enals afforded the same 
enantiomers of the reduction products in their methodologies.  
 
Figure 4.11 Rationalization for Modest Enantioselectivity of Geranial 
We sought to expand the enal scope by replacing the β-methyl substituent with a 
wider ranger of functional groups. Asymmetric synthesis of compounds containing a 
stereogenic benzylic CF3 group has been limited in literature.207-210 We decided to employ 
β-trifluoromethyl cinnamaldehyde in this reductive Petasis allylation methodology. (E)-
4,4,4-Trifluoro-3-phenylbut-2-enal 4.31c was synthesized and purified as a single isomer, 
which was subjected to the optimized conditions with hydrazide 4.23 and catalyst 4.25. 
Surprisingly, only 10% of the desired product 4.32c was isolated (Table 4.1, entry 1). We 
also noticed that when the racemic reaction was performed with unsubstituted BINOL (±)-




the same reaction, which afforded 84% yield with 78:22 e.r. (Table 4.1, entry 2). With 
repect to our previous observations in the development of tracless Petasis boronate 
additions, we reasoned that the identity of the chiral biphenol catalyst as well as the sulfonyl 
hydrazide employed in the reaction was crucial to both yield and selectivity. A two-
dimensional evaluation of both parameters was subsequently performed. Gratifyingly, Br2-
BINOL 4.34 provided promising enantiomeric control albeit with compromised yield 
(Table 4.1, entry 3, 57% yield, 91:9 e.r.). Switching the hydrazide to 4.30 resulted in an 
improved yield and slightly enhanced enantioselectivity (Table 4.1, entry 5, 86% yield, 
92:8 e.r.). Interestingly, (R)-Ph2-BINOL under these conditions afforded a completely 
racemic mixture, which implied that the increased sterics from the β-CF3 group might 
impede the formation of a catalyst-involved transition state. (R)-Br2-BINOL, with a smaller 
3,3’-substitution, eased the steric hinderance and well participated in forming a highly-
constricted Zimmerman-Traxler transition state. This new combination of hydrazide and 
catalyst proved to be general for other β-substituted enals (Figure 4.12). The 
enantioselectivity for 4.32c was further improved by employing 5 equivalents of t-BuOH 
under neat conditions (Table 4.1, entry 6, 85% yield, 97:3 e.r.), although these conditions 






Entry Hydrazide Catalyst Yield(%)a e.r.b 
1 4.23 4.25 10 — 
2 4.23 4.33 84 78:22 
3 4.23 4.34 57 91:9 
4 4.30 4.25 31 50:50 
5 4.30 4.34 86 92:8 
6c 4.30 4.34 85 97:3 
Reactions conditions: aldehyde (0.4 mmol), hydrazide (0.4 mmol) and powdered 3 Å molecular sieves (200 mg) were 
mixed in CH2Cl2 (1 mL) at room temperature for 2 h; CH2Cl2 was removed; allylboronate (0.6 mmol), catalyst, t-BuOH 
were added. aIsolated yield. bDetermined by chiral HPLC analysis. c5 equivalents of t-BuOH were employed under neat 
conditions.  
Table 4.1 Two-Dimensional Optimization for β-Trifluoromethyl Enal 
Enantioenriched hydrocarbon compounds containing a stereocenter at the benzylic 
position were thereby synthesized by the reductive Petasis allylation (Figure 4.12). Alkyl 
chains with different numbers of carbons were well tolerated at the benzylic position 
(Figure 4.12, 4.32a and 4.32b). The monofluoromethyl group was also efficiently 





a5 equivalents of t-BuOH were employed under neat conditions. 
Figure 4.12 Enantioselective Traceless Petasis Allylation of β-Alkyl Enals 
We next selected β-isopropyl enals as model substrates to demonstrate the effects 
of the olefin geometry on the stereochemical outcome (Figure 4.13). In the presence of (R)-
Br2-BINOL, (Z)-enal 4.35 afforded the desired 1,4-diene product 4.37 in useful yield and 
with excellent enantioselectivity (Figure 4.13, eq 1). As we anticipated, the same 
enantiomer of the product 4.37 was obtained by using (E)-enal 4.36 catalyzed by (S)-Br2-
BINOL (Figure 4.13, eq 2). These observations corroborated our hypothesis with regard to 
the modest enantioselectivity afforded by isomerizable enals (Figure 4.11), and revealed 





Figure 4.13 Effects of Enal’s Olefin Geometry on Stereochemical Outcome 
We turned our attention to β,β-diaryl enal substrates which would lead to products 
containing diarylmethane tertiary stereogenic centers. Chiral diarylmethane compounds 
are widely present in natural products and pharmacuticals.211 Developing catalytic 
asymmetric approaches to these compounds has attracted considerable attention in recent 
years.212-213 Isomeric pure β,β-diaryl enals were thus synthesized following Pfaltz’s 
procedure214 and assessed under the Petasis allylation conditions. The combination of 
hydrazide 4.30 and catalyst 4.34 remained to be the optimal conditions for this class of 
substrates, affording excellent yields and enantioselectivities regardless of the steric or 





Figure 4.14 Enantioselective Traceless Petasis Allylation of β,β-Diaryl Enals 
Diastereoselective Construction of Stereocenters with a 1,4-Relationship 
Asymmetric Petasis borono-Mannich crotylations of primary amines, as discussed 
in Chapter 2, afforded chiral homoallylic amines bearing two vicinal stereocenters. We 
envisioned that the analogous products afforded by crotylation of β,β-disubstituted enals, 
after 1,3-chirality transfer, would access compounds possessing two stereocenters with a 
1,4-relationship. β-Methyl cinnamaldehyde 4.24a was subjected to the crotylation 
conditions using (E)-crotylboronate 4.40 (Figure 4.15). The desired 1,4-syn product 4.42a 
was afforded in modest yield and with excellent selectivity. Changing the olefin geometry 




4.43b. β,β-Diaryl enal 4.38f also proved to be a viable substrate in this reaction, providing 
access to both 1,4-products 4.42b and 4.43b with good selectivity.  
 
a10 mol% of catalyst was used. 
Figure 4.15 Diastereoselective Traceless Petasis Crotylations of β,β-Disubstituted Enals 
Asymmetric Traceless Petasis Crotylation of Non-Branched Enals 
The enantiospecific 1,3-transfer of stereochemistry to a prochiral β-olefinic carbon 
was the key to the previously decribed reductive traceless Petasis allylation reactions. We 
scrutinized the crotylation results and proposed that when non-branched enals such as 




should maintain a stereogenic center at the 3-position, bearing a methyl group. We tested 
this hypothesis by subjecting cinnamaldehyde 4.44a to the crotylboration conditions using 
2-nitro-4-(trifluoromethyl)benzenesulfonohydrazide 4.23, biphenol catalyst 4.25 and (E)-
crotylboronate 4.40 (Figure 4.16). The desired 3-methyl-1,4-diene product 4.45a was 
isolated in a good yield and with excellent enantioselectivity. Other cinnamaldehyde 
derivatives were thereby explored and successfully converted to the corresponding 
enantioenriched 1,4-diene products with exceptional selectivities. Of note, these rearranged 
products 4.45a-f brought the alkene moiety out of conjugation with the aromatic system. 
Moreover, enantioenriched 1,4,7-triene 4.45g could also be obtained under similar 
conditions. β-Alkyl enal 4.44h displayed attenuated reactivity, which afforded the diene 






aReactions were run at 50 ℃ for 24 h. b14 mol% of catalyst was employed. c14 mol% of catalyst 4.34 was employed. 
Figure 4.16 Asymmetric Traceless Petasis Crotylation of Non-Branched Enals 
(Z)-Crotylboronate 4.41 was also incorporated with cinnamaldehyde 4.44a (Figure 
4.17, eq 1); however, significantly decreased yield was observed. It is worth noting that the 
product derived from (Z)-crotylboronate was the opposite enantiomer of the product from 
(E)-crotylboronate 4.40. This observation of divergency, together with the previous studies 
upon β-isopropyl cinnamaldehyde as illustrated in Figure 4.13, revealed that the 
stereochemical outcome of this traceless Petasis allylation reaction relied on the rigity of 




swiching the catalyst from (R) to (S), which resulted in good yield and enantioselectivity 
(Figure 4.17, eq 2).  
 
Figure 4.17 Effects of Crotylboronate’s Olefin Geometry on Stereochemical Outcome 
Conclusion 
This chapter describes two catalytic reductive traceless Petasis reactions that afford 
enantioenriched 1,4-dienes. The Petasis allylboration of β,β-disubstituted enals installs sp3 
stereogenic centers via a 1,3-chirality transfer. The Petasis crotylboration of non-branched 
enals affords enantioenriched 3-methyl-1,4-dienes (97:3 – 99:1 e.r.). Both reactions 
leverage the diazene rearrangement process. Moreover, diastereoselective crotylboration 
of β,β-disubstituted provides access to both 1,4-syn and 1,4-anti diene products with useful 
levels of stereoselectivity. Expanding the reductive traceless Petasis reactions to saturated 







All 1H NMR and 13C NMR spectra were recorded using Varian Unity Plus 500 MHz 
spectrometer at ambient temperature in CDCl3 (Cambridge Isotope Laboratories, Inc.). 
Chemical shifts in 1H NMR spectra are reported in parts per million from tetramethylsilane 
with the solvent resonance as the internal standard (deuterochloroform: δ 7.26 ppm). Data 
are reported as follows: chemical shift, multiplicity (app = apparent, br = broad, par obsc 
= partially obscure, ovrlp = overlapping, s = singlet, d = doublet, t = triplet, q = quartet, m 
= multiplet), coupling constant (Hz), and integration. Chemical shifts in 13C NMR are 
reported in ppm from tetramethylsilane with the solvent resonance as the internal standard 
(deuterochloroform: δ 77.0 ppm). All 13C NMR spectra were recorded with complete 
proton decoupling. Chemical shifts in 19F NMR spectra are reported in parts per million 
using 0.05% α, α, α-trifluorotoluene in deuterobenzene as the external standard. Infrared 
spectra were recorded on a Nicolet Nexus 670 FT-IR ESP spectrophotometer. High-
resolution mass spectra were obtained using a Waters Q-TOF mass spectrometer. LC-MS 
experiments were performed using an Agilent Single-Quad LC/MSD VL with single-quad 
low resolution (1 decimal place) capable of both ESI positive and negative modes using 
flow injection analysis. GC-MS experiments were performed using an Agilent GC-MS 
6890N equipped with a MS detector up to 800 m/z. The ionization is electron impact (EI) 
and software is ChemStation. Optical rotations were recorded on an AUTOPOL III digital 
polarimeter at 589 nm, and were reported as [α]T °CD (concentration in grams/100 mL 




with a diode array detector. Chiral columns include Chiralcel®OD (Chiral Technologies 
Inc., 25cm × 4.6mm I.D.), Chiralpak®AD-H (Chiral Technologies Inc., 25cm × 4.6 mm 
I.D.) and Chiralpak®IA (Chiral Technologies Inc., 25cm × 4.6 mm I.D.). Analytical thin 
layer chromatography was performed using EMD 0.25 mm silica gel 60-F plates. Flash 
column chromatography was performed on Sorbent Technologies 60 Å silica gel. Yields 
refer to chromatographically and spectroscopically pure compounds, unless otherwise 
stated. Catalyst loadings were calculated with respect to the amount of boronates. All 
reactions were carried out in oven-dried glassware under an argon or nitrogen atmosphere 
unless otherwise noted. HPLC grade THF, dichloromethane, Et2O and toluene were 
purchased from Fisher and VWR and were purified and dried by passing through as PURE 
SOLV® solvent purification system (Innovative Technology Inc.). Triethyl borate was 
distilled over CaH2 before use in the preparation of alkynyl boronates. Mesitylene was 
dried by and stored with 3 Å molecular sieves beads. The chiral biphenols were purchased 
or prepared according to known literature procedures.88 Allylboronate and crotylboronates 
were prepared according to our previously reported procedure.73 All other reagents were 
purchased from commercial suppliers and used without further purification. 
Preparation of Enals 
β-Alkyl enals were synthesized from the corresponding ketones by a three-step sequence: 





Step 1: To a 100-mL round bottom flask containing NaH (20 mmol, 60% mineral 
dispersion) and anhydrous THF (40 mL) at 0 ℃ was added triethyl phosphonoacetate (21.5 
mmol) dropwise. The reaction mixture was allowed to stir for 30 min at the same 
temperature, followed by a dropwise addition of a solution of the corresponding ketone (20 
mmol, in 20 mL anhydrous THF). The reaction mixture was stirred while being monitored 
by TLC until the ketone was consumed. Water (40 mL) was slowly added in and the 
reaction mixture was extracted with EtOAc (3 × 100 mL). The organic layers were 
combined and dried over Na2SO4, filtered, and concentrated under reduced pressure. The 
crude residue was subjected to flash chromatography (hexanes:EtOAc: 99/1 → 95/5) to 
afford the corresponding β,β-disubstituted ester in an isomerically pure form.  
Step 2: The unsaturated ester (20 mmol) was dissolved in 40 mL dry THF under Argon 
before being cooled to –78 °C. DIBAL-H (1.0 M in toluene, 2.4 equiv) was added dropwise 
over 5 min and the resulting mixture was stirred at –78 ℃ for 30 min. The reaction mixture 
was then allowed to warm to 0 ℃ and stirred for another 30 min. At the same temperature, 
the reaction was quenched by a dropwise addition of 2 M aqueous HCl. The organic layer 
was separated and the aqueous layer was extracted with EtOAc (3 × 100 mL). The 




pressure. The crude residue was subjected to flash chromatography (hexanes:EtOAc: 80:20) 
to afford the corresponding allylic alcohol.  
Step 3: To a 100-mL round bottom flask containing the allylic alcohol (10 mmol) obtained 
above, was added activated MnO2 (5 equiv) and anhydrous CH2Cl2 (25 mL) at room 
temperature. The reaction mixture was then allowed to stir for at least 24 h, while being 
monitored by TLC. After complete consumption of the starting material, the reaction 
mixture was filtered through a pad of Celite and rinsed by CH2Cl2. The resulting filtrate 
was concentrated under reduced pressure. The crude residue was subjected to flash 
chromatography (hexanes:EtOAc: 99:1 → 95:5) to afford the corresponding β,β-
disubstituted in an isomerically pure form.  
 
(E)-3-Phenylbut-2-enal (4.24a) was synthesized using acetophenone and all spectra were 
in agreement with reported data.217 Other β-aryl-β-methyl enals 4.24a-4.24f were 
synthesized in the same manner using corresponding aryl methyl ketones. β-Silyl-β-methyl 
enal 4.24g was synthesized in a different route (vide infra). Geranial 4.24k was synthesized 
by MnO2 oxidation of geraniol.218 
 
(E)-3-Phenylpent-2-enal (4.31a) was synthesized using propiophenone following the 
three-step synthetic sequence. All spectra were in agreement with reported data.219  
 
(Z)-3-Phenyltetradec-2-enal (4.31b) 




1H NMR (500 MHz, CDCl3) δ 9.44 (d, J = 8.2 Hz, 1H), 7.43 – 7.37 (m, 3H), 7.29 – 7.22 
(m, 2H), 6.10 (d, J = 8.2 Hz, 1H), 2.57 (t, J = 7.5 Hz, 2H), 1.46 – 1.38 (m, 2H), 1.33 – 1.19 
(m, 16H), 0.88 (t, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 193.8, 166.8, 137.8, 
128.9, 128.5, 128.4, 128.3, 39.7, 31.9, 29.6, 29.4, 29.3, 29.3, 29.1, 27.4, 22.7, 14.1. (Z)-
geometry was determined by NOESY.  








2,2,2-Trifluoroacetophenone was used following the above-mentioned three-step synthetic 
sequence. All spectra for intermediates [ethyl (E)-4,4,4-trifluoro-3-phenylbut-2-enoate and 
(E)-4,4,4-trifluoro-3-phenylbut-2-en-1-ol] were in agreement with reported data.220  
1H NMR (500 MHz, CDCl3) δ 9.55 (d, J = 7.5 Hz, 1H), 7.56 – 7.46 (m, 3H), 7.42 – 7.38 
(m, 2H), 6.64 (d, J = 7.5 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 191.5, 147.8 (q, J = 31.5 
Hz), 130.8, 130.5, 129.9, 128.8, 127.8, 122.7 (q, J = 275.0 Hz). 
ESIMS found 201.0 (calculated for [C10H8F3O]+: 201.0). 
 
(Z)-4-Fluoro-3-phenylbut-2-enal (4.31d) 
2-Fluoro-1-phenylethanone221 was used following the above-mentioned three-step 
synthetic sequence. All spectra for intermediates [ethyl (Z)-4-fluoro-3-phenylbut-2-enoate 
and (Z)-4-fluoro-3-phenylbut-2-en-1-ol] were in agreement with reported data.222 
1H NMR (500 MHz, CDCl3) δ 10.22 (dd, J = 7.2, 1.0 Hz, 1H), 7.55 – 7.48 (m, 2H), 7.47 
– 7.41 (m, 3H), 6.42 (dd, J = 7.2, 1.0 Hz, 1H), 5.73 (d, J = 47.1 Hz, 2H). 13C NMR (126 
MHz, CDCl3) δ 190.4 (d, J = 4.0 Hz), 153.2 (d, J = 14.5 Hz), 136.5 (d, J = 3.5 Hz), 130.4, 
129.6 (d, J = 2.9 Hz), 129.0, 126.9, 79.5 (d, J = 171.4 Hz).  
ESIMS found 165.1 (calculated for [C10H10FO]+: 165.1). 
 
(Z)-4-Methyl-3-phenylpent-2-enal (4.35) and (E)-4-methyl-3-phenylpent-2-enal (4.36) 
were synthesized divergently from isobutyrophenone following the three-step synthetic 




agreement with reported data.223-224 The final (Z)- and (E)-enals can be prepared as single 
isomers. All spectra were in agreement with reported data.225  
 
β,β-Diaryl enals 4.38 were synthesized from the corresponding ethyl 3-arylpropiolate and 
aryl boronic acid by a three-step sequence214: Cu-catalyzed conjugate addition226/DIBAL-
H reduction/MnO2 oxidation. 
 
Step 1: In a 100 mL round bottom flask ethyl 3-arylpropiolate (20 mmol, 1 equiv), aryl 
boronic acid (3 equiv), and CuOAc (2 mol%) were dissolved in 40 mL MeOH. The solution 
was degassed by three freeze-pump-thaw cycles and then stirred overnight at room 
temperature. The resulting mixture was filtered off Celite and the solvent was removed 
under reduced pressure. The crude residue was subjected to flash chromatography 
(hexanes:EtOAc, 95:5) to afford the corresponding α,β-unsaturated ester  in an isomerically 
pure form.  
Step 2: The unsaturated ester (15 mmol) was dissolved in 40 mL dry THF under Argon 
before being cooled to –78 °C. DIBAL-H (1.0 M in toluene, 2.4 equiv) was added dropwise 
over 5 min and the resulting mixture was stirred at –78 ℃ for 30 min. The reaction mixture 
was then allowed to warm to 0 ℃ and stirred for another 30 min. At the same temperature, 
the reaction was quenched by a dropwise addition of 2 M aqueous HCl. The organic layer 




combined organic layers were dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The crude residue was subjected to flash chromatography (hexanes:EtOAc, 4:1) 
to afford the corresponding allylic alcohol.  
Step 3: To a 100-mL round bottom flask containing the allylic alcohol (10 mmol) obtained 
above, was added activated MnO2 (5 equiv) and anhydrous CH2Cl2 (25 mL) at room 
temperature. The reaction mixture was then allowed to stir for at least 24 h, while being 
monitored by TLC. After complete consumption of the starting material, the reaction 
mixture was filtered through a pad of Celite and rinsed by CH2Cl2. The resulting filtrate 
was concentrated under reduced pressure. The crude residue was subjected to flash 
chromatography (hexanes:EtOAc, 99/1 → 95/5) to afford the corresponding β,β-
disubstituted enal in an isomerically pure form.  
 
(E)-3-(4-Methoxyphenyl)-3-phenylacrylaldehyde (4.38a) was synthesized using ethyl 
phenylpropiolate and 4-methoxyphenylboronic acid. All spectra were in agreement with 
reported data.214  
 
(E)-3-(4-Bromophenyl)-3-phenylacrylaldehyde (4.38b) 
Ethyl phenylpropiolate and 4-bromophenylboronic acid were used following the above-
mentioned three-step synthetic sequence.  
1H NMR (500 MHz, CDCl3) δ 9.52 (d, J = 7.9 Hz, 1H), 7.56 – 7.39 (m, 5H), 7.32 – 7.25 
(m, 2H), 7.25 – 7.17 (m, 2H), 6.56 (d, J = 7.9 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 




ESIMS found 287.0, 289.0 (calculated for [C15H12BrO]+: 287.0). 
 
(E)-3-(3,5-Bis(trifluoromethyl)phenyl)-3-phenylacrylaldehyde (4.38c) 
Ethyl phenylpropiolate and (3,5-bis(trifluoromethyl)phenyl)boronic acid were used 
following the above-mentioned three-step synthetic sequence.  
1H NMR (500 MHz, CDCl3) δ 9.59 (d, J = 7.7 Hz, 1H), 7.94 (s, 1H), 7.78 (s, 2H), 7.58 – 
7.42 (m, 3H), 7.38 – 7.26 (m, 2H), 6.61 (d, J = 7.7 Hz, 1H). 13C NMR (126 MHz, CDCl3) 
δ 192.5, 158.5, 142.2, 135.0, 132.2 (q, J = 33.9 Hz), 130.6, 130.3, 129.3, 128.9, 128.4, 
123.6, 122.9 (q, J = 272.9 Hz). 
ESIMS found 345.1 (calculated for [C17H11F6O]+: 345.1). 
 
(E)-3-(2-Methoxyphenyl)-3-phenylacrylaldehyde (4.38d) 
Ethyl phenylpropiolate and 2-methoxyphenylboronic acid were used following the above-
mentioned three-step synthetic sequence.  
1H NMR (500 MHz, CDCl3) δ 9.62 (d, J = 8.1 Hz, 1H), 7.44 – 7.33 (m, 4H), 7.31 – 7.24 
(m, 2H), 7.12 – 7.06 (m, 1H), 6.98 – 6.90 (m, 2H), 6.59 (d, J = 8.1 Hz, 1H), 3.68 (s, 3H).  
13C NMR (126 MHz, CDCl3) δ 194.0, 159.8, 157.6, 138.1, 131.4, 131.1, 130.4, 130.2, 
129.5, 129.0, 128.0, 120.5, 111.7, 55.5. 





(E)-3-(naphthalen-2-yl)-3-phenylacrylaldehyde (4.38e) was synthesized using ethyl 




3-(4-Fluorophenyl)propiolaldehyde214 and 4-methoxyphenylboronic acid were used 
following the above-mentioned three-step synthetic sequence.  
1H NMR (500 MHz, CDCl3) δ 9.44 (d, J = 8.1 Hz, 1H), 7.32 – 7.24 (m, 4H), 7.16 – 7.10 
(m, 2H), 6.91 – 6.85 (m, 2H), 6.54 (d, J = 8.1 Hz, 1H), 3.82 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 193.0, 163.3 (d, J = 249.9 Hz), 161.8, 160.7, 132.9 (d, J = 3.5 Hz), 132.5 (d, J = 
8.3 Hz), 131.7, 130.3, 125.8, 115.5 (d, J = 21.7 Hz), 114.1, 55.4. 




The synthetic route to β-silyl enal 4.24g was adapted from known literature.227  
[Cp*Ru(CNCH3)3]+PF6– (0.2 mol%) was added to a solution of 2-butyn-1-ol (25 mmol) 
and dimethylphenylsilane (30 mmol) in 25 mL acetone at 0 ℃. The reaction mixture was 
warmed up to room temperature. After 30 min, the mixture was filtered off a pad of Celite 




by column chromatography on silica gel using hexanes:EtOAc (2:1) as eluent to give allylic 
alcohol product in an isomerically pure form. To a 100-mL round bottom flask containing 
the allylic alcohol (10 mmol) obtained above, was added activated MnO2 (5 equiv) and 
anhydrous CH2Cl2 (25 mL) at room temperature. The reaction mixture was then allowed 
to stir at the same temperature, while being monitored by TLC. After complete 
consumption of the starting material, the reaction mixture was filtered through a pad of 
Celite and rinsed by CH2Cl2. The resulting filtrate was concentrated under reduced pressure. 
The crude residue was subjected to flash chromatography (hexanes:EtOAc, 95:5) to afford 
the corresponding (Z)-β-silyl enal 4.24g in 81% yield.  
1H NMR (500 MHz, CDCl3) δ 9.68 (d, J = 8.6 Hz, 1H), 7.53 – 7.46 (m, 2H), 7.43 – 7.33 
(m, 3H), 6.54 (dq, J = 8.6, 1.6 Hz, 1H), 2.11 (d, J = 1.6 Hz, 3H), 0.54 (s, 6H). 13C NMR 
(126 MHz, CDCl3) δ 192.9, 166.9, 142.9, 137.0, 133.6, 129.7, 128.3, 26.7, −0.9. 
ESIMS found 205.1 (calculated for [C12H17OSi]+: 205.1). 
 
Non-branched enals 4.44a-f were commercially available and used without purification. 
(2E,4E)-5-Phenylpenta-2,4-dienal (4.44g) and (E)-5-phenylpent-2-enal (4.44h) were 




General Procedure for Petasis Allylation of β,β-Disubstituted Enals to Prepare Racemic 
1,4-Dienes 
 
2-Nitro-4-(trifluoromethyl)benzenesulfonohydrazide 4.23 (0.4 mmol), a β,β-disubstituted 
enal (0.4 mmol), and oven-dried 3 Å powdered molecular sieves (200 mg) were added to 
a 10 mL reaction vial equipped with a magnetic stir bar. Dichloromethane (1.0 mL) was 
added to the vial and the reaction mixture was stirred at room temperature for 2 h, at which 
time the reaction mixture was concentrated first by rotary evaporation and then by static 
pressure vacuum (2 – 10 Torr) for 10 min. Racemic BINOL (0.09 mmol, 15 mol%), tert-
butanol (3 equiv, 1.2 mmol) and allylboronate (1.5 equiv, 0.6 mmol) were added and rinsed 
into the solution with anhydrous toluene (0.2 mL). The reaction was applied to sonication 
for 5 min to facilitate dissolution. The vial was then sealed with a rubber septum and 
attached to a balloon filled with argon. The mixture was allowed to stir at room temperature 
for 48 h, at which time the crude mixture was chromatographed on silica gel to afford the 




General Procedure for Petasis Allylation of β,β-Disubstituted Enals to Prepare 
Enantioenriched 1,4-Dienes 4.27 
 
2-Nitro-4-(trifluoromethyl)benzenesulfonohydrazide 4.23 (0.4 mmol), a β-methyl enal 
4.24 (0.4 mmol), and oven-dried 3 Å powdered molecular sieves (200 mg) were added to 
a 10 mL reaction vial equipped with a magnetic stir bar. Dichloromethane (1.0 mL) was 
added to the vial and the reaction mixture was stirred at room temperature for 2 h, at which 
time the reaction mixture was concentrated first by rotary evaporation and then by static 
pressure vacuum (2 – 10 Torr) for 10 min. (R)-Ph2-BINOL (0.04 mmol, 7 mol%), tert-
butanol (3 equiv, 1.2 mmol) and allylboronate (1.5 equiv, 0.6 mmol) were added and rinsed 
into the solution with anhydrous toluene (0.2 mL). The reaction was applied to sonication 
for 5 min to facilitate dissolution. The vial was then sealed with a rubber septum and 
attached to a balloon filled with argon. The mixture was allowed to stir at room temperature 
for 48 h, at which time the crude mixture was chromatographed on silica gel to afford the 
desired product.  





The 1.4-diene (0.3 mmol) was dissolved in dry THF (0.4 mL) under argon and cooled to 
0 ℃. 9-BBN (0.5 M in THF, 0.45 mL, 1.5 equiv) was added dropwise to the reaction, and 
the reaction was allowed to warm up to room temperature naturally. After one hour, the 
reaction was cooled to 0 ℃. 3 M NaOH solution (0.1 mL) was added slowly to the reaction, 
followed by dropwise addition of H2O2 (35% in water, 0.3 mL). The reaction was warmed 
to room temperature in 5 min. The reaction mixture was transferred to a separatory funnel 
using Et2O (5 mL) and H2O (5 mL). The organic layer was collected and the aqueous layer 
was extracted by Et2O (3 × 5 mL). The combined organic layers were dried with Na2SO4. 
Concentration under reduced pressure followed by flash column chromatography on silica 
gel afforded the desired terminal alcohol.  
Analytical Data for 1,4-Dienes 4.27 
(R,E)-Hepta-3,6-dien-2-ylbenzene (4.27a) 
The substrate was run in 0.4 mmol scale following the general procedure and the crude 
mixture was purified by flash column chromatography with hexanes to afford the pure 
product as a colorless oil. Yield: 57 mg, 83%. 
e.r.: 98:2. [α]D22 = –4.2 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.54a following the hydroboration/oxidation 
procedure, tr minor: 36.2 min., tr major: 37.8 min., [Chiralpak®IA column, 24 cm × 4.6 
mm I.D., hexanes:EtOH = 99.75:0.25, 1.0 mL/min, 210 nm].  
1H NMR (500 MHz, CDCl3) δ 7.36 – 7.16 (m, 5H), 5.91 – 5.79 (m, 1H), 5.67 (dd, J = 15.4, 




Hz, 1H), 2.79 (dd, J = 6.4, 6.2 Hz, 2H), 1.37 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 146.2, 137.2, 136.3, 128.4, 127.2, 126.6, 126.0, 115.0, 42.3, 36.7, 21.5. 
GCMS found 172.1 (calculated for C13H16: 172.1) 
IR (thin film, cm-1): 3026, 2969, 2871, 1493, 1452, 911.  
 
(R,E)-6-Phenylhept-4-en-1-ol (4.54a) 
This product was prepared following the general hydroboration/oxidation procedure in 
0.25 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 27 mg, 59%.  
e.r.: 98:2. [α]D22 = –7.8 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.16 (m, 5H), 5.65 (dd, J = 15.1, 6.9 Hz, 1H), 5.48 
(dt, J = 15.1, 6.8 Hz, 1H), 3.65 (td, J = 6.2, 6.2 Hz, 2H), 3.43 (qd, J = 6.9, 6.9 Hz, 1H), 
2.12 (td, J = 7.1, 7.1 Hz, 2H), 1.65 (tt, J = 6.9, 6.9 Hz, 2H), 1.40 (d, J = 6.2, 1H), 1.35 (d, 
J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 146.2, 135.7, 128.4, 128.3, 127.1, 126.0, 
62.5, 42.2, 32.4, 28.8, 21.5. 
ESIMS found 213.1 (calculated for [C13H18ONa]+: 213.1). 
IR (thin film, cm-1): 3381, 3027, 2962, 2933, 2870, 1493, 1451, 1060, 973.  
 
(R,E)-1-Fluoro-4-(hepta-3,6-dien-2-yl)benzene (4.27b) 
The substrate was run in 0.4 mmol scale following the general procedure and the crude 
mixture was purified by flash column chromatography with hexanes to afford the pure 




e.r.: 97:3. [α]D22 = –7.8 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.54b following the hydroboration/oxidation 
procedure, tr major: 13.4 min., tr minor: 15.1 min., [Chiralcel®OD column, 24 cm × 4.6 
mm I.D., hexanes:i-PrOH = 98:2, 1.0 mL/min, 250 nm].  
1H NMR (500 MHz, CDCl3) δ 7.21 – 7.13 (m, 2H), 7.03 – 6.94 (m, 2H), 5.84 (ddt, J = 
16.7, 10.1, 5.9 Hz, 1H), 5.62 (dd, J = 15.6, 6.6 Hz, 1H), 5.46 (dt, J = 15.6, 6.8 Hz, 1H), 
5.07 – 4.97 (ovrlp, 2H), 3.44 (qd, J = 7.0, 6.6 Hz, 1H), 2.78 (dd, J = 6.8, 5.9 Hz, 2H), 1.34 
(d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 161.2 (d, J = 243.9 Hz), 141.8 (d, J = 
3.1 Hz), 137.1, 136.1, 128.5 (d, J = 7.8 Hz), 126.8, 115.0, 115.0 (d, J = 21.0 Hz), 41.5, 
36.6, 21.5. 
GCMS found 190.1 (calculated for C13H15F: 190.1). 




This product was prepared following the general hydroboration/oxidation procedure in 
0.25 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 32 mg, 62%. 
e.r.: 97:3. [α]D22 = –7.1 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.19 – 7.11 (m, 2H), 7.01 – 6.93 (m, 2H), 5.60 (dd, J = 15.2, 
6.9 Hz, 1H), 5.45 (dt, J = 15.2, 6.9 Hz, 1H), 3.64 (t, J = 5.2 Hz, 2H), 3.41 (qd, J = 7.0, 6.9 




(br, 1H). 13C NMR (126 MHz, CDCl3) δ 161.2 (d, J = 243.5 Hz), 141.8 (d, J = 3.2 Hz), 
135.6, 128.5 (d, J = 4.0 Hz), 128.4, 115.0 (d, J = 21.0 Hz), 62.5, 41.5, 32.3, 28.8, 21.6. 
ESIMS found 231.1 (calculated for [C13H17FONa]+: 231.1). 
IR (thin film, cm-1): 3379, 2963, 2873, 1604, 1510, 1223, 1159. 
 
(R,E)-1-(Hepta-3,6-dien-2-yl)-3-methoxybenzene (4.27c) 
The substrate was run in 0.4 mmol scale following the general procedure and the crude 
mixture was purified by flash column chromatography with hexanes:EtOAc (150:1) to 
afford the pure product as a colorless oil. Yield: 72 mg, 89%. 
e.r.: 97:3. [α]D22 = –4.9 (c = 1.0, CHCl3). HPLC Analysis, tr major: 24.8 min., tr minor: 
26.1 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes, 0.5 mL/min, 230 nm].  
1H NMR (500 MHz, CDCl3) δ 7.24 (t, J = 7.8 Hz, 1H), 6.84 (d, J = 7.8 Hz, 1H), 6.80 (s, 
1H), 6.76 (d, J = 7.8 Hz, 1H), 5.86 (ddt, J = 16.7, 10.3, 6.4 Hz, 1H), 5.66 (dd, J = 15.5, 6.7 
Hz, 1H), 5.56 – 5.46 (m, 1H), 5.10 – 4.98 (ovrlp, 2H), 3.82 (s, 3H), 3.45 (qd, J = 7.1, 6.7 
Hz, 1H), 2.80 (dd, J = 6.4, 6.4 Hz, 2H), 1.37 (d, J = 7.1 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 159.6, 148.0, 137.2, 136.1, 129.3, 126.6, 119.6, 115.0, 113.2, 111.0, 55.1, 42.3, 
36.6, 21.4. 
GCMS found 202.2 (calculated for C14H18O: 202.1). 








The substrate was run in 0.4 mmol scale following the general procedure and the crude 
mixture was purified by flash column chromatography with hexanes to afford the pure 
product as a colorless oil. Yield: 60 mg, 60%.  
e.r.: 96:4. [α]D22 = +45.5 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.54d following the hydroboration/oxidation 
procedure, tr major: 66.8 min., tr minor: 70.5 min., [Chiralcel®OD column, 24 cm × 4.6 
mm I.D., hexanes:i-PrOH = 99:1, 0.5 mL/min, 210 nm].  
1H NMR (500 MHz, CDCl3) δ 7.54 (dd, J = 8.0, 1.2 Hz, 1H), 7.31 – 7.21 (ovrlp, 2H), 7.05 
(ddd, J = 8.0, 6.9, 2.1 Hz, 1H), 5.85 (ddt, J = 16.9, 10.1, 6.4 Hz, 1H), 5.64 (dd, J = 15.5, 
5.9 Hz, 1H), 5.53 (dt, J = 15.5, 6.4 Hz, 1H), 5.05 (dtd, J = 16.9, 1.6, 1.6 Hz, 1H), 5.00 (ddt, 
J = 10.1, 1.6, 1.5 Hz, 1H), 3.96 (qd, J = 7.0, 5.7 Hz, 1H), 2.80 (dddd, J = 6.4, 6.4, 1.6, 1.5 
Hz, 2H), 1.33 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 145.0, 137.1, 134.5, 
132.8, 128.2, 127.6, 127.5, 127.4, 124.3, 115.1, 40.6, 36.7, 20.3. 
GCMS found 250.0, 252.0 (calculated for C13H15Br: 250.0). 
IR (thin film, cm-1): 3054, 2971, 2872, 1639, 1470, 1439, 1023, 914.  
 
(R,E)-6-(2-Bromophenyl)hept-4-en-1-ol (4.54d) 
This product was prepared following the general hydroboration/oxidation procedure in 0.2 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 44 mg, 82%.  




1H NMR (500 MHz, CDCl3) δ 7.53 (dd, J = 8.0, 1.3 Hz, 1H), 7.30 – 7.19 (ovrlp, 2H), 7.04 
(ddd, J = 8.0, 7.1, 1.9 Hz, 1H), 5.63 (ddt, J = 15.3, 5.9, 1.3 Hz, 1H), 5.50 (dtd, J = 15.3, 
6.7, 1.4 Hz, 1H), 3.92 (qdd, J = 7.0, 5.9, 1.3 Hz, 1H), 3.65 (t, J = 6.5 Hz, 2H), 2.16 – 2.09 
(m, 2H), 1.71 – 1.60 (m, 2H), 1.31 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
145.0, 134.0, 132.8, 129.2, 128.1, 127.6, 127.5, 124.3, 62.5, 40.6, 32.3, 28.9, 20.3. 
ESIMS found 291.0, 293.0 (calculated for [C13H17BrONa]+: 291.0).  
IR (thin film, cm-1): 3340, 2935, 2902, 1470, 1023, 755.  
 
(R,E)-2-(Hepta-3,6-dien-2-yl)thiophene (4.27e) 
The substrate was run in 0.4 mmol scale following the general procedure and the crude 
mixture was purified by flash column chromatography with hexanes to afford the pure 
product as a colorless oil. Yield: 52 mg, 73%.  
e.r.: 99:1. [α]D22 = –43.7 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.54e following the hydroboration/oxidation 
procedure, tr minor: 59.1 min., tr major: 60.9 min., [Chiralpak®IA column, 24 cm × 4.6 
mm I.D., hexanes:EtOH = 99.75:0.25, 0.8 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 5.1 Hz, 1H), 6.94 (dd, J = 5.1, 3.4 Hz 1H), 6.81 
(d, J = 3.4 Hz, 1H), 5.85 (ddt, J = 17.1, 10.1, 6.3 Hz, 1H), 5.63 (dd, J = 15.3, 7.2 Hz, 1H), 
5.54 (dt, J = 15.3, 6.3 Hz, 1H), 5.09 – 4.98 (ovrlp, 2H), 3.71 (dq, J = 7.2, 6.9 Hz, 1H), 2.79 
(dd, J = 6.3, 6.3 Hz, 2H), 1.43 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 150.5, 
136.9, 135.7, 127.2, 126.6, 123.1, 122.7, 115.1, 38.0, 36.4, 22.3. 




IR (thin film, cm-1): 2972, 2922, 1637, 1454, 967, 916.   
 
(R,E)-6-(Thiophen-2-yl)hept-4-en-1-ol (4.54e) 
This product was prepared following the general hydroboration/oxidation procedure in 0.2 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (5:1) to afford the pure product as a colorless oil. Yield: 29 mg, 75%.  
e.r.: 99:1. [α]D22 = –29.9 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.14 (d, J = 5.1 Hz, 1H), 6.96 – 6.90 (m, 1H), 6.82 – 6.77 
(m, 1H), 5.62 (dd, J = 15.3, 7.2 Hz, 1H), 5.53 (dt, J = 15.3, 6.7 Hz, 1H), 3.72 – 3.63 (ovrlp, 
3H), 2.13 (td, J = 7.0, 6.7 Hz, 2H), 1.67 (tt, J = 7.0, 7.0 Hz, 2H), 1.41 (d, J = 6.9 Hz, 3H), 
1.29 (d, J = 5.4 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 150.6, 135.2, 129.0, 126.6, 123.1, 
122.7, 62.4, 38.0, 32.2, 28.6, 22.3. 
ESIMS found 197.1 (calculated for [C11H17OS]+: 197.1).  
IR (thin film, cm-1): 3409, 2966, 2932, 2870, 1452, 1372, 1234, 1057, 967, 850. 
 
(R,E)-1-(Hepta-3,6-dien-2-yl)naphthalene (4.27f) 
The substrate was run in 0.4 mmol scale following the general procedure, with the 
exception that the concentration was 1 M. The crude mixture after the reaction was purified 
by flash column chromatography with hexanes to afford the pure product as a colorless oil. 
Yield: 76 mg, 85%.  
e.r.: 95:5. [α]D22 = +48.9 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 




procedure, tr minor: 27.1 min., tr major: 28.4 min., [Chiralpak®IA column, 24 cm × 4.6 
mm I.D., hexanes:i-PrOH = 99:1, 1.0 mL/min, 280 nm]. 
1H NMR (500 MHz, CDCl3) δ 8.14 (d, J = 8.4 Hz, 1H), 7.86 (d, J = 8.3 Hz, 1H), 7.72 (d, 
J = 8.1 Hz, 1H), 7.55 – 7.41 (ovrlp, 3H), 7.39 (d, J = 7.1 Hz, 1H), 5.90 – 5.74 (ovrlp, 2H), 
5.54 (dt, J = 14.4, 6.5 Hz, 1H), 5.06 – 4.95 (ovrlp, 2H), 4.29 (qd, J = 6.9, 6.8 Hz, 1H), 2.79 
(dd, J = 6.5, 6.4 Hz, 2H), 1.51 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 142.1, 
137.2, 136.0, 133.9, 131.4, 128.9, 127.0, 126.7, 125.7, 125.6, 125.3, 123.6, 123.5, 115.0, 
37.0, 36.7, 21.0. 
GCMS found 222.1 (calculated for C17H18: 222.1).  
IR (thin film, cm-1): 3049, 2970, 2931, 1638, 1597, 1511, 1396, 973, 914.   
 
(R,E)-6-(Naphthalen-1-yl)hept-4-en-1-ol (4.54f) 
This product was prepared following the general hydroboration/oxidation procedure in 
0.25 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 37 mg, 62%.  
e.r.: 95:5. [α]D22 = +32.9 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 8.13 (d, J = 8.4 Hz, 1H), 7.86 (d, J = 7.7 Hz, 1H), 7.72 (d, 
J = 8.1 Hz, 1H), 7.54 – 7.41 (ovrlp, 3H), 7.38 (d, J = 6.4 Hz, 1H), 5.79 (dd, J = 15.4, 6.5 
Hz, 1H), 5.53 (dt, J = 15.4, 6.9 Hz, 1H), 4.26 (qd, J = 6.9, 6.5 Hz, 1H), 3.63 (td, J = 6.4, 
5.5 Hz, 2H), 2.13 (dt, J = 6.9, 6.8 Hz, 2H), 1.64 (tt, J = 6.8, 6.4 Hz, 2H), 1.49 (d, J = 6.9 
Hz, 3H), 1.23 (t, J = 5.5 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 142.1, 135.4, 133.9, 




ESIMS found 263.1 (calculated for [C17H19ONa]+: 263.1). 
IR (thin film, cm-1): 3367, 3048, 2928, 2869, 1597, 1510, 1451, 1396, 1058, 970. 
 
(S,E)-Hepta-3,6-dien-2-yldimethyl(phenyl)silane (4.27g) 
The substrate was run in 0.4 mmol scale following the general procedure with the exception 
that 5 equivalents of t-BuOH was used under neat conditions. The crude mixture was 
purified by flash column chromatography with hexanes to afford the pure product as a 
colorless oil. Yield: 81 mg, 88%.  
e.r.: 97:3. [α]D22 = +21.5 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol following the hydroboration/oxidation procedure, tr 
major: 24.6 min., tr minor: 26.6 min., [Chiralpak®IA column, 24 cm × 4.6 mm I.D., 
hexanes:EtOH = 99.8:0.2, 1.0 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.54 – 7.45 (m, 2H), 7.41 – 7.31 (ovrlp, 3H), 5.82 (ddt, J = 
16.6, 10.2, 6.4 Hz, 1H), 5.48 (dd, J = 15.4, 7.5 Hz, 1H), 5.28 – 5.16 (m, 1H), 5.04 – 4.93 
(ovrlp, 2H), 2.75 (dd, J = 6.5, 6.4 Hz, 2H), 1.80 (dq, J = 7.5, 7.2 Hz, 1H), 1.05 (d, J = 7.2 
Hz, 3H), 0.27 (ovrlp, 6H). 13C NMR (126 MHz, CDCl3) δ 137.9, 134.1, 133.9, 128.9, 127.6, 
124.2, 124.1, 114.4, 37.1, 25.7, 13.8, −4.8, −5.3. 
GCMS found 230.1 (calculated for C15H22Si: 230.1).  







This product was prepared following the general hydroboration/oxidation procedure in 
0.25 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 49 mg, 79%. 
e.r.: 97:3. [α]D22 = +20.2 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.51 – 7.45 (m, 2H), 7.37 – 7.31 (m, 3H), 5.45 (dd, J = 15.3, 
7.5 Hz, 1H), 5.25 – 5.15 (m, 1H), 3.61 (td, J = 5.8, 5.6 Hz, 2H), 2.07 (td, J = 7.0, 7.0 Hz, 
2H), 1.76 (dq, J = 7.5, 7.3 Hz, 1H), 1.64 – 1.56 (m, 2H), 1.21 (t, J = 5.6 Hz, 1H), 1.03 (d, 
J = 7.3 Hz, 3H), 0.25 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 138.0, 134.0, 133.2, 128.9, 
127.6, 126.0, 62.6, 32.8, 29.2, 25.5, 13.9, −4.9, −5.3. 
ESIMS found 249.2 (calculated for [C15H25OSi]+: 249.2). 
IR (thin film, cm-1): 3306, 3070, 2955, 2868, 1428, 1248, 1113, 972. 
 
(S,E)-6,10-Dimethylundeca-1,4,9-triene (4.27h) 
The substrate was run in 0.4 mmol scale following the general procedure and the crude 
mixture was purified by flash column chromatography with hexanes to afford the pure 
product as a colorless oil. Yield: 57 mg, 80%.  
e.r.: 85:15. [α]D22 = +17.1 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol following the hydroboration/oxidation procedure, tr 
minor: 21.8 min., tr major: 22.8 min., [Chiralpak®IA column, 24 cm × 4.6 mm I.D., 




1H NMR (500 MHz, CDCl3) δ 5.83 (ddt, J = 16.9, 10.1, 6.3 Hz, 1H), 5.43 – 5.24 (ovrlp, 
2H), 5.10 (dddd, J = 7.2, 5.7, 2.9, 1.5 Hz, 1H), 5.03 (dtd, J = 16.9, 1.8, 1.7 Hz, 1H), 4.98 
(ddt, J = 10.1, 1.7, 1.5 Hz, 1H), 2.74 (t, J = 6.3 Hz, 2H), 2.15 – 2.04 (m, 1H), 2.02 – 1.87 
(m, 2H), 1.68 (d, J = 1.4 Hz, 3H), 1.59 (s, 3H), 1.29 (dt, J = 7.5, 7.5 Hz, 2H), 0.97 (d, J = 
6.7 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 137.6, 131.1, 125.9, 124.8, 124.7, 114.7, 37.2, 
36.7, 36.3, 25.8, 25.7, 20.7, 17.7. 
GCMS found 178.2 (calculated for C13H22: 178.2).  
IR (thin film, cm-1): 2966, 2926, 1639, 1454, 1377, 971, 912.    
 
(S,E)-6,10-Dimethylundeca-4,9-dien-1-ol (4.54h) 
This product was prepared following the general hydroboration/oxidation procedure in 
0.25 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes/EtOAc (3/1) to afford the pure product as a colorless oil. Yield: 32 mg, 65%. 
e.r.: 85:15. [α]D22 = +18.1 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 5.42 – 5.26 (ovrlp, 2H), 5.08 (t, J = 7.1 Hz, 1H), 3.65 (t, J 
= 6.5 Hz, 2H), 2.11 – 2.03 (ovrlp, 3H), 1.98 – 1.88 (m, 2H), 1.67 (d, J = 1.3 Hz, 3H), 1.68 
– 1.58 (m, 2H), 1.58 (s, 3H), 1.37 (br, 1H), 1.27 (dt, J = 7.5, 7.5 Hz, 2H), 0.95 (d, J = 6.7 
Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 137.0, 131.2, 127.7, 124.7, 62.6, 37.2, 36.3, 32.5, 
28.9, 25.8, 25.7, 20.8, 17.7. 
ESIMS found 197.2 (calculated for [C13H25O]+: 197.2). 




General Procedure for Petasis Allylation of β,β-Disubstituted Enals to Prepare 
Enantioenriched 1,4-Dienes 4.32, 4.37, 4.39 
 
2-Nitrobenzenesulfonohydrazide 4.30 (0.4 mmol), a β,β-disubstituted enal (0.4 mmol), and 
oven-dried 3 Å powdered molecular sieves (200 mg) were added to a 10-mL reaction vial 
equipped with a magnetic stir bar. Dichloromethane (1.0 mL) was added to the vial and the 
reaction mixture was stirred at room temperature for 2 h, at which time the reaction mixture 
was concentrated first by rotary evaporation and then by static pressure vacuum (2 – 10 
Torr) for 10 min. (R)-Br2-BINOL (0.04 mmol, 7 mol%), tert-butanol (3 equiv, 1.2 mmol) 
and allylboronate (1.5 equiv, 0.6 mmol) were added and rinsed into the solution with 
anhydrous toluene (0.2 mL). The reaction was applied to sonication for 5 min to facilitate 
dissolution. The vial was then sealed with a rubber septum and attached to a balloon filled 
with argon. The mixture was allowed to stir at room temperature for 48 h, at which time 
the crude mixture was chromatographed on silica gel to afford the desired product.  
Analytical Data for 1,4-Dienes 4.32, 4.37, 4.39 
(R,E)-Octa-4,7-dien-3-ylbenzene (4.32a) 
The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 




e.r.: 97:3. [α]D22 = –31.0 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.55a following the hydroboration/oxidation 
procedure, tr minor: 69.1 min., tr major: 72.0 min., [Chiralcel®OD column, 24 cm × 4.6 
mm I.D., hexanes:i-PrOH = 99:1, 0.4 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.26 (m, 2H), 7.23 – 7.15 (ovrlp, 3H), 5.83 (ddt, J = 
16.6, 10.2, 6.4 Hz, 1H), 5.60 (dd, J = 15.3, 7.6 Hz, 1H), 5.46 (dt, J = 15.3, 6.5 Hz, 1H), 
5.06 – 4.95 (ovrlp, 2H), 3.12 (dt J = 7.6, 7.4 Hz, 1H), 2.77 (dd, J = 6.5, 6.4 Hz, 2H), 1.72 
(qt, J = 7.4, 7.4 Hz, 2H), 0.87 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 145.1, 
137.2, 135.2, 128.3, 127.5, 127.5, 125.9, 114.9, 50.7, 36.7, 28.9, 12.2. 
GCMS found 186.1 (calculated for C14H18: 186.1). 
IR (thin film, cm-1): 3082, 3028, 2961, 2931, 2874, 1639, 1602, 1493, 1452, 970, 913.   
 
(R,E)-6-Phenyloct-4-en-1-ol (4.55a) 
This product was prepared following the general hydroboration/oxidation procedure in 
0.25 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (4:1) to afford the pure product as a colorless oil. Yield: 38 mg, 75%. 
e.r.: 97:3. [α]D22 = –38.6 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.25 (m, 2H), 7.22 – 7.14 (ovrlp, 3H), 5.59 (dd, J = 
15.3, 7.7 Hz, 1H), 5.45 (dt, J = 15.3, 7.0 Hz, 1H), 3.63 (t, J = 6.5 Hz, 2H), 3.09 (dt, J = 7.7, 
7.5 Hz, 1H), 2.10 (dt, J = 7.0, 7.0 Hz, 2H), 1.74 – 1.66 (m, 2H), 1.67 – 1.59 (m, 2H), 1.26 
(br, 1H), 0.85 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 145.2, 134.6, 129.3, 




ESIMS found 205.2 (calculated for [C14H21O]+: 205.2).  
IR (thin film, cm-1): 3350, 3027, 2929, 2873, 1601, 1493, 1452, 1054, 968. 
 
(S,E)-Heptadeca-1,4-dien-6-ylbenzene (4.32b) 
The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 
afford the pure product as a colorless oil. Yield: 121 mg, 97%. 
e.r.: 96:4. [α]D22 = +9.8 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.55b following the hydroboration/oxidation 
procedure, tr major: 45.5 min., tr minor: 48.7 min., [Chiralcel®OD column, 24 cm × 4.6 
mm I.D., hexanes:i-PrOH = 99.6:0.4, 1.0 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.24 (m, 2H), 7.22 – 7.15 (ovrlp, 3H), 5.89 – 5.77 
(m, 1H), 5.60 (dd, J = 15.6, 7.7 Hz, 1H), 5.45 (dt, J = 15.6, 6.5 Hz, 1H), 5.07 – 4.95 (ovrlp, 
2H), 3.22 (dt, J = 7.7, 7.4 Hz, 1H), 2.76 (dd, J = 6.5, 6.4 Hz, 2H), 1.68 (dt, J = 7.4, 7.2 Hz, 
2H), 1.35 – 1.15 (ovrlp, 18H), 0.89 (t, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
145.4, 137.2, 135.5, 128.3, 127.5, 127.3, 125.9, 114.9, 48.9, 36.7, 36.0, 31.9, 29.7, 29.6, 
29.6, 29.6, 29.5, 29.3, 27.6, 22.7, 14.1. 
GCMS found 312.3 (calculated for C23H36: 312.3). 







This product was prepared following the general hydroboration/oxidation procedure in 
0.25 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (4:1) to afford the pure product as a colorless oil. Yield: 61 mg, 74%. 
e.r.: 96:4. [α]D22 = +14.7 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.28 (dd, J = 8.7, 6.7 Hz, 2H), 7.21 – 7.13 (ovrlp, 3H), 5.59 
(dd, J = 15.1, 7.7 Hz, 1H), 5.44 (dt, J = 15.1, 7.0 Hz, 1H), 3.63 (t, J = 6.5 Hz, 2H), 3.18 (dt, 
J = 7.7, 7.6 Hz, 1H), 2.09 (td, J = 7.3, 7.0 Hz, 2H), 1.70 – 1.60 (ovrlp, 4H), 1.33 – 1.15 (m, 
18H), 0.88 (t, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 145.4, 134.9, 129.1, 128.3, 
127.4, 125.9, 62.5, 48.9, 36.0, 32.4, 31.9, 29.6 (ovrlp, 2 peaks), 29.6, 29.6, 29.5, 29.3, 28.9, 
27.6, 22.7, 14.1. 
ESIMS found 331.3 (calculated for [C23H39O]+: 331.3). 
IR (thin film, cm-1): 3330, 3062, 3027, 2925, 2854, 1493, 1453, 1060, 969, 759. 
 
(S,E)-(1,1,1-Trifluorohepta-3,6-dien-2-yl)benzene (4.32c) 
The substrate was run in 0.4 mmol scale following the general procedure, with the 
exception that 5 equivalents of t-BuOH was used in the absence of toluene. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 
afford the pure product as a colorless oil. Yield: 75 mg, 83%.  
e.r.: 97:3. [α]D22 = +54.2 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 




procedure, tr major: 21.0 min., tr minor: 25.8 min., [Chiralcel®OD column, 24 cm × 4.6 
mm I.D., hexanes:i-PrOH = 98:2, 1.0 mL/min, 230 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.41 – 7.30 (ovrlp, 5H), 5.88 – 5.66 (ovrlp, 3H), 5.08 – 5.01 
(ovrlp, 2H), 3.98 (qd, J = 9.4, 7.4 Hz, 1H), 2.84 (dd, J = 6.5, 6.5 Hz, 2H). 13C NMR (126 
MHz, CDCl3) δ 135.7, 135.0 (q, J = 1.6 Hz), 134.6, 128.9, 128.7, 128.0, 126.0 (q, J = 280.2 
Hz), 124.4 (q, J = 2.6 Hz), 116.0, 53.2 (q, J = 27.6 Hz), 36.4. 
GCMS found 226.1 (calculated for C13H13F3: 226.1). 
IR (thin film, cm-1): 3069, 3038, 2983, 2902, 1640, 1456, 1255, 1165, 1110, 971, 919. 
 
(S,E)-7,7,7-Trifluoro-6-phenylhept-4-en-1-ol (4.55c) 
This product was prepared following the general hydroboration/oxidation procedure in 
0.25 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (4:1) to afford the pure product as a colorless oil. Yield: 46 mg, 75%. 
e.r.: 97:3. [α]D22 = +43.9 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.40 – 7.28 (ovrlp, 5H), 5.83 – 5.67 (ovrlp, 2H), 3.94 (qd, 
J = 9.4, 7.6 Hz, 1H), 3.64 (t, J = 6.5 Hz, 2H), 2.18 (td, J = 7.7, 6.3 Hz, 2H), 1.71 – 1.61 (m, 
2H), 1.28 (br, 1H). 13C NMR (126 MHz, CDCl3) δ 136.4, 135.1, 128.8, 128.7, 128.0, 126.0 
(q, J = 279.8 Hz), 123.8 (q, J = 2.3 Hz), 62.2, 53.2 (q, J = 27.6 Hz), 31.7, 28.8. 
ESIMS found 245.1 (calculated for [C13H16F3O]+: 245.1). 







The substrate was run in 0.4 mmol scale following the general procedure, with the 
exception that 5 equivalents of t-BuOH was used in the absence of toluene. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 
afford the pure product as a colorless oil. Yield: 59 mg, 77%. 
e.r.: 93:7. [α]D22 = –28.2 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.55d following the hydroboration/oxidation 
procedure, tr minor: 39.7 min., tr major: 42.4 min., [Chiralpak®IA column, 24 cm × 4.6 
mm I.D., hexanes:EtOH = 99:1, 1.0 mL/min, 230 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.30 (m, 2H), 7.29 – 7.21 (ovrlp, 3H), 5.83 (ddt, J = 
16.6, 10.2, 6.4 Hz, 1H), 5.72 – 5.56 (ovrlp, 2H), 5.08 – 4.98 (ovrlp, 2H), 4.59 (dd, J = 47.4, 
6.8 Hz, 2H), 3.71 (ddt, J = 16.9, 6.8, 6.8 Hz, 1H), 2.81 (dd, J = 6.4, 5.7 Hz, 2H). 13C NMR 
(126 MHz, CDCl3) δ 140.1 (d, J = 5.4 Hz), 136.5, 130.8, 129.6 (d, J = 5.4 Hz), 128.6, 128.0, 
126.9, 115.4, 85.9 (d, J = 174.8 Hz), 49.1 (d, J = 19.4 Hz), 36.7. 
GCMS found 190.1 (calculated for C13H15F: 190.1). 
IR (thin film, cm-1): 3081, 3030, 2967, 2898, 1639, 1495, 1454, 1002. 
 
(R,E)-7-Fluoro-6-phenylhept-4-en-1-ol (4.55d) 
This product was prepared following the general hydroboration/oxidation procedure in 
0.25 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 29 mg, 55%. 




1H NMR (500 MHz, CDCl3) δ 7.33 (dd, J = 7.5, 7.5 Hz, 2H), 7.28 – 7.19 (ovrlp, 3H), 5.72 
– 5.56 (ovrlp, 2H), 4.57 (dd, J = 47.3, 6.9 Hz, 2H), 3.74 – 3.60 (ovrlp, 3H), 2.16 (dt, J = 
7.0, 7.0 Hz, 2H), 1.67 (tt, J = 7.0, 6.9 Hz, 2H), 1.25 (t, J = 5.4 Hz, 1H). 13C NMR (126 
MHz, CDCl3) δ 140.1 (d, J = 5.5 Hz), 132.6, 129.0 (d, J = 5.2 Hz), 128.6, 127.9, 126.9, 
85.9 (d, J = 174.7 Hz), 62.4, 49.1 (d, J = 19.5 Hz), 32.1, 29.0. 
ESIMS found 209.1 (calculated for [C13H18FO]+: 209.1). 
IR (thin film, cm-1): 3361, 3030, 2936, 1495, 1453, 1007. 
 
(S,E)-(2-Methylocta-4,7-dien-3-yl)benzene (4.37) 
(Z)-4-methyl-3-phenylpent-2-enal was used as the substrate in 0.4 mmol scale following 
the general procedure. The crude mixture after the reaction was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 66 mg, 
82%. 
e.r.: 98:2. [α]D22 = +52.1 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.56 following the hydroboration/oxidation 
procedure, tr minor: 14.3 min., tr major: 15.9 min., [Chiralpak®AD-H column, 24 cm × 
4.6 mm I.D., hexanes:i-PrOH = 99:1, 1.0 mL/min, 230 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.25 (m, 2H), 7.22 – 7.13 (ovrlp, 3H), 5.82 (ddt, J = 
17.1, 10.1, 6.4 Hz, 1H), 5.65 (dd, J = 15.2, 9.0 Hz, 1H), 5.46 (dt, J = 15.2, 6.5 Hz, 1H), 
5.06 – 4.94 (ovrlp, 2H), 2.87 (dd, J = 9.0, 8.8 Hz, 1H), 2.76 (dd, J = 6.5, 6.4 Hz, 2H), 1.92 




(126 MHz, CDCl3) δ 144.9, 137.2, 134.0, 128.3, 128.3, 127.8, 125.8, 114.9, 57.3, 36.7, 
33.0, 21.1, 20.8. 
GCMS found 200.2 (calculated for C15H20: 200.2). 
IR (thin film, cm-1): 3084, 3029, 2957, 2867, 1639, 1453, 1385, 970, 913. 
The same product afforded by (E)-4-methyl-3-phenylpent-2-enal using (S)-Ph2-BINOL as 
the catalyst. Yield: 48 mg, 60%. e.r.: 94:6.  
 
(S,E)-7-Methyl-6-phenyloct-4-en-1-ol (4.56) 
This product was prepared following the general hydroboration/oxidation procedure in 
0.25 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 27 mg, 50%. 
e.r.: 98:2. [α]D22 = +39.3 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.24 (m, 2H), 7.21 – 7.11 (ovrlp, 3H), 5.65 (dd, J = 
15.2, 9.1 Hz, 1H), 5.45 (dt, J = 15.2, 6.9 Hz, 1H), 3.62 (t, J = 6.5 Hz, 2H), 2.84 (dd, J = 
9.1, 8.8 Hz, 1H), 2.10 (td, J = 7.1, 6.9 Hz, 2H), 1.90 (dqq, J = 8.8, 6.6, 6.6 Hz, 1H), 1.68 – 
1.58 (m, 2H), 1.30 (br, 1H), 0.94 (d, J = 6.6 Hz, 3H), 0.74 (d, J = 6.6 Hz, 3H). 13C NMR 
(126 MHz, CDCl3) δ 145.0, 133.4, 130.2, 128.3, 127.8, 125.8, 62.5, 57.3, 33.0, 32.3, 28.9, 
21.1, 20.8. 
ESIMS found 219.2 (calculated for [C15H23O]+: 219.2) 







The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with 
hexanes:EtOAc (100:1) to afford the pure product as a colorless oil. Yield: 91 mg, 86%. 
e.r.: 98:2. [α]D22 = –4.9 (c = 1.0, CHCl3). HPLC Analysis, tr major: 16.0 min., tr minor: 
18.1 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes, 1.0 mL/min, 230 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.31 (t, J = 7.6 Hz, 2H), 7.25 – 7.18 (ovrlp, 3H), 7.16 – 
7.08 (m, 2H), 6.90 – 6.83 (m, 2H), 5.95 (dd, J = 15.2, 7.5 Hz, 1H), 5.87 (ddt, J = 16.7, 10.1, 
6.4 Hz, 1H), 5.46 (dt, J = 15.2, 6.5 Hz, 1H), 5.10 – 4.99 (ovrlp, 2H), 4.69 (d, J = 7.5 Hz, 
1H), 3.80 (s, 3H), 2.86 (dd, J = 6.5, 6.4 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 158.0, 
144.3, 136.9, 136.2, 134.0, 129.5, 129.5, 128.5, 128.3, 126.2, 115.2, 113.7, 55.2, 53.1, 36.6. 
GCMS found 264.2 (calculated for C19H20O: 264.2). 
IR (thin film, cm-1): 3062, 3027, 2906, 2835, 1610, 1510, 1250, 1178, 1037. 
 
(S,E)-1-Bromo-4-(1-phenylhexa-2,5-dien-1-yl)benzene (4.39b) 
The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 
afford the pure product as a colorless oil. Yield: 109 mg, 87%. 
e.r.: 98:2. [α]D22 = –11.0 (c = 1.0, CHCl3). HPLC Analysis, tr major: 15.7 min., tr minor: 
16.9 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes, 0.5 mL/min, 230 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.44 – 7.38 (m, 2H), 7.34 – 7.26 (m, 2H), 7.25 – 7.18 (m, 




6.5 Hz, 1H), 5.08 – 4.98 (ovrlp, 2H), 4.67 (d, J = 7.4 Hz, 1H), 2.86 – 2.80 (ovrlp, 2H). 13C 
NMR (126 MHz, CDCl3) δ 143.4, 143.0, 136.6, 133.1, 131.4, 130.3, 130.3, 128.5, 128.4, 
126.4, 120.1, 115.4, 53.3, 36.6. 
GCMS found 312.1, 314.1 (calculated for C18H17Br: 312.1). 
IR (thin film, cm-1): 3062, 3027, 2895, 1638, 1486, 1074, 918. 
 
(S,E)-1-(1-Phenylhexa-2,5-dien-1-yl)-3,5-bis(trifluoromethyl)benzene (4.39c) 
The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 
afford the pure product as a colorless oil. Yield: 129 mg, 87%. 
e.r.: 98:2. [α]D22 = +3.3 (c = 1.0, CHCl3). HPLC Analysis, tr minor: 28.0 min., tr major: 
29.3 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes, 0.2 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.77 (s, 1H), 7.67 (s, 2H), 7.41 – 7.33 (m, 2H), 7.33 – 7.25 
(m, 1H), 7.24 – 7.15 (m, 2H), 5.95 (dd, J = 15.3, 7.5 Hz, 1H), 5.87 (ddt, J = 16.8, 10.2, 6.4 
Hz, 1H), 5.54 (dt, J = 15.3, 6.5 Hz, 1H), 5.13 – 5.03 (m, 2H), 4.86 (d, J = 7.5 Hz, 1H), 2.89 
(dd, J = 6.5, 6.4 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 146.7, 142.0, 136.2, 132.0, 131.7, 
131.6 (q, J = 28.4 Hz), 128.8, 128.7, 128.4, 127.0, 123.4 (q, J = 272.7 Hz), 120.6, 115.7, 
53.6, 53.6, 36.5. 19F NMR (470 MHz, CDCl3) δ –62.8. 
GCMS found 370.1 (calculated for C20H16F6: 370.1). 







The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 
afford the pure product as a colorless oil. Yield: 97 mg, 99%. 
e.r.: 98:2. [α]D22 = +9.9 (c = 1.0, CHCl3). HPLC Analysis, tr major: 25.8 min., tr minor: 
28.2 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes, 0.5 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.24 (m, 2H), 7.26 – 7.14 (ovrlp, 5H), 6.94 (dd, J = 
7.5, 7.5 Hz, 1H), 6.88 (d, J = 8.3 Hz, 1H), 5.96 (dd, J = 15.2, 7.2 Hz, 1H), 5.86 (ddt, J = 
16.6, 10.1, 6.1 Hz, 1H), 5.40 (dt, J = 15.2, 6.5 Hz, 1H), 5.15 (d, J = 7.2 Hz, 1H), 5.08 – 
4.97 (ovrlp, 2H), 3.76 (s, 3H), 2.84 (dd, J = 6.5, 6.1 Hz, 2H). 13C NMR (126 MHz, CDCl3) 
δ 156.9, 144.0, 137.1, 133.4, 132.5, 129.4, 129.2, 128.5, 128.0, 127.4, 125.8, 120.5, 115.1, 
110.8, 55.5, 46.6, 36.6. 
GCMS found 246.2 (calculated for C19H20O: 246.2). 




The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 
afford the pure product as a colorless oil. Yield: 99 mg, 87%. 
e.r.: 95:5. [α]D22 = +2.3 (c = 1.0, CHCl3). HPLC Analysis, tr major: 16.7 min., tr minor: 




1H NMR (500 MHz, CDCl3) δ 7.87 – 7.76 (ovrlp, 3H), 7.68 (s, 1H), 7.50 – 7.44 (m, 2H), 
7.37 – 7.29 (m, 3H), 7.30 – 7.21 (m, 3H), 6.08 (dd, J = 15.3, 7.5 Hz, 1H), 5.90 (ddt, J = 
16.7, 10.3, 6.3 Hz, 1H), 5.59 – 5.49 (m, 1H), 5.13 – 5.00 (m, 2H), 4.92 (d, J = 7.4 Hz, 1H), 
2.90 (t, J = 6.2 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 143.8, 141.5, 136.8, 133.5, 132.2, 
130.1, 128.7, 128.4, 128.0, 127.8, 127.6, 127.3, 126.7, 126.3, 126.0, 125.5, 115.3, 54.1, 
36.7. 
GCMS found 284.2 (calculated for C22H20: 284.2). 
IR (thin film, cm-1): 3058, 3026, 2978, 2893, 1637, 1600, 1507, 1493, 975. 
 
(R,E)-1-Fluoro-4-(1-(4-methoxyphenyl)hexa-2,5-dien-1-yl)benzene (4.39f) 
The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 
afford the pure product as a colorless oil. Yield: 96 mg, 85%. 
e.r.: 98:2. [α]D22 = –4.2 (c = 1.0, CHCl3). HPLC Analysis, tr major: 16.1 min., tr minor: 
18.4 min., [Chiralcel®OD column, 24 cm × 4.6 mm I.D., hexanes, 1.0 mL/min, 210 nm].  
1H NMR (500 MHz, CDCl3) δ 7.18 – 7.10 (m, 2H), 7.12 – 7.06 (m, 2H), 7.02 – 6.94 (m, 
2H), 6.89 – 6.83 (m, 2H), 5.95 – 5.80 (ovrlp, 2H), 5.43 (dt, J = 15.1, 6.5 Hz, 1H), 5.09 – 
4.97 (ovrlp, 2H), 4.66 (d, J = 7.3 Hz, 1H), 3.80 (s, 3H), 2.84 (dd, J = 6.5, 6.4 Hz, 2H). 13C 
NMR (126 MHz, CDCl3) δ 161.4 (d, J = 244.3 Hz), 158.1, 140.0 (d, J = 3.2 Hz), 136.8, 
135.9, 133.8, 129.8 (d, J = 7.8 Hz), 129.7, 129.4, 115.3, 115.1 (d, J = 21.1 Hz), 113.8, 55.2, 
52.3, 36.6. 




IR (thin film, cm-1): 3031, 3004, 2956, 2901, 2836, 1638, 1608, 1508, 1250, 1179, 1158, 
1037. 
General Procedure for Petasis Crotylations of β,β-Disubstituted Enals to Prepare Racemic 
1,4-Dienes 
 
2-Nitro-4-(trifluoromethyl)benzenesulfonohydrazide 4.23 (0.4 mmol), a β,β-disubstituted 
enal (0.4 mmol), and oven-dried 3 Å powdered molecular sieves (200 mg) were added to 
a 10-mL reaction vial equipped with a magnetic stir bar. Dichloromethane (1.0 mL) was 
added to the vial and the reaction mixture was stirred at room temperature for 2 h, at which 
time the reaction mixture was concentrated first by rotary evaporation and then by static 
pressure vacuum (2 – 10 Torr) for 10 min. Racemic Br2-BINOL catalyst (0.06 mmol, 10 
mol%), tert-butanol (1.2 mmol) and crotylboronate 4.40 or 4.41 (0.6 mmol) were added 
and rinsed into the solution with dry toluene (0.2 mL). The reaction was applied to 
sonication for 10 min to facilitate dissolution. The vial was sealed with a rubber septum 
and attached to a balloon filled with argon. The mixture was allowed to stir at 40 ℃ for 48 
h, after which time the reaction was cooled to room temperature and the crude mixture was 




General Procedure for Asymmetric Petasis Crotylations of β,β-Disubstituted Enals to 
Prepare Enantioenriched 1,4-Dienes 
 
2-Nitro-4-(trifluoromethyl)benzenesulfonohydrazide 4.23 (0.4 mmol), a β,β-disubstituted 
enal (0.4 mmol), and oven-dried 3 Å powdered molecular sieves (200 mg) were added to 
a 10-mL reaction vial equipped with a magnetic stir bar. Dichloromethane (1.0 mL) was 
added to the vial and the reaction mixture was stirred at room temperature for 2 h, at which 
time the reaction mixture was concentrated first by rotary evaporation and then by static 
pressure vacuum (2 – 10 Torr) for 10 min. (S)-Br2-BINOL catalyst (0.04 mmol, 7 mol%), 
tert-butanol (1.2 mmol) and crotylboronate 4.40 or 4.41 (0.6 mmol) were added and rinsed 
into the solution with dry toluene (0.2 mL). The reaction was applied to sonication for 10 
min to facilitate dissolution. The vial was sealed with a rubber septum and attached to a 
balloon filled with argon. The mixture was allowed to stir at 40 ℃ for 48 h, after which 
time the reaction was cooled to room temperature and the crude mixture was 





Analytical Data for 1,4-Dienes 4.42, 4.43 
((2S,5R,E)-5-Methylhepta-3,6-dien-2-yl)benzene (4.42a) 
The substrate was run in 0.4 mmol scale following the general procedure using (E)-
crotylboronate. The crude mixture after the reaction was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 44 mg, 
59%. 
e.r.: 98:2. d.r.: 16:1. [α]D22 = –5.2 (c = 1.0, CHCl3). HPLC Analysis, this compound was 
converted to the corresponding terminal alcohol 4.57a following the 
hydroboration/oxidation procedure, tr minor: 24.6 min., tr major: 29.8 min., 
[Chiralpak®AD-H column, 24 cm × 4.6 mm I.D., hexanes:EtOH = 99.5:0.5, 0.8 mL/min, 
210 nm].  
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.26 (m, 2H), 7.24 – 7.15 (ovrlp, 3H), 5.79 (ddd, J 
= 17.1, 10.3, 6.5 Hz, 1H), 5.61 (dd, J = 15.5, 6.7 Hz, 1H), 5.43 (dd, J = 15.5, 6.9 Hz, 1H), 
4.98 (d, J = 17.1 Hz, 1H), 4.94 (d, J = 10.3 Hz, 1H), 3.44 (qd, J = 7.0, 6.9 Hz, 1H), 2.92 – 
2.79 (m, 1H), 1.34 (d, J = 7.0 Hz, 3H), 1.10 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 146.3, 143.1, 133.9, 132.8, 128.3, 127.2, 125.9, 112.6, 42.1, 40.1, 21.5, 19.9. 
GCMS found 186.1 (calculated for C14H18: 186.1). 







This product was prepared following the general hydroboration/oxidation procedure in 0.2 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 25 mg, 60%.  
e.r.: 98:2. d.r.: 16:1. [α]D22 = –17.5 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.23 – 7.15 (ovrlp, 3H), 5.61 (dd, J = 
15.4, 6.8 Hz, 1H), 5.35 (dd, J = 15.4, 8.1 Hz, 1H), 3.62 (t, J = 6.7 Hz, 2H), 3.47 – 3.37 (m, 
1H), 2.33 – 2.22 (m, 1H), 1.62 – 1.50 (m, 2H), 1.34 (d, J = 7.0 Hz, 3H), 1.02 (d, J = 6.8 
Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 146.3, 134.5, 134.0, 128.4, 127.1, 126.0, 61.4, 
42.1, 39.8, 33.9, 21.5, 21.1. 
ESIMS found 205.2 (calculated for [C14H21O]+: 205.2). 
IR (thin film, cm-1): 3333, 3027, 2962, 2928, 2872, 1493, 1452, 1053, 973.   
 
((2S,5S,E)-5-Methylhepta-3,6-dien-2-yl)benzene (4.43a) 
The substrate was run in 0.4 mmol scale following the general procedure using (Z)-
crotylboronate. The crude mixture after the reaction was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 40 mg, 
54%. 
e.r.: >99:1. d.r.: 9:1. [α]D22 = +7.5 (c = 1.0, CHCl3). HPLC Analysis, this compound was 
converted to the corresponding terminal alcohol 4.58a following the 




[Chiralpak®AD-H column, 24 cm × 4.6 mm I.D., hexanes:EtOH = 99.5:0.5, 0.8 mL/min, 
210 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.31 (dd, J = 7.6, 7.6 Hz, 2H), 7.25 – 7.16 (ovrlp, 3H), 5.81 
(ddd, J = 17.2, 10.4, 6.5 Hz, 1H), 5.62 (dd, J = 15.5, 6.7 Hz, 1H), 5.43 (dd, J = 15.5, 6.7 
Hz, 1H), 5.00 (d, J = 17.2 Hz, 1H), 4.96 (d, J = 10.4 Hz, 1H), 3.45 (qd, J = 6.9, 6.7 Hz, 
1H), 2.92 – 2.78 (m, 1H), 1.36 (d, J = 6.9 Hz, 3H), 1.10 (d, J = 6.9 Hz, 3H). 13C NMR (126 
MHz, CDCl3) δ 146.3, 143.1, 133.9, 132.8, 128.3, 127.2, 125.9, 112.7, 42.2, 40.2, 21.5, 
19.9. 
GCMS found 186.1 (calculated for C14H18: 186.1). 
IR (thin film, cm-1): 2963, 2929, 2872, 1452, 1262, 1097, 1021, 804.   
 
(3S,6S,E)-3-Methyl-6-phenylhept-4-en-1-ol (4.58a) 
This product was prepared following the general hydroboration/oxidation procedure in 0.2 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 27 mg, 65%.  
e.r.: >99:1. d.r.: 9:1. [α]D22 = +35.7 (c = 0.5, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.22 – 7.16 (ovrlp, 3H), 5.61 (dd, J = 
15.4, 6.8 Hz, 1H), 5.34 (dd, J = 15.4, 8.1 Hz, 1H), 3.70 – 3.62 (m, 2H), 3.47 – 3.37 (m, 
1H), 2.37 – 2.18 (m, 1H), 1.64 – 1.50 (m, 2H), 1.34 (d, J = 7.0 Hz, 3H), 1.00 (d, J = 6.8 
Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 146.2, 134.4, 134.0, 128.4, 127.1, 126.0, 61.4, 
42.2, 39.8, 33.8, 21.5, 21.1. 








The substrate was run in 0.4 mmol scale following the general procedure using (E)-
crotylboronate. The crude mixture after the reaction was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 73 mg, 
62%. 
e.r.: 98:2. d.r.: 15:1. [α]D22 = –3.9 (c = 1.0, CHCl3). HPLC Analysis, this compound was 
converted to the corresponding terminal alcohol 4.57b following the 
hydroboration/oxidation procedure, tr minor: 25.6 min., tr major: 27.3 min., 
[Chiralpak®IA column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 1.0 mL/min, 250 
nm]. 
1H NMR (500 MHz, CDCl3) δ 7.15 – 7.07 (m, 2H), 7.10 – 7.03 (m, 2H), 7.01 – 6.93 (m, 
2H), 6.87 – 6.80 (m, 2H), 5.90 – 5.71 (ovrlp, 2H), 5.36 (dd, J = 15.4, 6.8 Hz, 1H), 5.03 – 
4.88 (ovrlp, 2H), 4.63 (d, J = 7.3 Hz, 1H), 3.79 (s, 3H), 2.97 – 2.86 (m, 1H), 1.11 (d, J = 
6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 161.3 (d, J = 244.4 Hz), 158.0, 142.7, 140.1 
(d, J = 3.2 Hz), 136.0, 135.9, 131.6, 129.8 (d, J = 7.8 Hz), 129.4, 115.0 (d, J = 21.1 Hz), 
113.8, 113.0, 55.2, 52.2, 40.2, 19.8.  
GCMS found 296.2 (calculated for C20H21FO: 296.2). 






This product was prepared following the general hydroboration/oxidation procedure in 0.2 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 35 mg, 56%.  
e.r.: 98:2. d.r.: 15:1. [α]D22 = –19.4 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.13 – 7.08 (m, 2H), 7.05 (d, J = 8.4 Hz, 2H), 7.00 – 6.92 
(t, J = 8.6 Hz, 2H), 6.84 (d, J = 8.4 Hz, 2H), 5.85 (dd, J = 15.3, 7.4 Hz, 1H), 5.28 (dd, J = 
15.3, 8.0 Hz, 1H), 4.61 (d, J = 7.4 Hz, 1H), 3.78 (s, 3H), 3.64 (t, J = 6.6 Hz, 2H), 2.42 – 
2.32 (m, 1H), 1.74 – 1.45 (m, 2H), 1.03 (d, J = 6.7 Hz, 3H). 13C NMR (126 MHz, CDCl3) 
δ 161.3 (d, J = 244.4 Hz), 158.0, 140.0 (d, J = 3.3 Hz), 137.5, 136.0, 131.5, 129.8 (d, J = 
7.9 Hz), 129.3, 115.0 (d, J = 21.2 Hz), 113.8, 61.3, 55.2, 52.2, 39.7, 33.8, 20.9. 
ESIMS found 315.2 (calculated for [C20H24FO2]+: 315.2) 




The substrate was run in 0.4 mmol scale following the general procedure using (Z)-
crotylboronate. The crude mixture after the reaction was purified by flash column 
chromatography with hexanes to afford the pure product as a colorless oil. Yield: 95 mg, 
81%. 
e.r.: 98:2. d.r.: 9:1. [α]D22 = +18.3 (c = 1.0, CHCl3). HPLC Analysis, this compound was 




hydroboration/oxidation procedure, tr major: 30.4 min., tr minor: 33.6 min., 
[Chiralpak®IA column, 24 cm × 4.6 mm I.D., hexanes:i-PrOH = 98:2, 1.0 mL/min, 250 
nm]. 
1H NMR (500 MHz, CDCl3) δ 7.15 – 7.10 (m, 2H), 7.08 (d, J = 8.4 Hz, 2H), 7.01 – 6.94 
(m, 2H), 6.89 – 6.82 (m, 2H), 5.90 – 5.72 (ovrlp, 2H), 5.37 (dd, J = 15.4, 6.8 Hz, 1H), 5.04 
– 4.90 (ovrlp, 2H), 4.64 (d, J = 7.3 Hz, 1H), 3.80 (s, 3H), 2.97 – 2.86 (m, 1H), 1.12 (d, J = 
6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 161.3 (d, J = 244.2 Hz), 158.1, 142.7, 140.1 
(d, J = 3.2 Hz), 136.0, 135.9, 131.6, 129.8 (d, J = 7.8 Hz), 129.4, 115.0 (d, J = 21.1 Hz), 
113.8, 113.0, 55.2, 52.2, 40.2, 19.8. 
GCMS found 296.2 (calculated for C20H21FO: 296.2). 
IR (thin film, cm-1): 3005, 2961, 2930, 2839, 1606, 1509, 1251, 1038.  
 
(3S,6S,E)-6-(4-Fluorophenyl)-6-(4-methoxyphenyl)-3-methylhex-4-en-1-ol (4.58b) 
This product was prepared following the general hydroboration/oxidation procedure in 0.2 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 44 mg, 70%.  
e.r.: 98:2. d.r.: 9:1. [α]D22 = +18.3 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.15 – 7.06 (m, 2H), 7.09 – 7.02 (m, 2H), 7.01 – 6.92 (m, 
2H), 6.87 – 6.80 (m, 2H), 5.85 (dd, J = 15.3, 7.4 Hz, 1H), 5.28 (dd, J = 15.3, 8.1 Hz, 1H), 
4.61 (d, J = 7.4 Hz, 1H), 3.79 (s, 3H), 3.64 (td, J = 6.6, 2.8 Hz, 2H), 2.43 – 2.24 (m, 1H), 




δ 161.3 (d, J = 244.4 Hz), 158.0, 140.0 (d, J = 3.0 Hz), 137.5, 135.9, 131.5, 129.8 (d, J = 
7.8 Hz), 129.3, 115.1 (d, J = 21.3 Hz) 113.8, 61.3, 55.2, 52.2, 39.7, 33.8, 20.9. 
ESIMS found 315.2 (calculated for [C20H24FO2]+: 315.2) 
IR (thin film, cm-1): 3330, 2958, 2929, 2837, 1606, 1508, 1250, 1179, 1038. 
General Procedure for Petasis Crotylations of Non-Branched Enals to Prepare Racemic 
1,4-Dienes 
 
2-Nitro-4-(trifluoromethyl)benzenesulfonohydrazide 4.23 (0.4 mmol), a non-branched 
enal 4.44 (0.4 mmol), and oven-dried 3 Å powdered molecular sieves (200 mg) were added 
to a 10 mL reaction vial equipped with a magnetic stir bar. Dichloromethane (1.0 mL) was 
added to the vial and the reaction mixture was stirred at room temperature for 2 h, at which 
time the reaction mixture was concentrated first by rotary evaporation and then by static 
pressure vacuum (2 – 10 Torr) for 10 min. Racemic BINOL (0.06 mmol, 10 mol%), tert-
butanol (3 equiv, 1.2 mmol) and (E)-crotylboronate 4.40 (1.5 equiv, 0.6 mmol) were added 
and rinsed into the solution with anhydrous toluene (0.2 mL). The reaction was applied to 
sonication for 5 min to facilitate dissolution. The vial was then sealed with a rubber septum 
and attached to a balloon filled with argon. The mixture was allowed to stir at room 
temperature for 48 h, at which time the crude mixture was chromatographed on silica gel 




General Procedure for Petasis Crotylations of Non-Branched Enals to Prepare 
Enantioenriched 1,4-Dienes 
 
2-Nitro-4-(trifluoromethyl)benzenesulfonohydrazide 4.23 (0.4 mmol), a non-branched 
enal 4.44 (0.4 mmol), and oven-dried 3 Å powdered molecular sieves (200 mg) were added 
to a 10 mL reaction vial equipped with a magnetic stir bar. Dichloromethane (1.0 mL) was 
added to the vial and the reaction mixture was stirred at room temperature for 2 h, at which 
time the reaction mixture was concentrated first by rotary evaporation and then by static 
pressure vacuum (2 – 10 Torr) for 10 min. (R)-Ph2-BINOL (0.04 mmol, 7 mol%), tert-
butanol (3 equiv, 1.2 mmol) and (E)-crotylboronate 4.40 (1.5 equiv, 0.6 mmol) were added 
and rinsed into the solution with anhydrous toluene (0.2 mL). The reaction was applied to 
sonication for 5 min to facilitate dissolution. The vial was then sealed with a rubber septum 
and attached to a balloon filled with argon. The mixture was allowed to stir at room 
temperature for 48 h, at which time the crude mixture was chromatographed on silica gel 





Analytical Data for 1,4-Dienes 4.45 
(S,E)-(4-Methylhexa-2,5-dien-1-yl)benzene (4.45a) 
The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 
afford the pure product as a colorless oil. Yield: 59 mg, 85%. 
e.r.: 97:3. [α]D22 = +10.2 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.59a following the hydroboration/oxidation 
procedure, tr major: 22.5 min., tr minor: 24.8 min., [Chiralpak®IA column, 24 cm × 4.6 
mm I.D., hexanes:EtOH = 99.5:0.5, 1.0 mL/min, 210 nm].  
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.24 (m, 2H), 7.24 – 7.14 (ovrlp, 3H), 5.81 (ddd, J 
= 17.1, 10.3, 6.6 Hz, 1H), 5.64 – 5.54 (m, 1H), 5.49 (dd, J = 15.4, 6.6 Hz, 1H), 5.06 – 4.90 
(ovrlp, 2H), 3.36 (d, J = 6.6 Hz, 2H), 2.92 – 2.83 (m, 1H), 1.11 (d, J = 7.0 Hz, 3H). 13C 
NMR (126 MHz, CDCl3) δ 143.0, 140.9, 135.5, 128.5, 128.3, 127.8, 125.9, 112.7, 40.2, 
39.0, 19.9. 
GCMS found 172.1 (calculated for C13H16: 172.1). 




This product was prepared following the general hydroboration/oxidation procedure in 0.3 
mmol scale and the crude mixture was purified by flash column chromatography with 




e.r.: 97:3. [α]D22 = +24.9 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.33 – 7.25 (m, 2H), 7.23 – 7.14 (ovrlp, 3H), 5.59 (dt, J = 
15.0, 6.8 Hz, 1H), 5.41 (dd, J = 15.0, 8.0 Hz, 1H), 3.70 – 3.62 (m, 2H), 3.34 (d, J = 6.8 Hz, 
2H), 2.36 – 2.24 (m, 1H), 1.66 – 1.46 (m, 2H), 1.28 (t, J = 5.4 Hz, 1H), 1.03 (d, J = 6.7 Hz, 
3H). 13C NMR (126 MHz, CDCl3) δ 140.8, 137.3, 128.4, 128.4, 127.8, 125.9, 61.4, 39.8, 
39.0, 33.8, 21.0. 
ESIMS found 191.1 (calculated for [C13H19O]+: 191.1) 
IR (thin film, cm-1): 3339, 3027, 2959, 2926, 1603, 1495, 1453, 1375, 1218, 1056, 972. 
 
(S,E)-1-Fluoro-4-(4-methylhexa-2,5-dien-1-yl)benzene (4.45b) 
The substrate was run in 0.4 mmol scale following the general procedure but at 50 ℃ in 
24 h. The crude mixture after the reaction was purified by flash column chromatography 
with hexanes to afford the pure product as a colorless oil. Yield: 49 mg, 65%. 
e.r.: 97:3. [α]D22 = +9.2 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.59b following the hydroboration/oxidation 
procedure, tr major: 40.3 min., tr minor: 44.2 min., [Chiralpak®AD-H column, 24 cm × 
4.6 mm I.D., hexanes:i-PrOH = 99.6:0.4, 1.0 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.21 – 7.04 (m, 2H), 7.01 – 6.93(m, 2H), 5.81 (ddd, J = 
16.9, 10.3, 7.1 Hz, 1H), 5.59 – 5.51 (m, 1H), 5.47 (dd, J = 15.3, 6.5 Hz, 1H), 5.07 – 4.87 
(ovrlp, 2H), 3.32 (d, J = 6.4 Hz, 2H), 2.95 – 2.72 (m, 1H), 1.11 (d, J = 6.9 Hz, 3H). 13C 
NMR (126 MHz, CDCl3) δ 161.3 (d, J = 243.5 Hz), 142.9, 136.4 (d, J = 3.2 Hz), 135.7, 




GCMS found 190.1 (calculated for C13H15F: 190.1). 
IR (thin film, cm-1): 3080, 2968, 2929, 1605, 1509, 1223, 1157, 972. 
 
(S,E)-6-(4-Fluorophenyl)-3-methylhex-4-en-1-ol (4.59b) 
This product was prepared following the general hydroboration/oxidation procedure in 
0.15 mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 22 mg, 70%.  
e.r.: 97:3. [α]D22 = +25.1 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.15 – 7.08 (m, 2H), 7.01 – 6.92 (m, 2H), 5.55 (dt, J = 14.5, 
6.7 Hz, 1H), 5.38 (dd, J = 14.5, 8.0 Hz, 1H), 3.65 (t, J = 7.2 Hz, 2H), 3.29 (d, J = 6.7 Hz, 
2H), 2.36 – 2.25 (m, 1H), 1.62 – 1.53 (m, 2H), 1.31 (br, 1H), 1.02 (d, J = 6.7 Hz, 3H). 13C 
NMR (126 MHz, CDCl3) δ 161.3 (d, J = 243.5 Hz), 137.4, 136.4 (d, J = 3.2 Hz), 129.7 (d, 
J = 7.8 Hz), 127.7, 115.1 (d, J = 21.2 Hz), 61.3, 39.7, 38.1, 33.7, 21.0. 19F NMR (470 MHz, 
CDCl3) δ –117.7 (ddd, J = 14.3, 9.0, 5.5 Hz). 
ESIMS found 209.1 (calculated for [C13H18FO]+: 209.1) 
IR (thin film, cm-1): 3384, 2960, 2931, 1601, 1509, 1222, 1157, 1058, 974. 
 
(S,E)-1-Methoxy-4-(4-methylhexa-2,5-dien-1-yl)benzene (4.45c) 
The substrate was run in 0.4 mmol scale following the general procedure but at 50 ℃ in 
24 h. The crude mixture after the reaction was purified by flash column chromatography 




e.r.: 98:2. [α]D22 = +5.7 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.59c following the hydroboration/oxidation 
procedure, tr major: 31.8 min., tr minor: 34.5 min., [Chiralpak®IA column, 24 cm × 4.6 
mm I.D., hexanes:EtOH = 99:1, 1.0 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.11 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.5 Hz, 2H), 5.81 (ddd, 
J = 17.0, 10.3, 6.5 Hz, 1H), 5.57 (dt, J = 15.4, 6.6 Hz, 1H), 5.46 (dd, J = 15.4, 6.7 Hz, 1H), 
5.10 – 4.90 (ovrlp, 2H), 3.80 (s, 3H), 3.30 (d, J = 6.6 Hz, 2H), 2.91 – 2.82 (m, 1H), 1.11 
(d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 157.9, 143.0, 135.2, 132.9, 129.4, 
128.2, 113.8, 112.7, 55.2, 40.2, 38.1, 19.9 
GCMS found 202.1 (calculated for C14H18O: 202.1). 
IR (thin film, cm-1): 3081, 2965, 2934, 2906, 2835, 1612, 1512, 1325, 1247, 1177, 1039. 
 
(S,E)-6-(4-Methoxyphenyl)-3-methylhex-4-en-1-ol (4.59c) 
This product was prepared following the general hydroboration/oxidation procedure in 0.3 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 50 mg, 75%.  
e.r.: 98:2. [α]D22 = +17.8 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.11 – 7.03 (m, 2H), 6.83 (d, J = 8.5 Hz, 2H), 5.56 (dt, J = 
15.2, 6.8 Hz, 1H), 5.37 (dd, J = 15.2, 8.0 Hz, 1H), 3.79 (s, 3H), 3.69 – 3.60 (m, 2H), 3.27 
(d, J = 6.8 Hz, 2H), 2.35 – 2.23 (m, 1H), 1.62 – 1.46 (m, 2H), 1.31 – 1.19 (m, 1H), 1.02 (d, 
J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 157.9, 136.9, 132.9, 129.3, 128.2, 113.8, 




ESIMS found 221.1 (calculated for [C14H21O2]+:221.1) 
IR (thin film, cm-1): 3382, 3015, 2929, 1512, 1216, 1039, 755. 
 
(S,E)-1-(4-Methylhexa-2,5-dien-1-yl)-2-nitrobenzene (4.45d) 
The substrate was run in 0.4 mmol scale following the general procedure but at 50 ℃ in 
24 h. The crude mixture after the reaction was purified by flash column chromatography 
with hexanes:EtOAc (50:1) to afford the pure product as a colorless oil. Yield: 69 mg, 79%. 
e.r.: 98:2. [α]D22 = +5.2 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.59d following the hydroboration/oxidation 
procedure, tr minor: 47.0 min., tr major: 57.0 min., [Chiralpak®IA column, 24 cm × 4.6 
mm I.D., hexanes:EtOH = 98:2, 1.0 mL/min, 254 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.88 (d, J = 7.5 Hz, 1H), 7.52 (dd, J = 8.5, 7.5 Hz, 1H), 
7.40 – 7.30 (ovrlp, 2H), 5.77 (ddd, J = 16.9, 10.3, 6.5 Hz, 1H), 5.55 (dt, J = 15.3, 6.2 Hz, 
1H), 5.49 (dd, J = 15.3, 6.5 Hz, 1H), 5.04 – 4.90 (ovrlp, 2H), 3.63 (d, J = 6.2 Hz, 2H), 2.92 
– 2.77 (m, 1H), 1.08 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 149.3, 142.6, 
137.0, 135.6, 132.9, 131.7, 127.1, 125.4, 124.5, 113.0, 40.2, 35.8, 19.7. 
GCMS found 217.1 (calculated for C13H15NO2: 217.1). 







This product was prepared following the general hydroboration/oxidation procedure in 0.3 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 45 mg, 64%.  
e.r.: 98:2. [α]D22 = +18.5 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ  7.90 – 7.83 (m, 1H), 7.56 – 7.46 (m, 1H), 7.38 – 7.33 (ovrlp, 
2H), 5.55 (dtd, J = 15.3, 6.5, 0.9 Hz, 1H), 5.39 (ddt, J = 15.3, 8.1, 1.4 Hz, 1H), 3.74 – 3.45 
(ovrlp, 4H), 2.38 – 2.17 (m, 1H), 1.66 – 1.45 (m, 2H), 1.25 (t, J = 5.1 Hz, 1H), 1.00 (d, J = 
6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 149.4, 138.6, 135.5, 132.9, 131.7, 127.2, 125.3, 
124.6, 61.2, 39.6, 35.8, 33.8, 20.8. 
ESIMS found 236.1 (calculated for [C13H18NO3]+: 236.1) 
IR (thin film, cm-1): 3357, 2960, 2926, 2873, 1610, 1526, 1448, 1352, 1057, 975, 858. 
 
(S,E)-1-Methoxy-2-(4-methylhexa-2,5-dien-1-yl)benzene (4.45e) 
The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with 
hexanes:EtOAc (100:1) to afford the pure product as a colorless oil. Yield: 65 mg, 81%. 
e.r.: 99:1. [α]D22 = +7.9 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.59e following the hydroboration/oxidation 
procedure, tr major: 31.9 min., tr minor: 34.7 min., [Chiralpak®AD-H column, 24 cm × 




1H NMR (500 MHz, CDCl3) δ 7.19 (dd, J = 8.0, 7.6 Hz, 1H), 7.14 (d, J = 7.4 Hz, 1H), 
6.91 (dd, J = 7.6, 7.4 Hz, 1H), 6.86 (d, J = 8.0 Hz, 1H), 5.81 (ddd, J = 16.9, 10.3, 6.5 Hz, 
1H), 5.59 (dt, J = 14.8, 6.7 Hz, 1H), 5.46 (dd, J = 14.8, 6.8 Hz, 1H), 5.04 – 4.90 (ovrlp, 
2H). 3.83 (s, 3H), 3.35 (d, J = 6.7 Hz, 2H), 2.92 – 2.79 (m, 1H), 1.10 (d, J = 6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 157.2, 143.2, 135.1, 129.6, 129.4, 127.2, 127.1, 120.4, 
112.5, 110.3, 55.3, 40.2, 32.9, 19.9. 
GCMS found 202.1 (calculated for C14H18O: 202.1). 
IR (thin film, cm-1): 3076, 2961, 2836, 1601, 1493, 1465, 1244, 1111, 1033. 
 
(S,E)-6-(2-Methoxyphenyl)-3-methylhex-4-en-1-ol (4.59e) 
This product was prepared following the general hydroboration/oxidation procedure in 0.3 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 48 mg, 72%.  
e.r.: 99:1. [α]D22 = +15.6 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.19 (dd, J = 8.0, 7.6 Hz, 1H), 7.12 (d, J = 7.4 Hz, 1H), 6.90 
(dd, J = 7.6, 7.4 Hz, 1H), 6.85 (d, J = 8.0 Hz, 1H), 5.59 (dt, J = 15.8, 6.6 Hz, 1H), 5.36 (dd, 
J = 15.8, 8.2 Hz, 1H), 3.82 (s, 3H), 3.67 – 3.61 (m, 2H), 3.32 (d, J = 6.6 Hz, 2H), 2.33 – 
2.22 (m, 1H), 1.66 – 1.45 (m, 2H), 1.41 (br, 1H), 1.00 (d, J = 6.7 Hz, 3H). 13C NMR (126 
MHz, CDCl3) δ 157.2, 136.8, 129.6, 129.2, 127.3, 127.2, 120.5, 110.3, 61.6, 55.3, 39.9, 
34.4, 33.1, 21.1. 
ESIMS found 221.1 (calculated for [C14H21O2]+: 221.1) 





The substrate was run in 0.4 mmol scale following the general procedure. The crude 
mixture after the reaction was purified by flash column chromatography with hexanes to 
afford the pure product as a colorless oil. Yield: 47 mg, 73%. 
e.r.: 99:1. [α]D22 = +6.4 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.59f following the hydroboration/oxidation 
procedure, tr major: 18.5 min., tr minor: 20.8 min., [Chiralpak®AD-H column, 24 cm × 
4.6 mm I.D., hexanes:EtOH = 99:1, 1.0 mL/min, 210 nm]. 
1H NMR (500 MHz, CDCl3) δ 7.32 (d, J = 1.9 Hz, 1H), 6.29 (dd, J = 3.0, 1.9 Hz, 1H), 
6.00 (d, J = 3.0 Hz, 1H), 5.80 (ddd, J = 17.2, 10.3, 6.5 Hz, 1H), 5.60 – 5.45 (ovrlp, 2H), 
5.08 – 4.92 (ovrlp, 2H), 3.35 (d, J = 4.4 Hz, 2H), 2.97 – 2.79 (m, 1H), 1.11 (d, J = 6.9 Hz, 
3H). 13C NMR (126 MHz, CDCl3) δ 154.7, 142.7, 141.1, 136.5, 124.3, 112.9, 110.2, 105.1, 
40.1, 31.4, 19.7. 
GCMS found 162.1 (calculated for C11H14O: 162.1). 
IR (thin film, cm-1): 3083, 2968, 2930, 1596, 1507, 1456, 1147, 1009, 970. 
 
(S,E)-6-(Furan-2-yl)-3-methylhex-4-en-1-ol (4.59f) 
This product was prepared following the general hydroboration/oxidation procedure in 0.3 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 33 mg, 61%.  




1H NMR (500 MHz, CDCl3) δ  7.33 – 7.29 (m, 1H), 6.28 (dd, J = 3.0, 1.9 Hz, 1H), 5.98 (d, 
J = 3.0 Hz, 1H), 5.55 (dt, J = 15.4, 6.5 Hz, 1H), 5.45 (dd, J = 15.4, 7.9 Hz, 1H), 3.66 (t, J 
= 6.0 Hz, 2H), 3.33 (d, J = 6.5 Hz, 2H), 2.36 – 2.26 (m, 1H), 1.65 – 1.45 (m, 2H), 1.32 (br, 
1H), 1.02 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 154.6, 141.1, 138.3, 124.2, 
110.2, 105.1, 61.3, 39.7, 33.9, 31.4, 20.8. 
ESIMS found 181.1 (calculated for [C11H17O2]+: 181.1) 
IR (thin film, cm-1): 3353, 2956, 2930, 2450, 1507, 1057, 1008, 971. 
 
((S,1E,4E)-6-Methylocta-1,4,7-trien-1-yl)benzene (4.45g) 
The substrate was run in 0.4 mmol scale following the general procedure but with 14 mol% 
catalyst. The crude mixture after the reaction was purified by flash column chromatography 
with hexanes to afford the pure product as a colorless oil. Yield: 43 mg, 54%. 
e.r.: 98:2. [α]D22 = +4.2 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.59g following the hydroboration/oxidation 
procedure, tr major: 30.1 min., tr minor: 33.6 min., [Chiralcel®OD column, 24 cm × 4.6 
mm I.D., hexanes:i-PrOH = 99:1, 1.0 mL/min, 230 nm].  
1H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 8.1 Hz, 2H), 7.30 (dd, J = 7.9, 7.7 Hz, 2H), 
7.24 – 7.17 (m, 1H), 6.40 (d, J = 15.8 Hz, 1H), 6.23 (dt, J = 15.8, 6.0 Hz, 1H), 5.82 (ddd, 
J = 17.1, 10.3, 6.6 Hz, 1H), 5.53 – 5.47 (ovrlp, 2H), 5.02 (d, J = 17.1 Hz, 1H), 4.97 (d, J = 
10.3 Hz, 1H), 2.93 (dd, J = 6.0, 5.4 Hz, 2H), 2.91 – 2.83 (m, 1H), 1.12 (d, J = 6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 143.0, 137.7, 135.4, 130.4, 129.1, 128.5, 126.9, 126.7, 




GCMS found 198.1 (calculated for C15H18: 198.1). 
IR (thin film, cm-1): 3060, 3026, 2966, 2928, 1636, 1495, 1450, 966, 913. 
 
(S,4E,7E)-3-Methyl-8-phenylocta-4,7-dien-1-ol (4.59g) 
This product was prepared following the general hydroboration/oxidation procedure in 0.2 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 32 mg, 75%.  
e.r.: 98:2. [α]D22 = +13.9 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 7.4 Hz, 2H), 7.32 – 7.27 (m, 2H), 7.22 – 7.17 
(m, 1H), 6.38 (d, J = 16.0 Hz, 1H), 6.20 (dt, J = 16.0, 6.6 Hz, 1H), 5.51 (dt, J = 15.3, 6.5 
Hz, 1H), 5.39 (dd, J = 15.3, 7.8 Hz, 1H), 3.71 – 3.63 (m, 2H), 2.90 (dd, J = 6.6, 6.5 Hz, 
2H), 2.38 – 2.23 (m, 1H), 1.65 – 1.53 (m, 2H), 1.25 (br, 1H), 1.02 (d, J = 6.7 Hz, 3H). 13C 
NMR (126 MHz, CDCl3) δ 137.6, 137.2, 130.4, 129.0, 128.5, 126.9, 126.7, 126.0, 61.4, 
39.7, 35.8, 33.9, 21.0. 
ESIMS found 217.2 (calculated for [C15H21O]+: 217.2) 
IR (thin film, cm-1): 3327, 3027, 2928, 1495, 1450, 1056, 969, 755. 
 
(S,E)-(6-methylocta-4,7-dien-1-yl)benzene (4.45h) 
The substrate was run in 0.4 mmol scale following the general procedure but with 14 mol% 
of 3,3’-Br2-BINOL catalyst. The crude mixture after the reaction was purified by flash 
column chromatography with hexanes to afford the pure product as a colorless oil. Yield: 




e.r.: 99:1. [α]D22 = +6.4 (c = 1.0, CHCl3). HPLC Analysis, this compound was converted 
to the corresponding terminal alcohol 4.59h following the hydroboration/oxidation 
procedure, tr major: 30.1 min., tr minor: 33.6 min., [Chiralcel®OD column, 24 cm × 4.6 
mm I.D., hexanes:i-PrOH = 99.6:0.4, 1.0 mL/min, 250 nm].  
1H NMR (500 MHz, CDCl3) δ 7.32 – 7.25 (m, 2H), 7.22 – 7.15 (ovrlp, 3H), 5.81 (ddd, J 
= 16.9, 10.3, 6.5 Hz, 1H), 5.50 – 5.34 (ovrlp, 2H), 5.09 – 4.91 (ovrlp, 2H), 2.88 – 2.79 (m, 
1H), 2.66 – 2.59 (m, 2H), 2.06 (td, J = 7.5, 5.7 Hz, 2H), 1.77 – 1.64 (m, 2H), 1.10 (d, J = 
6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 143.3, 142.6, 134.5, 128.8, 128.4, 128.2, 125.6, 
112.5, 40.3, 35.3, 32.1, 31.2, 20.0. 
GCMS found 200.2 (calculated for C15H20: 200.2). 
IR (thin film, cm-1): 3084, 3027, 2966, 2931, 2858, 1626, 1497, 1454, 970. 
 
(S,E)-3-Methyl-8-phenyloct-4-en-1-ol (4.59h) 
This product was prepared following the general hydroboration/oxidation procedure in 0.2 
mmol scale and the crude mixture was purified by flash column chromatography with 
hexanes:EtOAc (3:1) to afford the pure product as a colorless oil. Yield: 30 mg, 68%.  
e.r.: 99:1. [α]D22 = +18.7 (c = 1.0, CHCl3).  
1H NMR (500 MHz, CDCl3) δ 7.31 – 7.25 (m, 2H), 7.21 – 7.13 (ovrlp, 3H), 5.44 (dt, J = 
15.2, 6.7 Hz, 1H), 5.30 (dd, J = 15.2, 8.0 Hz, 1H), 3.65 (t, J = 6.7 Hz, 2H), 2.64 – 2.57 (m, 
2H), 2.32 – 2.19 (m, 1H), 2.03 (td, J = 6.8, 6.7 Hz, 2H), 1.68 (tt, J = 9.3, 6.8 Hz, 2H), 1.62 
– 1.47 (m, 2H), 1.28 (br, 1H), 1.00 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 




ESIMS found 219.2 (calculated for [C15H22O]+: 219.2) 
IR (thin film, cm-1): 3346, 3027, 2928, 2857, 1496, 1454, 1053, 971. 
Absolute Stereochemistry Determination for 1,4-Dienes 
 
A 10-mL reaction vial equipped with a magnetic stir bar was charged with enantioenriched 
1,4-diene 4.27a (0.3 mmol). MeOH (3 mL), Pd/C (5 mg) were successively added to the 
vial. The reaction mixture was purged by hydrogen gas from a balloon for 10 min, after 
which time the balloon was refilled with hydrogen and the reaction was allowed to stir 
under the H2 atmosphere for 12 h at room temperature. The reaction mixture was filtered 
by a short pad of Celite, and condensed in vacuo. Chromatography on silica gel eluted by 
hexanes afforded the desired reduced product. Yield: 43 mg, 81%.  
[α]D22 = –12.7 (c=1.0, CCl4). In lit:230 [α]D22 = –10 (CCl4).  
All spectra were in agreement with reported data.231 
 
A 10-mL reaction vial equipped with a magnetic stir bar was charged with enantioenriched 
1,4-diene 4.45a (0.3 mmol). EtOH (3 mL), PtO2 (10 mol%) were succesively added to the 
vial. The reaction mixture was purged by hydrogen gas from a balloon for 10 min, after 
which time the balloon was refilled with hydrogen and the reaction was allowed to stir 




a short pad of Celite, and condensed in vacuo. Chromatography on silica gel eluted by 
hexanes afforded the desired reduced product. Yield: 26 mg, 50%.  
[α]D22 = +6.3 (c=1.0, CHCl3). In lit:232 [α]D22 = +3.95 (neat).  
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